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Summary
Nano-sized mesoporous silica particles (MSN) with high colloidal stability attract growing interest
as drug delivery systems for targeted cancer treatment and as bioimaging devices. MSN nanoparti-
cles can feature a well-defined and tunable porosity at the nanometer scale, high loading capacity,
and multiple functionality for targeting and entering different types of cells. In order to examine the
functionality of the particles, highly-sensitive fluorescent live-cell imaging is a powerful method. It
enables the possibility to follow the nanoparticle uptake, intracellular fate and drug release. With
the knowledge gained by means of live-cell imaging experiments improvement on the synthesis side is
possible. This thesis is based on a close collaboration between the groups of T. Bein and C. Bräuchle,
whereas the synthesis part takes place in the group of T. Bein and the (live-cell) imaging in the
group of C. Bräuchle. The biocompatibility (especially the studies in mice) of selected MSN was
investigated in the group of E. Wagner. The goal of this thesis was to study the uptake behavior of
targeted MSN and various controlled (endosomal) release mechanism.
To prevent drug-leakage out of loaded mesopores capping systems were installed. Three possibil-
ities, namely surface coating, internal pore modification and molecular/particle pore gating, were
examined.
First surface coating with the already established supported lipid bilayer (SLB) was investigated.
Here a system published previously in our groups [1] was further improved by attaching targeting
ligands (folic acid or epidermal growth factor) to the supported lipid bilayer (SLB) sourrounded
mesoporous silica nanoparticles and exchanging the on-board photosensitizer to a red-shifted one
with an easier synthesis route. Efficient receptor-mediated cell uptake was demonstrated after 3 h
of incubation, whereas in this time range only a small amount of unspecific uptake seems to take
place. This nanoparticle system was shown to provide spatial and temporal control of cargo release
(in this case calcein and a rhodamine derivative) into the cytosol of cancer cells.
The second surface coating approach was carried out by means of a pH-responsive polymer (poly-
(2-vinylpyridine) (PVP)). Thereby the outcome was a highly stable modular toolbox for targeted
drug delivery, based on the sequential covalent attachment of different functionalities to the surface
of core-shell MSN. In the system presented here, PVP was used as a pH-responsive cap system,
with a shell of poly(ethylene glycol) (PEG) as solubilizing polymer. Additionally, folic acid and a
photosensitizer were attached to the PEG block for cell targeting and endosomal escape, if needed.
Uptake of the folic acid receptor targeted MSN was achieved with a high amount of internalized
MSN after 2 h, especially compared to unspecific uptake. It could be demonstrated in vitro, that
membrane permeable cargos (colchicine, DAPI) can be delivered without further attachment of
endosomal escape mechanisms, whereas for membrane-impermeable cargos (calcein) the photosensi-
tizer was needed as endosomal escape trigger. The designed systems exhibited a very high stability
in bio-fluids at different pH-values. Intravenous administration of the MSN in mice showed good
tolerance in vivo without any associated acute toxicity, and preferred localization in the liver.
Furthermore internal pore modifications were studied as capping systems. Controlled release was
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achieved by covalent linking of cargo with the MSN pore through a disulfide bond, which was cleaved
in a controlled manner. Additionally, a polymer with high buffering capacity (poly(amidoamine)
(PAMAM)) was attached on the particle surface for achieving endosomal escape over the proton
sponge effect. The particles need to get in contact with the cytoplasmic reducing milieu of the
target cells in order to reduce the disulfide bond. Different cargos (propidium iodide, 5(6)-carboxy-
X-rhodamine, colchicine and DAPI) were tested. We were able to show, that the charge of the cargo
molecule has to be considered, as the positively charged polymer forms a barrier for particle loading.
For uncharged molecules the time-dependent release behavior was investigated. The process starts
after approximately 10 h of incubation and it continued over the monitored time of 60 h. With a
control experiment, in which the buffering polymer was omitted, it could be proven that PAMAM
was the reason for endosomal release. Furthermore, the biocompatibility was examined and also
receptor-mediated cellular uptake, provided through attachment of the targeting ligands in a last
synthesis step.
Finally, molecular pore gating was investigated by attaching the enzyme carbonic anhydrase (CA) to
the surface of the MSN. This project was in an additional collaboration with the group of T. Carell.
The particle surface was equipped with an inhibitor for the enzyme, namely silaic acid. The usage
of this system is advantageous because of the following two aspects. First, CA is abundant in the
blood system and hence there would be supply, if a few enzymes got lost. Second the inhibitor-
enzyme binding is pH-responsive. In the neutral regime binding is favored, whereas in the acidic
compartments (e.g. in the endosomes) the inhibitor-enzyme binding breaks up. While the cargo
diffuses inside the pores of the MSN, like in the surface coated examples, the drug is released when
the particle reaches the acidic compartments. For a membrane-permeable cargo (DAPI) efficient
release into the cell could be detected. The localization of the particles after one day of incubation
with early/late endosomes or lysosomes proves the presence of an acidic mileu, as the particles
show exclusive co-localization with acidic compartments (late endosomes, lysosomes). Additionally,
targeting moieties can be attached on chemically modified carbonic anhydrase to achieve targeted
delivery.
The size of the pores used so far is rather small (∼ 2.5-5 nm), therefore newly prepared particles with
pores up to 13 nm were synthesized. Further already established strategies for controlled release were
tested. It was discovered that the coating with a supported lipid bilayer or PVP works as predicted
by our earlier experiments. However, the attachment of the photosensitizer AlPcS2a revealed an
unexpected behavior. After activation of the covalently attached photosensitizer spreading of the
photosensitizer over the whole cell was observed, contrary to experiments conducted in our groups
before with smaller pore size MSN. A first investigation of this behavior revealed no reasonable
explanation. Thus an intense follow-up study might be advisable. Nevertheless we were able to
demonstrate the release of different cargos (calcein, propidium iodide, alexa fluor dextran (10.000 Da)
out of these particles.
It has been further examined whether fusion (as release mechanism) of SLB coated MSN with cells
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can be revealed. To induce fusion two different peptides were applied, namely a reduced form
of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) peptides and
H5WYG (obtained from the fusion-inducing sequence in influenza viruses). The reduced SNARE-
model, established in the group of A. Kros, was investigated in collaboration with the group of
A. Kros. The first challenge, incorporating the peptides into the SLB, was successfully accomplished.
The first steps towards the release of model-drugs into cells were carried out. The overcome of the
final hurdles provides material for further investigations.
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1 Introduction
According to the “Deutsches Krebsforschungszentrum”, cancer is the second most common cause of
death in Germany, only exceeded by deceases of the circulatory system. [2] As cancer is a disease
of the body’s own cells, in other words an abnormal cell growth beyond the usual boundaries, it
is challenging to treat. Since cancer cells are no foreign material in the body, the immune system
does not recognize them as a diseases. The common treatment consists of surgery, radiation, and
chemotherapy, mostly in a combined manner. However these methods seriously affect the health of
the whole body. Moreover, metastasis often can’t be efficiently treated especially with local therapies
like surgery and radiation. Thus the main challenge is to find a drug or drug formation that kills
cancer cells but does not affect any other cell.
Currently, various promising approaches for cancer therapy are investigated, such as immunother-
apy, targeted cancer therapy, angiogenesis inhibition, hypothermia and photodynamic therapy. [3]
Whereby, immunotherapy aims at activating the immune system against the tumor [4], and was
announced to be the “turning point in cancer” by Science this year. [5] Targeted cancer therapy
focuses at blocking signaling pathways and inducing apoptosis by interfering with specific molecules
involved in cancer growth. [6] The formation of new blood vessels, which are needed for supply in
tumor formation are inhibited with angiogenesis inhibitors. [7] Hypothermia can be used in combina-
tion for example with radiation and induces cell-damage and subsequently cell death. [8] Especially
for the upper layers of tissue the photodynamic therapy is promising, where a photosensitizing
agent is used to induce cell-damage after light activation. [9] While clinical trials for immunother-
apy and hypothermia are in progress, some targeted cancer therapies, angiogenesis inhibitors and
photodynamic therapies are already approved for several types of cancer. [3]
The use of individual aspects of nanotechnology is another promising approach in cancer therapy
research, and is also the area of this thesis. With the help of nanotechnology nanodevices can be
created, that provide a broad field of application possibilities for cancer treatment, like gene therapy,
photodynamic therapy, radiotherapy/radiofreequency therapy, drug delivery or cancer theranostics
(combination of diagnosis and therapy). [10] The nanodevices that are generally investigated include
liposomes, nanoparticles, polymeric micells, dendrimers, carbon nanotubes and quantum dots. [10]
Most of the above mentioned nanotechnology derived systems aim to conceal and protect the drug
until it reaches its destination, the cancer, and are intended for an intravenous application. By
means of nanotechnology the properties of cancer therapeutics could be altered in order to increase
the solubility, decrease the degradation during the blood circulation and concentrate the drug at the
desired site of action. [11] There are several requirements such particles have to fulfill. First, they
should be nontoxic, also in its degradation products. Second the size is important. Particles that are
below 5-6 nm will get excreted very quickly by means of the renal filtration [12] whereas big particles,
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≥ 200 nm, are more likely to be taken up by the reticuloendothelial system (RES). [13] Further,
the particle should have a decent clearing mechanism after fulfilling its work (long clearance time
preferred) and should be colloidally stable in physiological conditions. [11] Last but not least, the
particles should be able to encapsulate the drug, provide a controlled release of the therapeutic agent
and preferentially can be targeted to the cells or tissue of interest. [11] Especially these requirements
are investigated in this work. The focus lies on mesoporous silica nanoparticles (MSN) with several
different modifications as possible new systems in drug delivery for cancer therapy.
An overview over the MSN systems, that have been studied in recent years in cooperation between
the groups of Prof. Bein and Prof. Bräuchle, will be provided. The thesis is organized in the
following way. After this short introduction (chapter 1) the theoretical background and the state
in the art of the research field of drug delivery with MSN (chapter 2, 3) are presented. The chapters
were published in Chemistry of Materials. [14] These chapters on the background of the work are
followed by the theory on fluorescence microscopy, imaging posibilities for MSN (chapter 4) and
the experimental methods used in this work (chapter 5).
In chapter 6 a surface coated MSN system is described. The MSN are coated with a supported
lipid bilayer, targeting moieties are attached, and their release behavior due to a covalently linked
photosensitizer was investigated. With the help of in vial and various in vitro (which include
experiments in living cells) experiments the functionality of the system was proven. The focus was
to investigate a system that could be used as a platform, as loading and targeting ligands can be
easily varied. The results presented in this chapter are published in Nano Letters. [15]
Chapter 7 describes a MSN-system with a pH-dependent polymer cap. This is another surface
coated system that this time is investigated in vial, in vitro (including live-cell-experiments) and in
vivo (animal experiments, here especially mice). Here the focus is laid on the pH-dependent release
behavior of the particles inside living cells as well as the bio-compatibility and targeting strategies.
The main part of the presented results are part of a submitted manuscript.
Chapter 8 discusses the possibility of internal pore modification (drug immobilization with the
help of disulfid-bridges) combined with a dendrimeric surface coating. The dendrimer-coating is
believed to provide another strategy beside photoactivation to rupture the endosomal membrane
and provides an endosomal escape strategy. Another aspect is the toxicity of the particles and the
ability to functionalize them with targeting-ligands.
In chapter 9 the molecular/particle pore gating approach is examined. In this case carbonic
anhydrase (CA) was used. It was attach to the MSN by modifying their particle surface with silaic
acid, which functions as CA-inhibitor in an neutral pH-regime. As silaic acid is provided at the
outer particle surface the binding enzyme blocks the pore entrances until the system reaches acidic
compartments and the reversible binding is cleaved. The release behavior after uptake into cells is
investigated, as well as the attachment of a targeting ligand to the chemically modified enzyme.
Parts of the last two chapters are in preparation for publication.
The last chapter (chapter 10) provides insight into other MSN-modifications. First the improve-
ments and difficulties in increasing the pore size are discussed. Afterwards, experiments with fusion
inducing peptides, namely SNARE-peptides and fusion peptide H5WYG, are depicted.
2
2 Drug delivery with mesoporous silica
nanoparticles
This chapter is adapted from the publication “Multifunctional Mesoporous Silica Nanoparticles as a
Universal Platform for Drug Delivery”, published in Chemistry of Materials, written in collaboration
with C. Argyo from the group of T. Bein. [14]
Multifunctional mesoporous silica nanoparticles (MSNs, size typically < 500 nm) have attracted
substantial attention in recent years due to their advantageous structural properties, such as a high
internal surface area and pore volume, tunable pore sizes, colloidal stability, and the possibility to
specifically functionalize the inner pore system and/or the external particle surface. These highly
attractive features make MSNs a promising and widely applicable platform for diverse biomedical
applications including bioimaging for diagnostics [16, 17], biosensing [18, 19], biocatalysis [20–22],
bone repair and scaffold engineering [23–25], and drug delivery. [26–28] Caruso and co-workers
established another interesting approach using mesoporous silica particles as templates to create
submicrometer-sized polymer capsules for drug delivery used in cancer therapy. [29–31]
Periodically ordered mesoporous silica, created by combining surfactant micellar aggregates with
reactive silica precursors, was discovered about 20 years ago by researchers at Mobil. [32, 33] In
particular, inorganic-organic (hybrid) core-shell nanoparticles based on mesoporous silica have re-
ceived great attention as drug delivery vehicles, where the decoration of the inner or outer surface
of the particles with organic molecules can impart important features for successful drug delivery.
MSNs have first been proposed around 2001 as nanocarriers for transporting therapeutics. [34] In-
spired by this simple concept (at that time still lacking control over cargo uptake or release), many
efforts were made in recent years to create multifunctional stimuli-responsive nanocarrier systems
consisting of MSNs as host materials. [35] This is based on the excellent material properties of MSNs
such as good biocompatibility, high loading capacity, and efficient encapsulation of cargo molecules
in their mesopores. Additional benefits include the possibility to design stimuli-responsive mecha-
nisms with spatiotemporal control of release of the cargo, and the efficient attachment of organic
surface functionalities including hydrophilic polymers, gate keepers, and targeting ligands, respec-
tively. [15, 36–41]
The delivery of anticancer therapeutics into cancer cells by employing nanoparticle carriers has made
significant progress in recent years. Here, the intention is to overcome common issues of conventional
systemic drug supply such as poor solubility, limited stability, rapid metabolization and excretion
of the drug, undesired side effects, and the lack of selectivity toward specific cells types. [42–44] The
encapsulation of therapeutics within nanocarriers that selectively target certain cell types or tissues
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represents a promising strategy to address these problems.
Figure 2.1: Schematic illustration of a multifunctional mesoporous silica nanoparticle (MSN) containing
the necessary features for a stimuli-responsive controlled release of the loaded cargo into the cytosol of a
targeted cell (SPION: superparamagnetic iron oxide nanoparticle, QD: quantum dot, PEG: poly(ethylene
glycol), Au-NP: gold nanoparticle, RGD: Arg-Gly-Asp amino acid sequence, EGF: epidermial growth factor,
PEI: poly(ethylene imine), H5WYG: endosomolytic peptide).
MSNs can be designed as a multifunctional platform for different stimuli-responsive trigger systems
for a specific drug release. Moreover, different strategies for achieving controlled endosomal escape
are discussed. Coating the nanoparticles with different organic shells improves biocompatibility,
facilitates attachment of targeting ligands for specific cellular recognition, and can be utilized for
the effective encapsulation of cancer therapeutics. Investigation of in vitro behavior of colloidal
particles, often fluorescently marked to track the particles in cells, with live-cell imaging serves to
evaluate targeting specificity and efficient delivery. The implementation of the above strategies and
features into one multifunctional drug delivery vehicle provides a promising basis for wide-ranging
applications in cancer therapy and diagnosis. These key prerequisites for efficient drug delivery
nanocarriers based on MSNs are schematically presented in Figure 2.1. They will be discussed in
more detail in the following sections.
2.1 Targeting and cellular uptake
Targeting. Insufficient target selectivity of drugs can cause unfavorable side effects and reduce
therapeutic efficacy. Especially in anticancer chemotherapy, limited selectivity of cytostatins and
cytotoxins toward tumor cells is responsible for many undesired side effects. The efficacy of the
treatment can be affected when nonspecific toxicity to normal cells prevents an effective dose that
is necessary to eradicate malignant cells. [45, 46] Extensive studies showed passive targeting of
nanocarriers in tumor tissue. [47, 48] Well-stabilized nanoparticles with optimal size and appropri-
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ate antifouling surface can remain in blood vessels long enough to accumulate at the tumor site.
Passive targeting relies on the enhanced permeability and retention (EPR) effect. This effect is
described as the tendency of particles of certain sizes, such as liposomes, nanoparticles, and macro-
molecular drugs, to preferentially accumulate in tumor tissue. Tumor vasculature typically exhibits
an increased permeability and is lacking effective lymphatic drainage. [49] Enhanced passive bioac-
cumulation via the EPR effect could be achieved by neutralizing the MSN surface with positively
charged groups. [50] However, the EPR effect is not universal for all types of tumor cells, and a lack
of cell-specific interactions might decrease therapeutic efficacy and induce multiple drug resistance
(MDR). [49, 51, 52]
Figure 2.2: Schematic representation of different stages of a targeted cellular uptake of a multifunctional
MSN and controlled release of the cargo into the cytoplasm of cancer cells. (1) Active docking to cell
surface receptor of a nanocarrier via targeting ligands; (2) Process of ligand/receptor-mediated endocytosis;
(3) MSN entrapped in endosome; (4) Intracellular transport and acidification of endosome; (5) Triggered
endosomal escape of nanocarrier, thus obtaining access to the cytoplasm; (6) Controlled delivery of the
cargo inside the cell.
In contrast, employing targeting ligands such as folic acid or macromolecules, like the epidermal
growth factor (EGF), in order to exploit the overexpression of certain receptors on tumor cell
surfaces can promote specific and active nanocarrier binding and cellular uptake. Active targeting
can be accomplished by covalent attachment of targeting molecules (ligands) to the particle surface.
The main challenge for targeted nanocarriers is to achieve high targeting specificity and drug delivery
efficiency simultaneously, while avoiding nonspecific binding and activation of immunogenic effects.
A recent advance has been reported by Brinker and co-workers, who combined a porous, inorganic
MCM-41-type silica core coated with a supported lipid bilayer to prevent cargo leakage by means
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of a short targeting peptide (SP94). [51] This small peptide was identified by phage display to
bind efficiently to hepatocellular carcinoma cells. The complementary receptor is still unknown.
In this study, a ligand recruitment procedure was described leading to efficient receptor-mediated
endocytosis of the nanocarriers.
Table 2.1: Diverse Targeting Ligands Used for Active and Specific Cell Recognition of Nanocarrier Based
on MSNs.
targeting ligand cell membrane receptor targeted cell line ref.
Folic Acid (FA) folate receptor (FR-α) HeLa, KB [15, 53–62]
RGDmotiv integrins HeLa, MCF-7,U87-MG,
HZ29, SCC-7
[63–66]
antibody ME1 mesothelin MM [67]
antibody ab2428 ErbB 2 MCF-7 [68]
antibody Herceptin HER2/neu BT-474 [69]
aptamer AS 1411 nucleolin MCF-7, MDA-MB-231 [70]
mannose mannose receptor MDA-MB-231 [71]
galactose galactose receptor HCT-116, Capan-1,
MDA-MB-231
[72]
hualuronic acid CD44 (RHAMM, CD168,
HARE)
MDA-MB-231 [73]
anisamide Sigma-receptor ASPC-1 [74]
EGF EGF-R HuH-7 [15]
SP94 unknown Hep3B [51]
FA, TEM-7, CD31 FR-α, TEM-7 antibody, CD31
antibody
MCF-7,HUVEC [75]
The small molecule folic acid (FA) has been widely investigated as targeting ligand and causes a
notable enhancement in uptake efficiency of MSN nanocarriers when attached to them (for Refer-
ences, see Table 2.1). Often, long spacers, e.g., PEG chains, are used for the covalent attachment
of the targeting ligands to the external surface of the MSNs. This linkage provides high flexibility
to obtain efficient binding of the targeting ligands to the cell membrane receptors. Ligands such as
FA, mannose, hyaluronic acid, and EGF (among others) used as targeting devices are abundantly
present in organisms. Moreover, the associated receptors are widely present on many eukaryotic
cells. This implies concerns about the achievable targeting specificity. In those cases, the significant
overexpression of receptors on cancer cells has been exploited. Extensive efforts have been made to
create actively targeted nanocarrier vehicles using ligands for specific recognition of the cell-surface
receptors as well as antibodies and DNA aptamers. Important examples are summarized in Table
2.1. Studies on antibodies attached to the nanoparticle surface via either electrostatic interactions
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or covalent linkage showed highly specific binding with high affinity to antigens overexpressed on
different cancer cell lines. [67, 68] MSN bioconjugates with DNA-aptamers were also investigated
and showed specific binding to nucleolin, a cell membrane protein overexpressed on breast cancer
cells. [70] However, concerns may arise about the stability of these systems in body fluids due to
potential degradation of the targeting ligands by extracellular nucleases or proteases, which may
reduce targeting efficiency of antibody- and aptamer-aided delivery concepts.
Endocytosis. In general MSNs are internalized into the cells via endocytosis. [27] For illustration, a
typical sequence of cytosolic delivery of therapeutics to cancer cells with mesoporous silica nanocar-
riers is depicted in Figure 2.2. The endocytic pathway is the most common uptake mechanism of
cells for many different nanoparticles and macromolecules. Endocytosis is a very complex process
by which cells absorb such particles by engulfing them with lipid bilayer forming vesicles. For this
purpose, a part of the cell membrane is used for creating an endosome. [76] Size and morphology of
the silica nanoparticles and functional groups on the external particle surface influence the ability of
MSNs to be internalized via endocytosis. [77–82] Utilizing such modifications of the MSNs can aid in
specific cellular uptake in a precisely controlled manner. In a study of Slowing et al., [83] endocytosis
of aminopropyl-functionalized MSNs was shown to be affected by caveolar inhibition suggesting a
cellular uptake via a caveolae-mediated mechanism. However it can be imagined that also other
cellular uptake mechanism, like the clathrin dependent endocytosis [84], play an important role in
cellular MSN uptake. Endocytosis of MSNs can be investigated via flow cytometry, transmission
electron microscopy, confocal microscopy, and other techniques. [85]
2.2 Endosomal escape
Recent studies have demonstrated that MSNs are able to undergo smooth cell internalization, but
endosomal escape has been identified as a bottleneck for the efficient delivery of macromolecular
substances or nanoparticles. [86] The entrapment in the endosomes could lead to degradation of the
nanocarriers and their cargo molecules by specific digestive enzymes when fusion with a lysosome
occurs. Thus, an important step in achieving an appropriate therapeutic effect is to facilitate the
endosomal escape and to ensure cytosolic delivery of the therapeutics.
Many anticancer therapeutics such as doxorubicin (DOX) feature cell membrane permeability, and
consequently, a trigger for endosomal escape is not required. These permeable drugs only require
a means of preventing premature release from the nanocarrier to avoid global distribution in the
organism and targeted transport into cancer tissue to achieve a sufficiently high local drug con-
centration. Nevertheless, a large number of molecular and macromolecular therapeutics are either
hydrophobic or membrane impermeable. Therefore, the multifunctional nanocarrier vehicles should
provide an efficient endosomal escape mechanism for the local delivery of the drug molecules into
the cytoplasm, thus gaining access to the targeted cell compartments or to the nucleus.
Excellent strategies for achieving endosomal escape are provided by nature. Evolution created
bacteria and viruses, which are able to penetrate membranes via different mechanisms to escape
the endosomal pathway and to reach their target sites. Thus, it would be desirable to transfer
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these very efficient natural mechanisms to the drug delivery vehicles. Different mechanisms such
as pore formation in the endosomal membrane, pH-buffering effects of protonable groups (“proton
sponge”), or fusion into the lipid bilayer of endosomes have been proposed to facilitate the endosomal
escape. [87]
In addition, photochemical methods to rupture the endosomal membrane have been introduced to
MSNs. [1, 15, 86] In a study by Sauer et al., [86] MSNs were taken up into cells and transported
within endosomes, but no release of the cargo into the cytoplasm could be detected during incuba-
tion. In order to overcome the barrier of endosomal entrapment, photoinduced endosomal release
via excitation of a photosensitizer (PS) was employed. Photochemical internalization (PCI) using
PS that generate reactive oxygen species upon photoactivation is a powerful tool to overcome trap-
ping by the endosomal membrane. [88] Initial approaches of combining PS with mesoporous silica
as a drug carrier did not provide a covalent bond of the PS to the particles. This could lead to
uncontrolled spreading of the compounds and toxic effects on the cells. To achieve a more spatially
controlled activity of nanodevices operating with PS, it is desirable to bind the PS directly to the
surface of the mesoporous particles. Thus, a mesoporous core-shell system with covalently surface-
linked PS was designed that provides an on-board trigger for light-activated endosomal membrane
rupture. [1] The nanocarriers can be loaded with model drugs in a broad size-range and are encap-
sulated by a SLB. The controlled release mechanism in living cells operates in a two-step cascaded
manner, where the SLB is disintegrated by singlet oxygen in a first step and, second, the endosomal
membrane is ruptured causing efficient cytosolic drug release. This nanodevice for drug delivery is
capable of stimuli-responsive and localized endosomal escape and drug release without the systemic
cell toxicity exhibited by common (dissolved) PS. In order to create a general photoactivatable
drug delivery platform being applicable in biological environments, such as cancer tissue, further
improvements have to be accomplished. Strategies for red-light activation have already been investi-
gated. [15, 72] The activation of the photosensitizer with low energy light reduces the phototoxicity
and significantly increases the depth of tissue penetration, which will be crucial when activation in
vivo is required.
Another promising endosomal release strategy is based on the proton sponge effect, in which osmotic
swelling and membrane rupture of endosomes is initiated by macromolecules with high buffering
capacities. [89] This mechanism does not require an external stimulus, and custom-made nanocarriers
can activate an “automatic” pathway for endosomal escape. Several cationic lipids and polymers,
such as poly(ethylene imine) (PEI), possess substantial buffering capacity below the physiological
pH which is a potential trigger to escape the endosomal entrapment. [91, 92] The cationic polymers
or particles enter the cell via endocytosis, subsequently being entrapped in the endosome. Upon
intracellular trafficking to late endosomes or lysosomes, the compartment is acidified from an initial
physiological pH value of 7.4 to around 5 (see also Figure 2.3). [90] Thus, the overall protonation
level for PEI increases drastically. [93] The accumulation of positive charge inside the endosome is
coupled with a passive influx of chloride anions through ion channels to maintain electroneutrality.
The large increase of ion concentration within the endosome in turn results in an inflow of water
molecules, which causes osmotic swelling and subsequent membrane rupture. Employment of the
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Figure 2.3: Schematic illustration of the acidification process inside cells after endocytosis. After reaching
the cell, particles are uptaken via endocytosis and passed on, from early endosomes with a pH around 7.4
to late endosomes, and finally lysosomes with a pH around 5. [90]
proton sponge effect would provide an elegant solution for the problem of endosomal entrapment of
MSNs. However, the exact mechanism is not fully understood. It is still an open question whether
there has to be a high-capacity buffering agent present that is subsequently protonated and highly
charged or if an already highly charged surface of particles is also sufficient to cause counterion
influx, endosome swelling, and rupture. Lin and co-workers reported on MSNs with negatively
charged surface functionalization achieving endosomal escape via the proton sponge effect. [83]
More negatively charged nanoparticles would escape more easily from endosomes of cancer cells
owing to their high buffering capacity. The zeta potential of the silica nanoparticles seems to have a
great impact on the ability of particles to escape the endolysosomal pathway. However, such highly
negatively charged nanoparticles exhibit unfavorable cellular uptake behavior due to electrostatic
repulsion with the negatively charged cell membrane. Nanocarriers providing protonable groups at
mildly acidic conditions should result in much more efficient cellular uptake and subsequent drug
release to the cytosol. In general, the proton sponge effect is a promising intrinsic endosomal escape
pathway that should be further investigated.
An alternative mechanism uses endosomolytic peptides to achieve endosomal release. [94] The lipid
bilayer-enclosed MSNs established by Brinker and co-workers were equipped with such an endoso-
molytic peptide (H5WYG) (Figure 2.4). [95] This peptide sequence is a subunit of the glycoprotein
hemagglutinin of the influenza virus A and undergoes a conformational change upon protonation.
H5WYG peptides were often employed in combination with nanocarriers, but experimental evi-
dence for the exact molecular mechanism was not provided so far. [96–98] It is speculated, that
different endosomal escape pathways take place, such as the proton sponge effect (protonation of
the histidin residues of the peptide) or fusion of the endosomal membrane with the SLB. Further
investigations are needed to evaluate the exact mechanism, which could lead to the full exploitation
of this endosomal escape pathway. In general, endosomal entrapment was found to be a bottleneck
in efficient cytosolic delivery of nonpermeable drug molecules and additional efforts have to be made
9
2 Drug delivery with mesoporous silica nanoparticles
Figure 2.4: “Protocell” consisting of MSN-supported lipid bilayers with targeting peptides (SP94) and
endosomolytic peptides (H5WYG) attached to the outer periphery of the nanoconstructs. [99]
to overcome this entrapment. A complete understanding of the diverse escape mechanisms is highly
desirable.
2.3 Controlled release of cargo
Extensive in vitro studies have been performed to gain insights regarding the feasibility of employing
MSNs as drug nanocarriers. Cargo release in a controlled manner is highly desirable, since side effects
can be drastically reduced by locating delivery to single cells or target tissue and since the optimal
amount of drug can be liberated.
As discussed above, MSNs serving as drug delivery vehicles can be functionalized on the external
particle surface with stimuli-responsive molecules, nanoparticles, polymers, and proteins acting as
caps and gatekeepers for such a controlled release of various cargos. Delivery of antitumor drugs and
other pharmaceutical cargos such as enzymes or oligonucleotides requires effective protection from
undesired degradation in harsh environments, such as the stomach and intestines. On the other
hand, when injected into the bloodstream, such a drug delivery device should offer perfect enclosure
of the cargo to prevent undesired premature release and systemic distribution before reaching the
targeted tissue or cells. The most common pore sealing strategies can be classified into three different
types of gatekeepers, i.e. molecular/particle pore gating, coating of the external particle surface,
and internal pore binding. Reported in vial and in vitro studies and the diverse opening mechanisms
based on external or internal stimuli are presented in Tables 2.3.1 and 2.3.2, respectively.
2.3.1 External Stimuli
A broad spectrum of triggers for specific cargo release has been described. Triggers such as light,
external magnetic fields and temperature require activation of the release mechanism from the
outside. [101, 113, 116] These systems provide perfect control over temporal and spatial release of the
drugs into the targeted tissue or cells, but tissue penetration in in vivo studies can limit performance.
Temperature changes have also been investigated to release encapsulated molecules. [116, 119]
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Table 2.2: Controlled Cargo Release Mechanisms Triggered by External Stimuli.
external gating system opening mechanism cargo release ref.
stimulus experiments
UV-vis light
(λ = 240-639
nm)
Molecular Pore Gating
thymidine dimers cleavage dye in vial [100]
cylcodextrin (CD) dethreading dye in vial [101]
cucurbit[6]uril photothermal dethreading dye in vial [102]
nitroveratryl cleavage anticancer drug in vial [103]
carbamate
Coating
polymer shell photolysis, dye in vial [104, 105]
dethreading in vitro
SLB photolysis dye, in vitro [1, 15, 106]
therapeutic in vitro
Internal Pore Modification
coordinative bonds cleavage dye in vial [107]
IR-light
(λ = 808 nm)
Coating
aptamer DNA shell photothermal in vitro [108]
dehybridization in vitro [108]
Pore Modification
coordinative bonds photothermal cleavage anticancer drug in vitro [109]
Magnetic field
+ absorber
Molecular/Particle Pore Gating
DNA thermal cleavage dye in vial [110]
SPIONs heat-shock induced cleavage dye in vitro [111]
of disulfide linker
Au-NPs cleavage of dye in vial [112]
boroester linker
Coating
PEI/NIPAM thermal phase transition dye, enzyme in vial [113]
Temperature
Molecular/Particle Pore Gating
biotin-avidin cleavage of DNA linker dye in vial [114]
Au-NPs cleavage of DNA linker dye in vial [115]
Coating
paraffin melting dye, in vitro [116]
anticancer drug
polymer phase transition dye, antibiotic, in vial [117–119]
anticancer drug in vial
in vitro
Molecules
Molecular Pore Gating
DNA competitive displacement dye in vial [120–122]
in vitro
glycoprotein cleavage of dye, in vitro [123]
boroester linker antifungal drug in vitro
18-crown-6 competitive anti-inflammatory in vial [124]
displacement drug in vial
SLB lysis dye, colchicine in vitro [39]
Light can also be used to activate various opening mechanisms. [100, 102] Recently, Bein, Bräuchle
and co-workers could demonstrate an improved system consisting of MSNs coated with an SLB and
equipped with a covalently attached PS. [15] The SLB was shown to seal the pores and to prevent
premature release of the loaded cargo. Upon photoactivation of the PS with red light, generation
of reactive oxygen species initiated cargo release due to rupture of the SLB. Photosensitizers are
promising components of nanocarrier systems for efficient drug delivery because they can simulta-
neously serve as a means for endosomal escape and for triggering controlled release in combination
with SLB-coated MSNs.
2.3.2 Internal stimuli
In contrast to external stimuli, internal stimuli like changes in pH, enzymatic reactions, and reducing
agents can provide intrinsic and autonomous release of the loaded cargo molecules from the meso-
porous host system. Many mechanisms for controlled closure and release have been developed in
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Table 2.3: Controlled Cargo Release Mechanisms Triggered by Internal Stimuli.
internal gating system opening mechanism cargo release ref.
stimulus experiments
pH (acidic)
Molecular/Particle Pore Gating
SPIONs cleavage of anti-inflammatory in vitro [125]
boroester linker drug
Au-NPs cleavage of dye in vial [112, 126]
boroester linker
CD dethreading dye, in vial, [127–130]
anticancer drug in vitro
[2]pseudorotaxane dethreading dye in vial [131]
curcubit[6]uril dethreading dye in vial [132, 133]
Coating
saccharides cleavage of in vial [134]
boroester linker
layered double dissolution dye in vial [135]
hydroxides (LDH)
polymer phase transition anticancer drug, in vial, [95, 117, 136]
insulin, dye in vitro [103, 137–140]
coordination polymer cleavage anticancer drug in vitro [141]
chitosan phase transition anti-inflammatory drug, in vial, [68, 142, 143]
anticancer drug in vitro
Internal Pore Modification
coordinative bonds cleavage anticancer drug in vial, [109, 144]
in vitro
acetal linkage cleavage peptide in vitro [145]
electrostatic interactions cleavage anticancer drug in vitro [146]
template extraction anticancer drug in vitro, [147]
in vivo
hydrazone linkage cleavage anti-inflammatory drug in vitro [148]
pH (basic)
Molecular Pore Gating
β-lactoglobulin phase transition dye, anti- in vial [149]
inflammatory drug
lysozyme detaching dye in vitro [150]
sulfophenyl isothiocyanate cleavage anti-inflammatory drug in vial [41]
enzymes
Molecular Pore Gating
azopyridine derivatives cleavage dye, anticancer drug in vitro [151]
cucurbit[7]uril competitive displacement dye in vial [152]
[2]pseudorotaxane cleavage of ester linker dye in vial [153]
biotin-avidin enzymatic digestion dye in vial [40]
Coating
hyaluronic acid cleavage dye, anticancer drug in vitro [73]
ethylene glycol ester cleavage dye, anticancer drug in vitro [154]
peptides cleavage dye in vial [155]
starch derivatives enzymatic digestion dye, anticancer drug in vitro [156]
lactose derivatives enzymatic digestion dye in vial [157]
reducing
agent
Molecular Pore Gating
CD cleavage of dye in vial [130]
disulfide linker
ssDNA cleavage of anticancer drug, in vitro [158]
disulfide linker ssDNA
Coating
collagen cleavage of dye, ssDNA in vial [159]
disulfide linker
polymer cleavage of dye in vial, [105, 140, 160]
disulfide linker in vitro
Internal Pore Modification
disulfide linkage cleavage enzyme, cysteine in vial, [86, 161]
in vitro
molecules
Molecular Pore Gating
ATP aptamer competitive dye in vial, [162–164]
displacement in vitro
insulin derivatives competitive insulin, cAMP in vial [165]
displacement
Au-NPs dehybridization dye in vial [166]
of DNA linker
Coating
enzyme multilayers phase transition insulin in vial [167]
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recent years, often with a view on utilizing such biologically relevant changes in the cell environment
encountered by the particles upon endocytosis.
Thus, pH changes have been used to open gates at the pores of the mesoporous nanoparticles, and
changes in redox potential could be used to cleave disulfide bridges. pH-responsive nanocarriers have
been designed to achieve a site-selective controlled release, because tumor and inflammatory tissues
are more acidic than normal tissue and blood. Importantly, the acidification of endosomes inside
targeted cells can be utilized to trigger pH-responsive intracellular release of the cargo molecules. [68,
141, 148] Zink and co-workers have described a pH-responsive dethreading of bulky β-cycodextrin
molecules upon protonation of a complementary stalk located at the pore entrances and the resulting
efficient DOX release in vitro.
In the context of oral administration, nanocarrier systems have been designed with acid-stable
gatekeepers to be able to pass the stomach without premature release. After passing the acidic
environment, pH-responsive caps can be cleaved in the basic milieu of the intestines to efficiently
release the loaded pharmaceuticals. [41, 149, 150] Enzyme-responsive controlled release can be highly
efficient once the nanocarriers have entered the cancer tissue or the cytosol of targeted cells. Many
intracellular and extracellular enzymes are overexpressed in cancer tissue and exhibit increased
activity, resulting in preferential cargo release at those locations. [151, 155] Summarizing, molecular
and particle-based pore gating or coatings, removable by either intracellular or external triggers,
can provide exquisite control over the location and time of cargo release during drug delivery.
2.4 Biological and pharmaceutical relevance
On-demand cargo release from the mesopores of silica nanoparticles has been proven to be feasible.
To understand the biological and pharmaceutical activity of the MSN drug delivery systems in
vitro and in vivo, it is useful to investigate the response of cells, such as knock-down of certain
genes, stimuli-responsive labeling of cell compartments, destruction of the microtubule network,
or apoptosis of cancer cells. [1, 39, 168, 169] Depending on the charge of the cargo, the surface
of the nanocarriers has to be tuned and the release systems need to be adjusted to the scope of
the application. Diverse model systems have been developed to learn more about the complex
processes during cellular uptake of MSNs and subsequent drug release. The focus of this work is
not on discussing the challenges of preclinical studies but to provide information about the mode of
operation of multifunctional MSNs in the biological environment. For instance, attaching fluorescent
dyes to the MSNs provides the possibility to directly observe the behavior of the nanocarriers and
the cells. Common dyes include rhodamine or fluorescein derivatives, as well as ATTO or ALEXA
dyes. [59, 80, 86, 170] Fluorescent cargo and/or labeling of cell compartments also aids in the
examination of the intracellular processes.
Drug loading of small anticancer therapeutics can be achieved by simple immersion of the particles
into a concentrated solution of the desired drug, followed by sealing with the gating mechanism un-
der study. Efficient loading was shown by Bein, Bräuchle and co-workers upon adsorbing colchicine,
propidium iodide, phalloidin, chromobodies, calcein, or a rhodamine derivative into MSNs, which
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were subsequently sealed by an SLB. [1, 15, 39] Doxorubicin (DOX) is a commonly used anticancer
therapeutic due to its efficient induction of apoptosis in cancer cells, and it is fluorescent, thus
enabling direct microscopic observation. [171] Several DOX-containing systems have been investi-
gated, ranging from Fe3O4@mSiO2 nanocapsules [172] to hollow MSNs, [173–175] to mesoporous
silica-coated gold nanorods, [108] and to MSNs including targeting functionalities like aptamers. [70]
Imaging the release of various cargos from MSN with different capping and release systems was
a main goal of this work. In vitro methods can verify the encapsulation of a large amount of
Figure 2.5: Knockdown of GFP genes with siRNA-loaded, PEGylated (P), and carboxy-
tetramethylrhodamine-labeled (T) MSN with a pore diameter of 23 nm (P-T-MSN23) in vivo. In vivo
optical images before (a) and after (b, top) removal of tumors and quantitative analysis of GFP-expressing
tumors (b, bottom). (c) Optical microscopic images of a tissue section after 4’,6-diamidino-2-phenylindole
(DAPI) staining show considerable reduction in GFP expression in the siGFP-P-T-MSN23-treated tumor,
compared with tissue treated with P-T-MSN23. [169]
drug molecules in MSN carriers, which increases their efficiency. This was proven in a study of
Tian and co-workers. [168] They demonstrated a significant increase of early and late apoptosis
of paclitaxel-loaded MSNs on MCF-7 cells compared to free drug molecules. Gene transfection or
oligonucleotide delivery with MSNs has not been studied to a large extent yet, and in most reported
cases, the oligonucleotides are only adsorbed on the external surface of the MSNs or incorporated in
a polymer shell of coated MSNs. [176] Milligan and co-workers used so-called “protocells” for GFP
and IL-10 gene delivery in vitro and in vivo, but no proof of gene adsorption inside the pores was
provided. [176, 177] Tamanoi and co-workers attached siRNA to the external surface of coated MSNs
with the aid of PEI and observed gene silencing of EGFP. [178] Attachment of the oligonucleotides
exclusively on the external particle surface could cause concerns about premature degradation via
abundantly available ribonucleases. Therefore, controlled loading of siRNA into large pores of MSNs
is a highly desirable approach that is expected to provide efficient protection from bioerosion.
In addition to extensive in vitro investigations, the first in vivo application of MSNs was reported in
2008. [179] Recently, Nel and co-workers presented a successful proof of principle aimed to overcome
DOX resistance in a mouse xenograft model with PEI-PEG functionalized MSNs. [180] Unfortu-
nately, heterogeneity in the tumor microenvironment, such as differences in the vascularity, possibly
influences the efficacy of drug delivery in vivo. Further research is necessary to evaluate the MSN
distribution in tumor models, particularly with targeting ligands to ensure the capability of the
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delivery systems to efficiently reach all cells within the tumor tissue. Nevertheless, these early ex-
periments provide strong evidence that MSNs are promising candidates for improved cancer therapy
and that they are able to reduce side effects for healthy tissues. [181, 182] Furthermore, very promis-
ing results for siRNA delivery were obtained by Min and co-workers. [169] They showed successful
delivery of GFP downregulating siRNA in a tumor xenograft mouse model (Figure 2.5). The re-
duction of GFP fluorescence could be observed with optical imaging in vivo (Figure 2.5 a,b) and
more clearly in tissue sections (Figure 2.5 c). Although the results demonstrate the feasibility of
this approach, the system is still lacking control over pore sealing and a release mechanism.
In addition to possible cancer therapeutics and gene delivery, there are also studies for inhibitor
delivery and delivery of cytokines. [59, 183] A detailed overview on in vivo biosafety evaluations and
diagnostic/therapeutic applications of MSNs has recently been provided by Shi and co-workers. [184]
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3 Multifuncional mesoporous silica
nanoparticles
This chapter is adapted from the publication “Multifunctional Mesoporous Silica Nanoparticles as a
Universal Platform for Drug Delivery”, published in Chemistry of Materials, written in collaboration
with C. Argyo from the group of T. Bein. [14]
3.1 Synthesis of inorganic silica cores
MSNs acting as host systems for therapeutics provide high loading capacity within the porous system
and protection of the guest molecules from degradation and from detection by the immune system.
Furthermore, the nanocarrier systems can be utilized for the transport of hydrophobic molecules
through biological media, thus increasing the therapeutic effect at the desired location.
The synthesis of ordered mesoporous silica materials has been extensively studied in recent years, [185–
188] including sol-gel processes to create MCM-41 [189] and SBA-15, [190] among various different
structure types. [191–193] Fine-tuning of the reaction parameters such as concentrations, pH value,
chemical nature of the surfactants, temperature, and time allows for a precise adjustment of size,
morphology, and pore structure of the mesoporous silica.
The scope of conventional mesoporous materials such as MCM-41 for applications in drug delivery
is limited due to their relatively large particle sizes in the micrometer range. Cellular uptake
studies of nanoparticles showed that particle sizes less than 120 nm are preferred for endocytic
uptake. [194] Thus, efforts have been made to obtain spherical MSNs in that size range. [195–199]
For example, a standard synthesis route, following addition of surfactant template, silica source,
and organotrialkoxysilanes to a highly basic aqueous solution at elevated temperatures to create
MCM-41-like nanoparticles, is used by many research groups. [142, 181, 200–203] Another versatile
approach for obtaining stable suspensions of MSNs in high yields was developed in our group. Here,
triethanolamine is exploited as base and as complexing ligand for the silica precursor and is used to
tune the particle size (to about 80 nm). [36, 204] Their worm-like pore structure with pores growing
from the center to the periphery suggests a seed-growth mechanism (Figure 3.1 c). Interest in the
delivery of large cargo molecules, such as enzymes or oligonucleotides, leads to a growing research
activity in the synthesis of MSNs with large pores (10-20 nm, Figure 3.1 d). [205, 206]
In order to gain access to the pores, the templating surfactant molecules have to be removed. This
can be achieved either by calcination or with extraction methods. To overcome impediments such
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Figure 3.1: Transmission electron micrographs of (a) MCM-41-type nanoparticles ref [207], (b) micrometer-
sized SBA-15 material ref [208] ), (c) colloidal MSNs with worm-like pore structure (Bein and co-workers),
and (d) monodispersed MSNs with large pores (>15 nm). ref [205]
as reduction in pore size, particle agglomeration, removal of organic moieties, or low degree of
condensation of the silica network, Cauda et al. established a new approach that combines the
advantages of both aforementioned methods for template removal. [209] Here, a liquid-phase high
temperature “calcination” of MSNs is performed in a high-boiling organic solvent leading to a higher
degree of silica condensation while maintaining the colloidal nature of the nanoparticles.
In order to exploit the whole potential of MSNs for drug delivery applications, it is desirable to add
functionality to the silica scaffold. Molecular functionality attached to the surfaces of inorganic silica
can dramatically change the properties of the obtained material, which is important in host-guest
interactions with the cargo. The incorporation of organic moieties at specific locations is intended
to fine-tune surface and materials properties and is a subject of current research. [210, 211] The
spatially selective modification of the internal pore system and the external particle surface with
organic and inorganic moieties is often an essential requirement for these materials to operate as
multifunctional drug carriers exhibiting the required features. External surface functionalization
is particularly important for colloidal and chemical stability as well as for interactions with the
environment, such as modifying the particles for specific cell targeting or attaching large molecules
for pore gating and improving biocompatibility. [83, 212–215] On the other hand, internal organic
moieties can supply enhanced interaction or covalent binding sites for cargo molecules, such as drugs
or proteins, which allows for control over diffusional transport, delivery kinetics, and stability of the
therapeutic molecules. [136, 216, 217]
In general, there are several approaches to achieve functionalization of silica materials. The most
important functionalization strategies are via postsynthetic grafting and via co-condensation, be-
sides the synthesis of periodic mesoporous organosilicas (PMO) and employment of metal organic
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Figure 3.2: Site-selective delayed co-condensation approach for creating bifunctional MSNs. In a first
step, a mixture of organosilane (green) and tetraethylorthosilicate (TEOS) in an aqueous solution containing
template and base catalyst creates a functionalized nanoparticle core. Subsequently, the nanoparticle growth
is completed by addition of pure TEOS (blue) resulting in an unfunctionalized silica shell around the core.
Finally, the addition of another organotriethoxysilane (RTES, R represents an organic moiety, red) and
TEOS forms an external skin with different functionality.
reagents. [189, 218–220] In order to gain control over the location of the functional groups in
silica nanoparticles, Bein and co-workers established a site-selective delayed co-condensation ap-
proach. [37, 221] Here, bifunctional MSNs with a selective functionalization of the interior and
an orthogonal functionality at the external particle surface in different onion-like shells can thus
be prepared (Figure 3.2).This strategy opens new possibilities for the design of numerous highly
functionalized porous nanoparticles with applications in controlled drug delivery.
3.2 Modification of silica cores
Surface modification with organic and inorganic species can introduce a large variety of function-
alities for controlling diffusion and release of cargo molecules and cell surface recognition, among
others. The potential to design biocompatible external surfaces of nanoparticles providing tunable
interactions with the biological environment by attachment of molecular or macromolecular moi-
eties for biomedical applications has been recently demonstrated. [40, 41, 86] The combination of
the properties of such an external functional shell and the advantageous structural properties of the
mesoporous silica core can create multifunctional drug carriers, making the delivery process highly
controllable.
Gating One of the important functionalities in this context is triggered release of the cargo through
specially designed gating concepts. In general, gatekeepers can be classified into three different
types, namely molecular/particle pore gating, surface coating, and internal pore modifications
(cf. Figure 3.3). Pore gating systems can consist of either bulky molecular groups or nanoparti-
cles, such as proteins, superparamagnetic iron oxide nanoparticles (SPIONs), or gold nanoparticles
(Au-NPs) which block the pore entrances for efficient sealing of the interior mesoporous environ-
ment. [40, 111, 166] These macromolecular structures are either degradable or attached to the silica
particle surface via linkers that are cleavable upon exposure to certain stimuli. [125, 156] Very
good pore sealing can also be achieved by a complete coating of the MSNs. For instance, poly-
mers, oligonucleotides, or supported lipid bilayers (SLB) have been shown to prevent premature
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Figure 3.3: Strategies for controlled release can be classified into three different types, molecular/particle
pore gating (a,b), surface coating (c,d), and internal pore modification (e,f). (a) Mesoporous silica nanorods
capped with superparamagnetic iron oxide nanoparticles (SPIONs) containing redox-responsive cleavable
disulfide linkers; [111] (b) temperature-dependent programmable molecular valve system consisting of
avidin caps being opened by melting the DNA linkers; [114] (c) temperature-dependent phase transition
of PNIPAM-coating on MSNs; [118] (d) disulfide-linked polymeric network at the outlet of mesoporous
silica allowing redox-responsive controlled release of the cargo [160] (e) schematic release mechanism for a
pH-responsive system based on coordination bonding in mesopores; [144] and (f) light-activated cis/trans
isomerization of azobenzene groups inside mesopores expels the cargo. [222]
cargo release. [15, 39, 51, 53, 95, 99, 108, 177, 223, 224] Often, phase transitions or competitive
displacement reactions lead to opening of the pores and efficient cargo delivery. [117, 120] The third
strategy for controlled cargo release involves attachment of the cargo molecules in the porous system
of the silica nanocarriers. Coordinative or covalent bonds can be cleaved by certain stimuli such as
competitively binding molecules or reducing agents to activate cargo release. [107, 109, 161] Zink
and co-workers have presented different nanocarriers with on-demand controllable release mecha-
nisms, including nanoimpellers consisting of azobenzene groups that have been described to trigger
UV-light-activated release of a cell membrane-impermeable dye. [222]
Biocompatibility and Stability For applications of MSNs as nanocarriers, biocompatibility and
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low toxicity are required. A modification of the nanoparticle surface with functional shells, such
as polymer coatings, charged groups, or a supported lipid bilayer was found to decrease particle
aggregation and improve stability in biological media. For instance, functionalization of the particle
surface with phosphonate groups was shown to improve the stability and dispersibility of MSNs
in aqueous media. [128, 225] This modification helped to prevent interparticle aggregation, and
redispersion after a drying process was highly improved. [16] In general, MSNs provide good bio-
compatibility, but the high surface area and a low degree of condensation of the silica framework can
promote a high rate of dissolution. [226, 227] Bare, nonfunctionalized MSNs featuring silanol groups
at their surface dissolve fairly rapidly in simulated body fluid under physiological conditions and pro-
duce soluble silicic acid species (which are found to be nontoxic). [228] The rate of silica dissolution
is dependent on particle size, functionalization, degree of silica condensation, and pore morphology.
A surface functionalization can prevent fast degradation and provide prolonged stability of MSNs in
biological media. For example, a hydrophilic polymer shell such as poly(ethylene glycol) (PEG) or
an SLB on colloidal MSNs improves stability in water, maintains monodispersity, and can minimize
nonspecific adsorption of proteins on the nanoparticle surface. [35, 53, 128] Such a polymer coating
provides a protective shell for the silica surface, which is important when prolonged circulation time
in an organism is required for effective drug delivery. PEGylation can hinder capture by organs
of the reticuloendothelial system (RES) and consequently slow down biodegradation. [229] Hemo-
compatibility is another important attribute of MSNs. Surface functionalization of bare MSNs can
reduce or even completely prevent thrombogenic effects and nonspecific protein adsorption on MSN
surfaces. [230] For example, heparin-coated core-shell MSNs have recently been described. [231] Hep-
arin is a highly sulfated, anionic polysaccharide, known for its anticoagulant properties. This novel
nanoscale system combines the efficiency of heparin in preventing blood-clotting with multifunc-
tional core-shell MSNs featuring excellent structural properties and colloidal stability. In general,
MSNs with organic shells offer multifunctionality and improved biocompatibility and hemocompat-
ibility and are expected to have potential as blood-stream-injectable drug-delivery systems offering
new options for cancer therapy.
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A common technique to perform live-cell imaging is fluorescence microscopy because it offers the
ability to monitor cell interactions after the cells were labeled, with fluorescent dyes. Nowadays,
many site-specific fluorescent dyes to mark defined cell compartments are commercial available. [232]
Furthermore nanostructures such as mesoporous silica nanoparticles can be marked with fluorescent
dyes and the interaction of particles with cells can then be monitored. [1, 14, 39, 86, 233] These
experiments lead to a better understanding of the interaction between nanoparticles and cells, and
are an important first step in developing new materials for medical applications.
In this thesis live-cell imaging was employed to observe the uptake and cellular fate of function-
alized mesoporous silica nanoparticles, their release behavior as well as for the activation of the
photoinduced endosomal escape.
The following section aims to give a general introduction to fluorescence principles on the basis of
the Jablonsky-Diagram. Furthermore, requirements for dyes used in live cell imaging and related
problems are discussed. Finally, the utilized spinning disc setup is described along with the principal
for confocal microscopy.
4.1 Fluorescence principle
The basic physical principles behind fluorescent microscopy [234, 235] can be described by a look
at the Jablonsky-Diagram (Figure 4.1). A fluorescent molecule is capable of gaining energy by
absorption of photons if the energy of the photon is equal the energy difference of its energetic levels.
From the electronic ground state S0 the molecule gets excited to a higher (electronic) state (e.g.
S1, S2) and therein in vibrational and/or rotational excited states by absorbing a photon. Internal
conversion, vibrational relaxation and intersystem crossing can then take place or relaxation by
emission of a photon.
For live-cell fluorescent microscopy the energy of absorbed and emitted photons is normally in the
visible light range. The energy E is inversely related to the wavelength (λ) of the absorbed photon’s:
E = h · c
λ
(4.1.1)
Hereby, h is the Plank’s constant and c is the speed of light in vacuum.
To come from higher energy levels back to the ground state the molecule can emit a photon with
the corresponding wavelength (fluorescence), which normally takes place in the nanosecond range.
Beside the singlet excited states also triplet excited state can be reached. This process is called
intersystem crossing and is more likely if the triplet state vibrational energy levels overlap with
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lowest energy levels in S1. In this case the electron undergoes a forbidden transition (spin transition)
and owing to this, it can take microseconds for the electron to come back to the singlet ground state
which involves another spin transition. Meanwhile it is also possible, that another photon excites a
triplet-triplet transition and it would take even longer to come back to the ground state.
Figure 4.1: Jablonsky-Diagram displaying the energy states of a molecule and the times that the various
steps in the fluorescence excitation and emission and phosphorescence take. The diagram is taken from
ref. [234].
In addition to the light emitting processes also emission-free possibilities for returning to a favorable
lower energy level. The vibrational energy is then transferred e.g. to neighboring molecules and
lost for fluorescence. But it is unlikely for a fluorescent molecule to get back to the ground level
only using vibrational relaxation. Beside vibrational relaxation internal conversion plays a role. In
the case of internal conversion the system changes between electronic states without energetic loss,
by going from a low vibrational state of a higher electronic state to a high vibrational state of a
lower electronic state. Internal conversion can also be followed by vibrational relaxation. Within
picoseconds a molecule is able to come to the lowest energy level of S1.
Because of the energy difference between the vibrational modes of the electronic ground state and
the first singlet excited state, normally a total relaxation, without any photon emission, to the
ground state is not preferred.
Due to the non-radiant relaxation behavior there is a shift to lower energy in the maximum of the
emission wavelength in comparison to the maximum in the absorption wavelength, the so called
“Stokes shift”. Apart from that, the emission and absorption spectra exhibit a symmetry due to
the similarity of transitions. Depending on the electronic, vibrational and rotational states of a
fluorophore the excitation spectra a broader or smaller.
4.2 Requirements for used dyes
A suitable fluorescent dye is pivotal for fluorescence microscopy. In the following several requirements
for the fluorescent dye will be presented. Prerequisite for a high fluorescence is a dye which has a
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high quantum yield and a long lifetime. The quantum yield ΦFl hereby is defined as [235]:
ΦFl =
Number of photons emitted as fluorescence
Number of absorbed photons (4.2.1)
A higher quantum yield means an increase in fluorescence intensity and alternative competing
photochemical processes like bleaching and free radical formation become less likely. [234] Especially
for cell experiments it is often useful to have dyes with a high quantum yield because one wants to
observe processes over a longer time range and it wouldn’t be of advantageous if the bleaching of
the dye takes place to fast. An example for such an experiment would be the observation of cargo
release out of endosomes, as the dye is highly concentrated inside the endosome and after release
into the cytosol it gets highly diluted. If the dye also bleached fast there wouldn’t be a chance to
detect the spreading inside the cytosol.
Photobleaching normaly occurs due to destruction of the dye, mostly because of the generation of
reactive oxygen species (ROS) like singlet oxygen (1O2). As a result the total number of ground
state molecules is permanent reduced, the higher the light intensity, the faster this process will
take place. With laser light as excitations source photobleaching can occur within a few microsec-
onds. [236] The less dye molecules are present, the faster there will be no fluorescence left to detect,
and for example spreading of a dye could not be observed. Thus in most cases, photobleaching
is undesirably. Nevertheless there are cases like the photoactivated endosomal escape where the
generation of reactive oxygen species is desired. There dyes are used on purpose which are known to
generate a high amount of singlet oxygen, for example porphyrine or phtalocyanine derivatives. [237]
The produced singlet oxygen destroys selectively the surrounding environment of the activation area
like cancer tissue.
Another useful property in fluorescence microscopy is fluorescence enhancement that may occur
because of enviroment changes, like intercalation into special structures (e.g. DNA or RNA), binding
to ions (like calcium ions) or changes in pH. [238–240]
An effect that can be used in order to easily image spreading of a dye inside cells is the use of so called
“quenchable” dyes. Quenching is the reversible loss of fluorescence due to non-covalent interactions
between a fluorophor and it’s surrounding. It can occur due to e.g. förster resonance energy trans-
fer (FRET) charge transfer reaction, biochemistry or static quenching, if ground-state fluorophores
associate to other molecules (in the case of identical molecules this is called “self-quenching”). [234]
Calcein represents a suitable quenchable dye, because of its self-quenching abilities, at a concentra-
tion of about 30 µM the fluorescence intensity of calcein decreases already. [241] Therefore calcein
is often used e.g. in liposome-fusion experiments.
Furthermore it is possible to combine two or three dyes for one measurement. However before doing
so it is of great importance to check their fluorescence excitation and emission spectra, in order to
avoid overlapping which would lead to cross-fluorescence. Particular the excitation spectra would
be problematic, if they posses a broad spectral range and therefore the dye could be excited with
various wavelength. To circumvent the problems that would arise from broad fluorescent emission
spectra it is often useful to use alternating excitation in order to separated the images from each
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other.
4.3 Spinning disc microscope
To study living cells with fluorescence microscopy a high spatial resolution in 3D and a high time
resolution is crucial to gain new insights and answer open questions for example in regard to drug
delivery as will be presented in the chapter 6 - 10. The best tool for this is a spinning disc microscope.
Lateral resolution for optical microscopes is expressed by the Rayleigh criterion: [242]
dlateral =
0.61λ
N.A. (4.3.1)
where λ is the wavelength of the light and N.A. the Numerical Aperture, defined as follows:
N.A. = n · sinφ (4.3.2)
with φ being the half-angel of the light cone entering the microscope objective and n the refractive
index of the medium, between objective and sample. [235]
The Rayleight criterion states, that two objects can be laterally resolved if the central maximum
of one point-object overlaps with the first minimum of the other one. The axial resolution daxial is
then given by: [242]
daxial =
2nλ
N.A. (4.3.3)
Figure 4.2: Schematic representation of a spinning disc setup. Picture is taken from ref. [243]. Laser
light, crosses both rotating discs, is focused on the sample with confocal illumination and subsequently
fluorescence passes back trough the pinhole disc and reflected by a beamsplitter onto the detector, usually
a CCD camera.
A confocal microscope is improved in comparison to a simple fluorescence microscope by introducing
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pinholes in the excitation and detection pathway. The function of the pinholes is to block the out
of focus fluorescence, and thereby increase the resolution, especially in the axial direction, as the
width of the point spread function is reduced, as well as the intensity of the side lobes. By varying
the size of the pinholes one can further influence the diffraction.
Confocal microscopes can be further improved, leading to spinning disc confocal microscopes, by
substituting the pinholes with a spinning disk unit consisting of two fast rotating discs. On one disc
there are multiple lenses, concentrically arranged and on the other one pinholes are installed, allowing
for multiple simultaneously scans. With these discs it is now possible to screen many confocal spots
over the sample and perform a faster imaging compared to a scanning confocal microscope, leading
to a high time resolution. A disadvantage is however, that strong lasers are needed, as much light
gets lost while passing the pinhole. Nevertheless the above mentioned advantages justify the usage
of these kind of microscopes.
A schematic figure of the optical configuration of a Yokogawa spinning disc unit is given in Figure 4.2.
The laser light first passes a lens disc with Fresnel microlenses. With these lenses the laser beams
Figure 4.3: Schematic representation of the Zeiss Cell Observer SD, utilizing a Yokogawa spinning disc
unit CSU-X1. The laser light enters the spinning disc head and is further directed to the microscope to
illuminate the sample. The emitted fluorescence again passes the spinning disc head, a dichroic mirror
seperates the signal spectrally and is imaged onto two EMCCD cameras.
are perfectly aligned to the following pinhole disc. Both Discs are rotating (max. 10.000 revolutions
per minute) so that the specimen must not be scanned for acquiring a picture, contrary to confocal
microscopy. An objective ensures the beam to be focused on the specimen. The fluorescent light
then comes back trough the objective and passes the pinhole disc, where again out of focus light
is cut off. After the pinhole disc a dichromatic beam-splitter separates the fluorescent from the
excitation light since the have different wavelengths. The fluorescence can go through filter sets
,corresponding to the spectra of the used dyes, to the detection EMCCD-camera. [243]
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In this work all measurements were performed on the commercially available Zeiss Cell Observer
SD, utilizing a Yokogawa spinning disc unit CSU-X1. A schematic representation of the beam path
can be seen in Figure 4.3. Four lasers (405, 488, 561 and 639 nm), that can be selectively chosen
in desired combinations over an acusto-optical-tunable-filter (AOTF), are available. Over a single-
mode optical fiber the lasers are directed into the spinning disk unit. The laser beam passes the
rotating microlense and pinhole arrays and enters the microscope, where it illuminates the sample
trough an objective. A motorized stage controls the position of the sample in x-/y- position and
a piezo-stage controls the z-position. The emitted fluoresecence goes back through the objective,
passes the pinhole array and by means of an dichroic mirror is directed to the EMCCD cameras.
Appropriate dichroic mirrors and filters, that arr located in front of the cameras, split the emission
light.
4.4 Imaging
This section is adapted from the publication “Multifunctional Mesoporous Silica Nanoparticles as a
Universal Platform for Drug Delivery”, published in Chemistry of Materials, written in collaboration
with C. Argyo from the group of T. Bein. [14]
The imaging possibilities for MSNs and their combinations with other materials range from optical
microscopy to magnetic resonance imaging and to ultrasonic imaging, near-infrared imaging, and
other techniques. In this thesis, we will focus on optical microscopy and its applicability to gain real-
time observation of MSNs in cell cultures and tissues. Other imaging techniques and the preparation
methods for functionalized hybrid nanoparticles, such as silica nanoparticles containing magnetic
cores, have been extensively discussed elsewhere. [17, 184, 244, 245] In this context, MSNs are
being developed as a platform for incorporation of nanocrystals or for doping with active species
including iron oxide nanocrystals, quantum dots, gold nanoparticles, and manganese or gadolinium
ions. These types of multifunctional nanocarriers attract great interest with a view on theranostic
applications.
There are different possibilities to fluorescently label MSNs. Depending on the desired type of
labeling (removable or not), fluorescent dye molecules can be attached to the inner and outer particle
surface by covalent linkage via postsynthetic grafting, incorporation into the silica framework, or
pH-/redox-sensitive linkage. Diffusion of dye molecules or nanoparticles like quantum dots inside
the pores has been investigated as well. [246] In that case, efficient enclosure of the fluorescent cargo
in the mesopores can be achieved by an SLB or other bulky molecules used as valves. Diffusion
dynamics of fluorescent molecules in porous silica materials were intensively studied with fluorescence
microscopy. Bräuchle and co-workers could image single dye molecules [247–249] as well as the
anticancer agent DOX [233] moving inside mesoporous channels of silica materials. Such studies are
crucial for understanding diffusion processes and confirm the need for defined surface modifications
for controlling adsorption and desorption processes of the cargo molecules in the mesoporous system.
Functionalization of the mesoporous interior with amino-groups in order to achieve positively charged
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surfaces resulted in preferential and increased uptake of negatively charged siRNA constructs. [250]
Issues of cargo loading efficacy may arise due to electrostatic repulsion when negatively charged
molecules like double stranded DNA should be absorbed into nanocontainers featuring negative
surface charge. [251] On the other hand, electrostatic interactions may not be too strong; otherwise,
they can cause entrapment in the porous system, and consequently, cargo release is inhibited. The
stability of the cargo to be transported is a key factor in particle design, especially if the goal is to
efficiently deliver sensitive cargos like siRNA. Fluorescent donor-acceptor pairs offer the possibility
to investigate the stability of oligonucleotides inside the pores by measuring the Förster resonance
energy transfer (FRET). [250, 251] Thus, the stability of oligonucleotides in specifically functional-
ized mesopores after adsorption was demonstrated. Since nanocarriers provide protection against
diverse biological attacks, incorporation of oligonucleotides into the mesopores of silica materials is
very promising for future experiments in gene delivery, especially because previous efforts in delivery
so far have focused on oligonucleotides attached to the external particle surface. [176, 178]
Another useful method to monitor the release of payload from the pores of MSNs in real-time is
FRET. For that purpose, Lee and co-workers attached a FRET donor-acceptor pair of coumarin and
fluorescein isothiocyanate (FITC) to the cap system β-cyclodextrin located at the pore entrances
of MSNs. After light activation, cleavage of the gatekeepers occurred and subsequently the FRET-
signal vanished due to great distance of the donor-acceptor pair. [252]
Figure 4.4: Internalization of epidermal growth factor receptor (EGFR) targeted MSNs with supported
lipid bilayer. [15, 253] (a) Trajectory of an MSN during uptake into HuH7 cells. The particle was tracked
4 min after addition of the particles on top of the cells, for 5 min and 50 s at a temporal resolution of 150
ms/frame. Three phases are typically observed during the internalization process. [254] The starting point
of the trajectory is indicated with an arrow. The overlying color boxes indicate the three phases. Yellow:
phase I, slow active transport; green: phase II, anomalous and confined diffusion; red: phase III, active
transport with back and forth movement. (b) Instantaneous velocities of the trajectory shown in (a) and
(c-e) the mean square displacement (MSD) plots of the three phases obtained from several trajectories. The
corresponding plots from the trajectory are indicated in blue. The analysis of the trajectories was performed
with the help of the viro-tracker developed by Godinez et al. [255] to localize the xy-coordinates and with
the help of the transport-program developed by Arcizet et al. [256] to calculate MSD plots. [253]
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Optical imaging is also the most widely used technique to study the feasibility of custom-made
drug nanocarriers based on MSNs. The direct release and distribution of cargo inside cells can be
monitored via fluorescence microscopy. Furthermore, precise investigations of uptake behavior and
cellular internalization mechanisms of MSNs in single cells can be realized. Methods that were devel-
oped to evaluate the uptake behavior of viruses and single polymeric gene carriers (polyplexes) were
extensively exploited by Bräuchle and co-workers. [254, 257–259] Subsequently, the internalization
Figure 4.5: (I) Comparison of FITC-tagged MSN with ICG-tagged MSN (50-100 nm). (a, b) Biodistri-
bution of MSN-NH2-FITC in an anesthetized rat before and after (90 min) i.v. injection. The experimental
conditions were set at 492 nm (excitation) and 518 nm (emission) and (a) a longer shutter time (60 s) for a
visible imaging and (b) 30 s shutter time. (c) Biodistribution of MSN-TA-ICG in an anesthetized rat before
and after i.v. injection for 90 min. MSN-TA-ICG sample showed less interference of autofluorescence in a
shorter shutter period (30 s). (d) MSN-TA-ICG in nude mice after i.v. injection for 3 h. (II) Dissected
organs from a rat sacrificed after i.v. injection of MSN-TA-ICG for 3 h. (a) representative white-light and
(b) fluorescent images. (III) In vivo biodistribution of silicon percentage in various organs of rat after i.v.
injection of MSN-TA-ICG for 6 h. [260]
of epidermal growth factor receptor (EGFR) targeted MSNs into living cells was also investigated.
Detailed information on the internalization pathway, the behavior of the MSNs inside the cells,
and information on unexpected interactions between the particles and the cell can be gathered by
life-cell imaging, and consequently, possible challenges can be monitored. Similar to the behavior of
polyplexes, it was observed that porous silica nanoparticles exhibit three phases of motion during
their internalization (Figure 4.4). The particle motion was measured on a sensitive fluorescence
wide field microscope and analyzed with single particle tracking methods. In the first phase, the
particles attach to the cell membrane and consequently show a slow directed movement, provoked
by movement of the subjacent actin cytoskeleton mediated by the EGF receptor and linker proteins.
With the transition to phase II, the particles are internalized into the cells. Phase II consists of
either normal, anomalous, or confined diffusion or a combination of all three. Normal diffusion
is often hindered in the cytoplasm by the local microenvironment (cytoskeleton, organelles, large
molecules, etc.). Phase III shows much faster, active transport of the particles entrapped inside
30
4.4 Imaging
endosomes along the microtubule network via motor proteins with velocities up to 2 µm/s.
Optical microscopy also provides the capability to image in vivo. However, attenuation of photon
propagation and a poor signal-to-noise ratio due to autofluorescence of the tissue can cause difficulties
and should be considered in the selection of the type of dye and its concentration. Nevertheless, the
high loading capability of MSNs makes them promising candidates to overcome this problem. Thus,
Lo and co-workers could study the spatial distribution of MSNs with positive surface charge and
loaded with indocyanine green (ICG) via near-infrared microscopy inside anesthetized rats. [260] In
that case, the biodistribution of the optical MSN probe was evaluated in comparison to FITC-labeled
MSNs. FITC seems to be not appropriate for in vivo optical imaging, since tissue penetration depth
of the fluorescent signal of this dye is too small and consequently not detectable. NIR fluorescent dyes
can be clearly detected after intravenous injection for evaluating particle accumulation inside the
liver and kidney and partially in lungs, spleen, and heart. Further verification of the biodistribution
in the dissected organs can be seen in Figure 4.5.
Optical microscopy utilizing NIR fluorescent dyes offers the possibility to investigate long-term
biodistribution of nanocarrier systems, since it is a noninvasive method and animal models do not
need to be sacrificed. As observed in such experiments, bare MSNs seem to face the problem of
being cleared through the reticuloendothelial system (RES), such as spleen or liver, and the EPR
effect is decreased. [47, 228, 260] Further modifications of the particle surface including PEGylation
of the MSNs are needed to avoid the activation of the immune system. [261]
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5.1 Chemicals
The following chemicals were used as received without further purification: Alexa Fluor 488 Dex-
tran (AFD, MW 10 kDa, Invitrogen); Alexa Fluor®568 Phalloidin (Invitrogen); Al(III) phthalo-
cyanine chloride disulfonic acid (AlPcS2a, Frontier Scientific); calcein (Sigma-Aldrich, ≥ 90 %);
CellLight®Early Endosomes-GFP/ Lysosomes-GFP/ Tubulin-GFP, BacMam 2.0 (Invitrogen); col-
lagen A (Biochrom AG); colchicine (Sigma-Aldrich); dextran, fluorescein (10.0000 MW, Invitro-
gen); 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)-2000] (ammo-
nium salt) (DSPE-PEG2000-FA, Avanti Polar Lipids); DPBS (no calcium, no magnesium, Invit-
rogen); dulbecco’s modified eagle’s medium : F12 (1:1) (Invitrogen); dulbecco’s modified eagle’s
medium (DMEM):F12 (1:1) (Invitrogen) with Glutamax I; epidermal growth factor (EGF, Pepro-
Tech, > 98 %); fetal bovine serum (Invitrogen); FITC-H5WYG (Enzo Life Science, ≥ 88 %);
folic acid (FA, Sigma, > 97 %); folic acid deficient roswell park memorial institute 1640 medium
(RPMI 1640, Invitrogen); hank’s balanced salt solution (HBSS; calcium, magnesium, no phenol red,
Invitrogen); H5WYG (Enzoo life science, ≥ 88 %); LysoTracker®Red DND-99 (Invitrogen); pro-
pidium iodid (Sigma-Aldrich); wheat germ agglutinin (WGA) Alexa Fluor 488/ 647 conjugate (In-
vitrogen). DOPE-PEG4-(KIAALKE)3 (LPK, 50 µM), DOPE-PEG4- (EIAALEK)3 (LPE, 50 µM),
cholesterol-PEG12- (KIAALKE)3 (CPE, 50 µM), (EIAALEK)3- carboxyfluorescein (E-cf, 50 µM)
and (KIAALKE)3- carboxyfluorescein(K-cf, 50 µM) were provided by the group of Prof. Kros (Uni-
versity of Leiden). Doubly distilled water from a Millipore system (Milli-Q Academic A10) was
used. All cell or cell compartement staining reagents were applied as proposed by the producer.
5.2 Cell culture
KB cells were grown in folic acid deficient Roswell Park Memorial Institute 1640 medium (RPMI 1640,
Invitrogen) supplemented with 10 % fetal bovine serum (FBS). HeLa cells were cultivated in Dul-
becco’s modified Eagle’s medium (DMEM):F12 (1:1) (Invitrogen) with Glutamax I medium supple-
mented with 10 % FBS. Tubulin-GFP expressing HuH7 cells and wildtype HuH7 cells were grown
in Dulbecco’s modified Eagle’s medium : F12 (1:1) (Invitrogen) supplemented with 10 % FBS. All
cells were cultured at 37◦C in a 5 % CO2 humidified atmosphere. PCR was routinely performed in
order to guaranty mycoplasma infection free cells.
KB cells were seeded on ibidi-Treat µ-Slides (IBIDI), HeLa and tubulin GFP expressing HuH7 cells
on collagen A - coated LabTek chambered cover glass (Nunc). For live cell imaging the cells were
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seeded 72, 48 or 24 h before measuring, at a cell density of 0.75 x 104, 1 x 104 or 2 x 104 cells / cm2
respectively.
5.3 Microscopy in live cells
Live-cell imaging was performed on a confocal setup based on the Zeiss Cell Observer SD, utilizing
a Yokogawa spinning disc unit CSU-X1 (cf. Chapter 4). The system was equipped with a 1.40 NA
100x or 63x Plan apochromat oil immersion or a 0.45 NA 10x air objective from Zeiss. 3D images
were acquired with an axial distance of 0.2 µm.
Table 5.1: Filter-dye combinations used in the measurements described in Chapters 6 - 10.
Fluorophor λabs[nm] λfl[nm] λexc[nm] Detection ref.
BP filter
DAPI 356 500 405 525/50 [262]
AFD 488 495 519 488 525/50 [263]
bodipy ∼ 500 ∼ 510 488 525/50 [264]
Calcein 470 509 488 525/50 [265]
carboxyfluorescein 492 517 488 525/50 [266]
FITC 490 520 488 525/50 [267]
GFP 488 510 488 525/50 [268]
WGA 488 495 519 488 525/50 [269]
LysoTracker Red DND-99 577 590 561 629/60 [270]
Propidium Iodide 535 617 561 629/60 [271]
5(6)-Carboxy-X-rhodamine (RD) 570 595 561 629/60 [272]
AlPcS2a ∼ 650-700 ∼ 690 639 690/60 [273]
Atto 633 629 657 639 690/60 [274]
The exposure time was 0.1 s for all experiments and the frame rate varied in the range from 3
to 0.03 Hz, depending on the experiment. In the excitation path a quad-edge dichroic beamsplit-
ter (FF410/504/582/669-Di01-25x36, Semrock) was installed. For two or three-color detection a
dichroic mirror (560 or 660 nm, Semrock) and band-pass filters 525/50, 629/60 and 690/60 (Sem-
rock) were placed in the detection path depending on the used dyes (Table 5.1). Separate images
for each fluorescence channel were acquired by using two separate electron multiplier charge coupled
devices (EMCCD) cameras (Photometrics Evolve™).
The used lasers for an excitation of the single dyes, their maximum excitation and emission wave-
length and the associated filters are listed in Table 5.1, the applied laser-power densities which vary
for the experiments described in Chapter 6 - 10 are displayed in Table 5.2.
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Table 5.2: Laser Power densities used for the experiments listed for each Chapters in W/mm2.
* 0.12 and 0.06 W/mm2 for imaging and 1.2 W/mm2 for photoactivation.
λexc[nm] Fluorophor Chapter
6 7 8 9 10.1 10.2 10.3
405
DAPI - 0.16 0.16 0.16 - - -
488
AFD488 - - - - 0.39 - -
bodipy - - - - - 0.62 1.1
Calcein 0.39 0.39 - - 0.29 - 0.39
carboxy- - - - - - 1.1 -
fluorescein
FITC - - - - 0.37 - 0.62
GFP 0.62 1.1 6.6 0.48- - - -
1.1
WGA488 0.39 0.29 0.14 - - -
561
Lysotracker - - - - - - 0.042
Red
PI - - 0.39 - 0.39 - -
RD 1.2 - 2.1 - - - -
639
AlPcS2a* 0.12/ 0.12/ - 0.06/ - -
1.2 1.2 - 1.2 - -
Atto633 - 0.011- 0.011- 0.011 - 0.012- 0.012-
0.12 -0.12 0.011 - 0.12 -0.10
5.3.1 Uptake studies
To evaluate the functionality of the folic acid ligand, KB cells were incubated with nanoparticles
for 2-5 h at 37◦C under a 5 % CO2 humidified atmosphere. In the case of live cell imaging the
cell membrane was stained afterwards by adding a final concentration of 10 µg/mL wheat germ
agglutinin Alexa Fluor 488 conjugate (WGA488, Invitrogen) to the cell medium. After 1 min, the
cell medium was removed, the cells were washed twice with cell medium, and imaged immediately.
In the case of fixed cells the latter were washed three times after the 2-5h incubation time with PBS
(Invitrogen). Afterwards 200 µL of 4 % paraformaldehyde (PFA, Science Service) were added for
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15 min. After removing the PFA, the cells were washed three times with PBS and stained with a
final concentration of 10 µg/mL WGA488 in cell medium. After 1 min the cell medium was removed,
the cells were washed twice with PBS and imaged.
In control experiments, the FA receptors on the KB surface were blocked by pre-incubation of the
cells with 3 mM folic acid (Sigma) for 2 h at 37◦C under a 5 % CO2 humidified atmosphere, bprior
to addition of particles.
In case of EGF, instead of staining the cell membrane HuH7 cells with GFP tagged tubulin were
used for live cell imaging. The wildtype HuH7 cells were treated equivalent to the live cell imaging of
the KB cells. When applying HuH7 tubulin the cell medium was exchanged with CO2-independent
medium (Invitrogen) after the incubation time and imaged immediately. For control experiments,
EGF receptors on the HuH7 surface were saturated by pre-incubating the cells with 0.2 µM EGF
for 2 h at 37◦C under a 5 % CO2 humidified atmosphere, before adding particles.
5.3.2 Controlled release of cargo and endosomal escape with photoactivation
Cells were incubated with the corresponding particles 16 - 22 h prior to the measurements at 37◦C
under a 5 % CO2 humidified atmosphere. Shortly before imaging, the medium was replaced by
CO2-independent medium (Invitrogen). During the measurements all cells were kept on a heated
microscope stage at 37◦C. The photosensitizer AlPcS2a was activated by 1.2 W/mm2 of 639 nm
light for 1 min.
5.3.3 Elevation of pH induced controlled endosomal release
The release of cell-membrane permeable cargo due to pH-dependent opening of the PVP-coating
inside the endosomes was measured by incubating cells with particles for several hours.
MSN-PVP-PEG-NH2: In the case of colchicine-release, tubulin GFP expressing HuH7 were
incubated with colchicine loaded particles (100 µg/mL) for 18 h at 37◦C under a 5 % CO2 humidified
atmosphere. For DAPI-release HeLa cells were incubated with DAPI-loaded particles (25 µg/mL)
for 15 min, 15 h and 46 h at 37◦C under a 5 % CO2 humidified atmosphere.
MSN-D3: Cells were incubated 5 - 48 h prior to the measurements at 37◦C under a 5 % CO2
humidified atmosphere. Shortly before imaging, the medium was replaced by a CO2-independent
medium (Invitrogen). In order to clearly show the tubulin-structures the pictures were specially
processed: a rolling ball background subtraction (rolling ball radius:500 for tubulin structures and
300 for zoom in on tubulin structures) was used to remove the background and the z-stack could be
depicted as a z-projection of the standard deviation.
MSN-phSA-CA: HeLa cells were incubated 7 - 24 h prior to the measurements with DAPI-loaded
particles (33 µg/mL) at 37◦C under a 5 % CO2 humidified atmosphere.
Nuclei staining kinetics with DAPI.
HeLa cells were measured 5, 11, 24, 33, 49, and 61 h after incubation with the samples MSN-
D3-MTS-DAPI, MSN-NH2-MTS-DAPI and the supernatant of MSN-D3-MTS-DAPI (after particle
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separation). Each time point was measured with an independently incubated set of cells. In order
to evaluate the fluorescence of the nucleoli, the z-stack position was set exclusively in the region of
the nuclei. The integrated intensity of a region of interest (ROI) around the nuclei was determined
(44 - 104 nuclei for each data point) and divided by the area of the ROI. Consequently, the average
integrated density per nuclei area (± standard deviation, represented by error bars) could be plotted
dependent on the incubation time.
Shortly before imaging, the medium was replaced by a CO2-independent medium (Invitrogen).
During the measurements all cells were kept on a heated microscope stage at 37◦C. The subsequent
imaging was performed as described in the Spinning disk confocal microscopy section.
5.3.4 Endosomal compartment staining.
The staining of the early/late endosome or the lysosome with GFP, commercially available CellLight©
staining from Invitrogen was used (CellLight© Early Endosome-GFP, Late Endosome-GFP, and
Lysosome-GFP, BacMam 2.0). The cells were simultaneously incubated with MSNs and the Bac-
Mam 2.0 reagent. The concentration of the labeling reagent has been chosen with 25 particles per
cell (PCP) of the BacMam 2.0 reagent (cf. staining protocol [275]). For incubation, the cells stayed
at 37◦C under 5 % CO2 humidified atmosphere for 21 - 24 h until the measurement.
5.3.5 LPK-Ecf staining
The incorporation of the lipid-PEG-peptideK construct into the SLB of SLB@MSN the freshly
prepared particles were mixed with the fluorescent-labeled counter-peptide E. In those experiments
15 µL of MSN (∼ 1 mg/mL) were mixed with 12 µL carboxy-fuorescein-labeled E-peptide (E-cf,
50 µM) and the co-localization was measured on cover-slip.
5.3.6 SNARE-peptide mediated fusion experiments
Experiments without nanoparticles have been performed with HeLa cells in order to test the func-
tionality of CPE and LPK in terms of membrane incorporation and binding to K/E-cf.
Hereby the cell medium was replaced by 100 µL HBSS (or in a control with CO2-independent
medium (Invitrogen) supplemented with 10 % FBS). 10 µL CPE/LPK (50 µM) were added directly
on top of the cells without medium, followed by HBSS.
After 1 min incubation the cells were washed once with HBSS, followed by 10 µL carboxy-fluorescein-
labeled peptide (K-cf/E-cf) again to the top of the cells without medium and HBSS afterward. Again
after 1 min incubation the cells were washed three times with HBSS and imaged in HBSS.
For the investigation of MSN with cells, the pretreatment of the cells was the same, CPE was used to
introduce a SNARE-motive to the cell surface. Instead of K/E-cf, SLB@MSN-LPK were incubated
with the cells. Depending on the desired incubation time HBSS or RPMI 1640 medium without FBS
was used for the incubation of the cells. Incubation times longer than half an hour were performed
in RPMI 1640 medium without FBS at 37◦C under a 5 % CO2 humidified atmosphere.
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5.4 UV-VIS spectroscopy
UV-VIS spectra were recorded with a NanoDrop ND 1000 spectrometer. Usually, 2 µL of sample
were used and all presented spectra are background corrected for water absorption.
In the following chapters all of the above presented methods have been employed. The following
chapters discusses research of various aspects where fluorescence microscopy and cell culture were
applied to answer some questions in the field of drug delivery.
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6 Targeted drug delivery in cancer cells with
red light photoactivated mesoporous silica
nanoparticles
This project was performed in collaboration with Dr. Stephan Mackowiak, Alexandra Schmidt,
Christian Argyo and Constantin von Schirnding, Prof. Thomas Bein and Prof. Bräuchle. The Par-
ticle Synthesis and Characterization was manly performed by Alexandra Schmidt (group of T. Bein).
The Chapter is adapted from and based on the publication “Targeted Drug Delivery in Cancer Cells
with Red-Light Photoactivated Mesoporous Silica Nanoparticles”, published in Nano Letters [15].
The delivery of large amounts of cancer therapeutics specifically into the cytosol of cancer cells still
faces significant challenges. Beside the lack of specificity in uptake by cancer cells these challenges
include delivery of a large amount of cargo, release of the cargo into the cytosol and an easy synthesis
in only one delivery system. Notably, release of the drug from the endosome poses a significant hurdle
on the way toward drug delivery with high efficacy. In this Chapter, we will present a system that
provides solutions for all of these aspects by externally triggering the release with a photosensitizer.
In particular, a photoactivatable drug delivery system based on core-shell colloidal mesoporous silica
nanoparticles (MSN) was employed, which allows exact spatial and temporal control of the release
of the cargo from both the MSN and the endosome. [39, 221] Core-shell MSN are more suitable than
regular MSN for this task because they can have different functionalizations in the core and the
shell. This allows us to optimize the core functionalization, for example, for cargo uptake or covalent
binding of the cargo to the coreby disulfide bridges. [86] Moreover, the surface functionalization can
be chosen to implement various gating mechanisms, such as surrounding the MSN with a lipid
bilayer to enclose the cargo in it. [1, 39] Previously, our groups published a photoactivatable drug
delivery system performing some of the above-mentioned tasks. [1] The current system, as can be
seen in Figure 6.1 is improved in three key areas. The used photosensitizer (PS) will be activated
by red light instead of blue light; the synthesis is significantly simplified, and targeting ligands
have now been added to the system. The function of the photosensitizer is to solve the problem
of endosomal entrapment. Other approaches addressing this issue such as taking advantage of the
proton sponge effect, [89, 276] employing fusogenic or endosomolytic peptides, [51, 99, 277, 278] and
the drop in pH inside the endosome will be discussed in the following Chapters. The photoactivation
approach offers a solution for a defined and located initiation of the cargo release through an external
stimulus in the form of a laser beam. The laser beam can be directed into the cancer tissue and
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Figure 6.1: Schematic illustration of the multifunctional mesoporous silica nanoparticle (MSN-SHin-
COOHout) surrounded with a supported lipid bilayer (SLB) containing the necessary features for a stimuli-
responsive controlled release (photosensitizer) of the loaded cargo (calcein, rhodamine derivative) into the
cytosol of a targeted (folic acid to FA receptor, EGF to EGF receptor) cell .
activated at the right time point. The activation of the photosensitizer with red light instead of
blue light reduces the phototoxicity and significantly increases the depth of tissue penetration, [279]
which will be crucial when activation in vivo is required as shown by the Kataoka group. [280] In
comparison to regular photochemical internalization and other photoactivatable systems our system
exhibits specific uptake by cancer cells due to the presence of targeting ligands. Schlossbauer et
al. [1] presented MSN with photosensitizers that allowed free choice and controlled release of the
cargo. However, the issue of the targeting capability of the system was not addressed. Febvay et
al. [281] used MSN with photosensitizers in their studies as well, but the cargo had the role of
the photosensitizer; that is, the cargo selection was very limited. Moreover, the photosensitizer,
that is, cargo, was covalently bound to the MSN core, and hence a suitable release mechanism
was not present. Yang et al. [282] used lipid-coated mesoporous silica nanoparticles as carriers for
photosensitizers but aimed at improving photodynamic therapy (PDT). Gary-Bobo et al. [72] also
used their combination of PS and MSN to enhance PDT by a combination of photosensitizer and
cancer drugs. In the case of Lee et al., [283] the photosensitizer served as a gate-opening mechanism.
However, the PS was adsorbed inside the pores, and the cargo was attached on the surface via
singlet oxygen-sensitive linkage, and therefore the key feature of MSN having a high internal loading
capacity was not utilized here. In most of these systems the MSN served as improvement of PDT,
whereas in our system the photosensitizer specifically serves as gate-opening mechanism and as
a trigger for endosomal escape. In the current approach, we covalently link the photosensitizer
molecule (PS) to the MSN surface and encapsulate the MSN with a supported lipid bilayer (SLB)
to retain the drug. This allows for choosing a drug different from the PS and implementing a gating
mechanism as well. Furthermore, the targeting mechanism presented by Febvay et al. was based on
a streptavidin-coated nanoparticle and a cell surface that was stained with the antibody P-gp. [281]
40
6.1 Synthesis and Characterization
While this demonstrates the targeting effect in principle, this specific targeting system is rather rare
for cancer cells. Here we introduce the choice between two targeting ligands to our MSN, namely,
folic acid (FA) as an example of a small molecule ligand and epidermal growth factor (EGF) as an
example for a protein ligand. Both ligands are relevant for cancer cell targeting. For this purpose,
targeting ligands (TL) are inserted into the SLB by diffusion to achieve specific uptake of the drug
delivery vehicle by cancer cells.
In the following, first the synthesis and characteristics of our drug delivery system are disussed.
Subsequently, live cell microscopy studies will be presented to evaluate the functionality of the
employed targeting ligands and the release of the cargo from the MSN by photoactivation.
6.1 Synthesis and Characterization
Figure 6.2: Synthesis pathway of core (Green) shell (Red) MSN with covalently linked AlPcS2a (Red Star)
via PEG-linker (Black Chain) and surrounded by DOPC/DOTAP supported lipid bilayer with targeting
ligand (Green Star, TL), before the formation of the SLB, the MSN core is loaded with a cargo (yellow), in
our case calcein or a rhodamine derivative. Drawing is not to scale.
The core-shell MSN were synthesized via a sol-gel method using tetraethylorthosilicate (TEOS) as a
silica source and CTAC as a pore template (cf. appendix Chapter 1 for details and ref. [221]). The
MSN core was functionalized with thiol groups and the surface with cyano groups. The transmission
electron microscope (TEM) image of the MSN (MSN-SHin-CNout) shows spherical particles with
a mean diameter of 70 nm (Figure 6.3 a). The mesoporous channel structure radiating from the
particle center is apparent in the image. From dynamic light scattering (DLS) and nitrogen sorption
experiments a mean particle size of 69 nm and a mean pore size of 5.2 nm was determined (black
squares in Figure 6.3b and c). To promote endosomal escape and subsequent delivery of the cargo
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Figure 6.3: (a) TEM image showing bare MSN (I). The scale bar is 20 nm. (b) Particle sizes of species I-IV
in Figure 6.2 obtained by DLS measurements. All curves, except of species I (black curve), are shifted by a
value of 30 along the y-axis for clarity. (c) Pore size distributions of species I-IV. The exact values of the
maxima are given in Table 2 in the appendix. Data are shifted by a value of 0.3 along the y-axis for clarity.
Species I (black curve) represent MSN-SHin-CNout, species II (red curve) are MSN-SHin-COOHout, species
III (green curve) are MSN-SHin-PEGd8NH2, species IV (blue curve) are MSN-SHin-PEGd8-AlPcS2aout,
species VI (cyan curve) are DOPC/DOTAP-SLB@MSN-CARGOin-PEGd8-AlPcS2aout.
into the cytosol, we employ a photoactivation approach. Herefore, a red-light sensitive photosensi-
tizer, aluminum phthalocyaninedisulfonate (AlPcS2a), is covalently linked to the surface of the MSN
via an octamer PEG-linker. The PEG-linker is functionalized with amino groups on both ends. In
the first reaction step, the surface cyano groups of the MSN (MSN-SHin-CNout) are hydrolyzed to
carboxyl groups (MSN-SHin-COOHout), and subsequently the PEG-linker is attached to the MSN
surface via EDC amidation (MSN-SHin-PEGd8-NH2). The 13C solid state NMR (ssNMR) shows
the successful implementation of these three steps (Figure 6.4 a). The resonance of the carboxyl
group appears at 180 ppm upon hydrolysis of the cyano groups (red trace in Figure 2a). Follow-
ing EDC amidation, the carboxyl group disappears, and the C-O and CH2 resonances, both from
the PEG-linker, appear at 70 and 42 ppm, respectively (green trace in Figure 6.4 a). The other
resonances originate from the functionalized silanes of the MSN (cf. appendix for details). The
different surface functionalizations, including the attachment of the PEG-linker, are apparent in the
final relative mass levels of the thermogravimetric analysis (TGA) curves as well (Figure 6.4 b and
Table 2). Species MSN-SHin-PEGd8-NH2 with the PEG-linker has a significantly greater mass loss
than species MSN-SHin-CNout and MSN-SHin-COOHout. The slightly lower mass loss of species
MSN-SHin-COOHout in comparison to species MSN-SHin-CNout originates from a more stable silica
network that is formed during the 3 h heating in HCl, where the cyano is converted to carboxylic acid
groups. The more stable silica network is apparent from the reduced BET surface area, as measured
by N2 sorption experiments, as well (cf. appendix for details). Subsequently, AlPcS2a is attached
to the free remaining amino group of the PEG-linker by linking the PEG-NH2 group with one of
the two sulfonate groups of AlPcS2a (MSN-SHin-PEGd8-AlPcS2aout). The PEG-linker is required
here because direct attachment of the AlPcS2a to the MSN surfaces results in a significantly reduced
pore accessibility and particle aggregation. The successful attachment of AlPcS2a is inferred from
the IR spectrum (cf. appendix Figure 6) and the TGA (blue curve in Figure 6.4 b). The mass
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loss for species MSN-SHin-PEGd8-AlPcS2aout is comparably large due to the high molecular mass
of AlPcS2a. In particular, the ratio of the mass loss going from species MSN-SHin-PEGd8-NH2 to
MSN-SHin-PEGd8-AlPcS2aout and from species MSN-SHin-COOHout to MSN-SHin-PEGd8-NH2 is
2. This can be related to the molecular mass ratio of the PS and the PEG, which is 2 as well.
To utilize the above multifunctional nanoparticles as drug delivery vehicles, a cargo was loaded into
the MSN pores, and the entire nanoparticle was enclosed by a supported lipid bilayer to prevent
premature release of the cargo from the MSN core. The cargo was loaded into the MSN by incubating
them in a concentrated solution of the cargo overnight. In our system different types of cargo can
be loaded. Here we show two examples, calcein and a rhodamine derivative. After the loading of
the cargo the SLB is formed around the nanoparticle via the solvent exchange method as published
by Cauda et al. [39] The SLB consists of a lipid mixture of 70 vol% of 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) and 30 vol% of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). We
note that the length of the PEG-linker, as described above, should not be too long because otherwise
the formation of the SLB around the nanoparticle can be difficult. The DLS data (Figure 6.3 b)
show that the modifications of the MSN surface, the attachment of the PEG-linker, the linking of
the photosensitizer, and the formation of the 70 vol% DOPC/30 vol% DOTAP shell (SLB) result
in colloidal systems with slightly varying hydrodynamic particle sizes (Figure 6.3 b and Table 2 in
appendix, respectively). We note that the hydrodynamic sizes can also reflect a weak agglomeration
behavior. In particular, it appears that the presence of carboxyl- or sulfonyl groups, either directly
Figure 6.4: (a) Solid state 13C NMR spectra of species MSN-SHin-CNout, MSN-SHin-COOHout, MSN-
SHin-PEGd8-NH2. It shows the successful conversion of the surface cyano groups to carboxyl groups and
the subsequent linkage of the PEG8 linker to the MSN shell. Spectra for MSN-SHin-COOHout (red) and
MSN-SHin-PEGd8-NH2 (green) are shifted by a value of 2 x 106 each for clarity reasons. (b) Thermo-
gravimetric analysis of species MSN-SHin-CNout, MSN-SHin-COOHout, MSN-SHin-PEGd8-NH2 and MSN-
SHin-PEGd8-AlPcS2aout. The relative mass losses are given in Appendix, Table 2.
on the MSN surface or on the AlPcS2a, results in an increase of the effective particle size (red
circles and blue inverse triangles in Figure 6.3 b, respectively). In contrast, the presence of PEG
molecules on the MSN surface as well as the presence of the SLB results in a decrease of the effective
particle size (green triangles and cyan diamonds in Figure 6.3 b). In both cases, the origin of the
size decrease can be attributed to the weaker interactions between the particles caused by steric or
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electrostatic stabilization. The accessible pore size as obtained by nitrogen sorption measurements
is barely affected by the various surface modifications, as expected for particles that feature true
core-shell spatially distributed functionalities (Figure 6.3 c and cf. appendix for details). The
permeability of the SLB and the opening of the SLB by photoactivation were examined in situ
with a cuvette, containing a semipermeable membrane (for details see appendix). Figure 6.5 shows
the release of cargo, either calcein (blue triangles) or a rhodamine derivative (RD) (black squares),
from the MSN-PS-SLB (DOPC/DOTAP-SLB@MSN-CARGOin-PEGd8-AlPcS2aout). The amount
Figure 6.5: Release kinetics of calcein (solid blue triangle) and a rhodamine derivative (RD, solid black
squares) before and after photoactivation at 3 h with light of λ = 639 nm and 0.55 mW/mm2 for 1 min
of MSN-PS-SLB measured in situ. Only after photoactivation a significant amount of cargo is released,
demonstrating the impermeability of the SLB before. Analogously, the SLB can be opened by addition of
triton to the MSN solution after a 3 h time period. For both calcein (open blue triangles) and the RD (open
black squares) the release by triton is slower as compared to the opening of the SLB by photoactivation.
of released cargo over a 3 h time period before opening the SLB is minimal, demonstrating the
integrity of the SLB. After 3 h in the cuvette the SLB was opened either by photoactivation or
triton addition. To open the SLB through photoactivation the MSN-PS-SLB particles were exposed
to 639 nm light with a power density of 0.55 mW/mm2 for 1 min, resulting in an activation of the
photosensitizer and singlet oxygen production. The singlet oxygen reacts with the double bonds of
the DOPC and opens the SLB. This is apparent from the strong increase of fluorescence starting
after 3 h, originating from the release of the cargo from the MSN core (solid symbols in Figure 6.5).
Alternatively, the SLB can be opened by triton addition (open symbols in Figure 6.5). A strong
increase of fluorescence for calcein (open blue triangles) and RD (open black squares) is apparent.
However, the SLB opening via photoactivation seems to be more efficient, judging from the release
rate of the cargos after induced SLB opening. Besides the prevention of premature release of the
cargo from the MSN core, the SLB offers the opportunity to add various targeting ligands to our
nanoparticle system. In the following section, we will discuss how our MSN-PS-SLB system can be
modified with two different targeting ligands, namely, folic acid (FA) and epidermal growth factor
(EGF). The efficient modification of our drug delivery system with various targeting ligands as the
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final step in the synthesis allows for tuning of our multifunctional nanoparticles for a wide range of
cell types without constructing a completely new system for each cell type.
6.2 Targeting in vitro
Most cancer cells have specific receptors overexpressed on their surface. These receptors are only
present in small concentrations or not at all on the surface of healthy cells. Ideally, a drug deliv-
ery system can be easily modified to make it specific for multiple cancer cell types. The system
presented above offers this opportunity because the MSN-PS-SLB (DOPC/DOTAP-SLB@MSN-
CARGOin-PEGd8-AlPcS2aout) is only modified at the very end of the synthesis for a specific tar-
geting ligand (TL). The basic building block for adding the targeting ligand to the MSN-PS-SLB
(VI) is a DSPE-PEG2000-TL conjugate molecule. This building block is inserted into the SLB
by incubating the MSN-PS-SLB (DOPC/DOTAP-SLB@MSN-CARGOin-PEGd8-AlPcS2aout) with
DSPE-PEG2000-TL at 37◦C for 3 h (FA) and 12 h (EGF), respectively (final step in Figure 6.2).
In the studies presented here, we chose FA and EGF as targeting ligands because their receptors are
commonly overexpressed on a wide range of cancer cells. [284, 285] FA receptors are overexpressed on
various cell lines such as HeLa cells and KB cells, [284] and the EGF receptor is abundant on HuH7
cells, for example. [258] The functionality of the targeting ligands on our nanoparticle system was
evaluated by performing competition experiments and by evaluating the MSN-PS-SLB-TL (SLB-
TL@MSN-CARGOin-PEGd8-AlPcS2aout) uptake with live cell confocal fluorescence microscopy. In
a competition experiment the MSN-PS-SLB-TL are incubated with cells that were either previously
incubated with free targeting ligand or not. Preincubation of cells with free targeting ligand will
block the specific receptors on the cell surface. Consequently, uptake of the MSN-PS-SLB-TL
should only happen unspecific and therefore is expected to take much longer than receptor-mediated
endocytosis.
To evaluate the functionality of the FA ligand, KB cells were used. In the experiments shown
in Figure 6.6a the cells were preincubated with FA for 2 h at 37◦C before the MSN-PS-SLB-FA
particles were added to the cells and incubated for 3 h at 37◦C. Recording z-stacks of the cells
with a spinning disk confocal fluorescence microscope allows us to indicate MSNs inside or outside
the cell. A typical cut through the cell is shown in Figure 6.6. It shows that in KB cells only a
few individual particles are present inside the cell (Figure 6.6 a), whereas full stacks emphasize the
quasi absence of nanoparticles inside the cell, independent of the chosen focal plane. In contrast,
incubation of MSN-PS-SLB-FA with KB cells that were not preincubated with FA before resulted in
significant uptake of particles (Figure 6.6 b). The nanoparticles appear in the single representative
z-slice as well as in the full stack, through the entire height of the cell. This clearly demonstrates
that the particles are taken up by receptor-mediated endocytosis and that unspecific uptake of the
particles by KB cells is small after 3 h incubation time (see also in Figure 7 in the appendix).
In the case of the EGF ligand, we synthesized the DSPE-PEG2000-EGF conjugate as described
in the appendix. Similar to the FA experiments, we performed competition experiments with the
EGF ligand. Experiments were performed with HuH7 cells, which are known to overexpress the
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Figure 6.6: Unspecific and receptor-mediated endocytosis of MSN-PS-SLB particles with folic acid ligand
(MSN-PS-SLB-FA) by KB cells and MSN-PS-SLB particles with EGF ligand (MSN-PS-SLB-EGF) by HuH7
cells with GFP tagged tubulins (HuH7tub), respectively. (a) Incubation of MSN-PS-SLB-FA particles with
FA preincubated KB cells for 3 h at 37◦C . (b) Incubation of MSN-PS-SLB-FA particles with KB cells, not
FA preincubated, for 3 h at 37◦C . (c) Internalization of MSN-PS-SLB-EGF particles by HuH7tub with
EGF preincubated and (d) non pre-incubated HuH7tub cells. The KB cell membrane is shown in green and
the particles in red. For HuH7tub the GFP tagged tubulins are shown in green and the particles in red.
Images were taken with live KB cells and HuH7tub cells. The scale bar represents 10 µm.
EGF receptor. [258] Figure 6.6 c shows that in the case of pre-incubation of HuH7 cells with EGF
almost no MSN-PS-SLB-EGF particles are endocytosed by the HuH7 cells after 3 h. In contrast, a
significant number of the particles is present inside the cells when the cells were not preincubated
with EGF (Figure 6.6 d). Again typical slices of the z-stacks are shown in Figure 6.6 c,d (see also
Figure 8 in appendix). The above results demonstrate that our MSN-PS-SLB nanoparticles can be
modified efficiently to meet the specific requirements of various cancer types and to ensure a specific
receptor-mediated uptake. In addition, in the two cell types discussed here the unspecific uptake of
the NPs is very small after 3 h. Both are important factors for successful drug delivery vehicles in
order to prevent damage of healthy cells by cancer therapeutics. Furthermore, the targeting ligand
is introduced after the completion of the synthesis of the actual nanoparticle system. This offers
more flexibility to separately synthesize both the nanoparticle system and the DSPE-PEG2000-TL
because possible incompatible reaction conditions can be avoided. This allows for selecting the
synthesis strategies for both components more freely, which is considered a significant advantage
for the incorporation of fragile peptides into these systems. Besides the specific uptake of the drug
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delivery vehicle by cancer cells, it is of key importance for efficient drug delivery to release the drug
into the cytosol, and ideally to do so with spatial and temporal control. In the following, we will
show that our system provides the means to achieve this.
6.3 Cargo Release by Photoactivation
One of the main challenges for drug delivery with high efficacy is to overcome the endosomal en-
trapment in order to release the drug into the cytosol. In combination with MSN, three strategies
have been pursued so far to solve this issue, namely, employing polycations, [54] fusion or endoso-
molyticproteins, [51, 99, 278] or photosensitizers. [1, 280, 281] In the case of MSN coated with a
polycation, targeting capabilities were shown, but release of cargo was not, and no gating mecha-
nism, to keep the drug enclosed, was presented. [54] The fusion or endosomolytic protein approach
is a rather complicated and costly strategy, but it works well as has been demonstrated. [51, 99, 277]
However, for both methods an external control of the exact location and time of the cargo release is
not possible. A photoactivation approach provides both of these capabilities. In the studies where
MSN and photosensitizers were used, the photosensitizer was either loaded as a cargo into MSN [281]
or covalently attached to them. [1] The covalent attachment of the photosensitizer is advantageous
compared to loading it into the MSN pores. The ratio of MSNto photosensitizer is more easily
controlled, the loading capacity of the MSN can be completely used for the drug, and a spatial
separation between drug and photosensitizer exists. This could be important considering that the
singlet oxygen, produced by photoactivation of the photosensitizer, will most likely damage the drug
when not spatially separated from it. In previous work from our group, [1] the photosensitizer had
to be excited by blue light, which cannot penetrate the tissue very deeply. [279]
Figure 6.7: (a)Uptake of free calcein (green) and free AlPcS2a (red) by KB cells after 20 h incubation at
37◦C under 5 % CO2 humidified atmosphere. (b) Uptake of MSN loaded with calcein (green), covalent
attached AlPcS2a (red) and SLB after 20 h incubation at 37◦C under 5 % CO2humidified atmosphere.
Intensity scale is the same in both images. The fluorescence of calcein and AlPcS2a is slightly shiftet against
each other to show the colocalization clearer. Calcein is only transported into the cell in significant amounts
when it is loaded into the MSN. Scale bar represents 10 µm.
Moreover, the attachment of the used photosensitizer to the MSN surface was synthetically more
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involved. Here we have improved both of these aspects by using a different photosensitizer, namely,
AlPcS2a. First, it is photoactivatable with red light, and thereby the phototoxicity caused by light
activation with blue light is reduced. Additionally, the potential depth of tissue penetration of the
activation laser is increased by a factor of about 5. The latter feature will become important if
this drug delivery system is tested in vivo. Nishiyama et al. demonstrated this by using AlPcS2a
for a transfection of the conjunctival tissue in rat eyes. [280] Finally, AlPcS2a can be more easily
attached to the MSN surface than the previously used photosensitizer because a sulfonate group
can be directly linked to an amino group.
Figure 6.8: Fluorescence microscopy of MSN-PS-SLB-FA nanoparticles loaded with calceininside HeLa
cells, after an incubation time of 16 h. (a-c) Calcein (green) and AlPcS2a (red) are colocalized (yellow) prior
to photoactivation. (d) Intensity profile along the white line in the merged image for both. (e-h) 1 min, (i-l)
5 min, and (m-p) 10 min after photoactivation. The scale bar represents 10 µm.
To verify that the drug delivery mechanism works in vitro, we incubated MSN-Calcein-PS-SLB-
FA nanoparticles for 3 h with HeLa cells. In comparison to the incubation with free calcein, the
incubation of the nanoparticles containing calcein as a cargo produces a significantly higher calcein
concentration inside the cell (Figure 6.8 a). The uptake of free calcein by KB cells is negligible
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(Figure 6.7). This demonstrates that our drug delivery system can be used to efficiently transport
membrane impermeable cargos into the cell. Before photoactivation, calcein and the photosensitizer
are colocalized (yellow color in Figure 6.8 c) and exhibit a dot-like pattern, indicating that calcein
and the MSN-PS-SLB-FA particles are still inside the endosomes (Figure 6.8 a-c). This demonstrates
that the escape from the endosome does not happen automatically and that a mechanism is required
to overcome this key challenge in the field of drug delivery.
To induce the opening of the SLB coat around the MSN and the following endosomal escape in a
cascaded manner, we activated the integrated photosensitizer AlPcS2a with 1.2 W/mm2 of 639 nm
light for 1 min, at similar conditions as those used for the in situ experiment in Figure 6.5. As a
result, 1 min after activation an increase of the green fluorescence caused by calcein through the
entire cell and in particular in the nucleus can be observed (Figure 6.8e/h). In contrast, no change of
the red fluorescence pattern originating from the photosensitizer is observed; only a small decrease in
fluorescence can be seen due to photobleaching during the photoactivation step. This trend continues
over time as is apparent from the images taken at 5 min (Figure 6.8 i-k) and at 10 min (Figure 6.8 m-
o) after photoactivation. In the merged image after 1, 5, and 10 min (Figure 6.8 g/k/o), the
presence of the green signal becomes dominant, indicative of a lower colocalization between calcein
and photosensitizer due to the spreading of calcein in the cell. The green fluorescence is observed in
particular inside the cell nucleus. This time-series of images shows that photoactivation can open the
SLB and the endosome via an activation cascade, resulting in the release of calcein into the cytosol.
While the green fluorescence from calcein is present through the entire cytosol after photoactivation
(Figure 6.8 e/i/m), the dot-like pattern of the red fluorescence, caused by the PS on the MSN, does
not change (Figure 6.8 f/j/h). This shows that, in contrast to calcein, the MSN does not escape
from the endosomes. The reason for this behavior is unknown but has been observed before. [281]
However, we note that free PS in endosomes does spread after photoactivation (see Figure 6.9) in
Figure 6.9: Uptake of free AlPcS2a by HeLa cells after 20 h incubation at 37◦C under 5 % CO2 humidified
atmosphere. (a) Before photoactivation (b) 50 s after photoactivation with 1.2 W/mm2 of 639 nm light (c)
100 s after photoactivation. The spreading of the AlPcS2a is apparent. (d) Intensity trace of one endosome
marked by white circle in a - c. Scale bar represents 10 µm.
contrast to particle bound PS, and it is therefore not believed that particle bound PS causes much
damage to the cell. We also payed particular attention to the fact that there remained no free PS left
in the particle solution after the photosensitizer-attachment. Monitoring with Nanodrop UV-VIS
spectroscopy revealed, that it takes several washing steps, even after the human eye can not detect
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any left PS, to remove unbound PS. As can be seen in Figure 6.10a already supernatant 4, i.e. after
four washing steps, should be PS-free. But the supernatant is not PS-free before 8 washing cycles
(Figure 6.10 b). The destruction of cells through photosensitizers is also discussed in the literature,
Figure 6.10: (a) Supernatants of the washing procedure of the sample MSN-SHin-PEGd8-AlPcS2aout.(b)
UV-VIS data taken from the supernatants of the washing procedure of the sample MSN-SHin-PEGd8-
AlPcS2aout. No free photosensitizer could be detected in supernatants 8-10.
and if the photosensitizer is not located close to the cell membrane it cannot cause necrosis. [286]
The induction of apoptosis is dependent on the cell line, the overall light dose, the localization,
the type of photosensitizer, concentration of the photosensitizer, and many more parameters, and
therefore it should be subject of continuing intensive studies. However, for the intensities in the
range of 0.12-1.2 W/mm2, which were used in this work, the system works without observable
damage. Furthermore, the lifetime of singlet oxygen is relatively short (around 2 x 10−7 s [287]). We
emphasize that the cargo is located in the channels of the MSN, whereas the photosensitizer is clearly
separated from the pores via a PEG-linker and located at the outside of the MSN. Consequently the
singlet oxygen cannot destroy much of the cargo or of the cell membrane during the activation, as it
cannot diffuse inside the pores or too close toward the cell environment in this short time. In addition
to calcein, our multifunctional system can be loaded with various cargos. For example, we loaded
the MSN core (MSN-SHin-PEGd8-AlPcS2aout) with a rhodamine derivative (RD). Subsequently,
the loaded MSN core (MSN-CARGOin-PEGd8-AlPcS2aout) was surrounded by an SLB, and FA
was inserted into the SLB, resulting in MSN-RD-PS-SLB-FA (SLB-TL@MSN-CARGOin-PEGd8-
AlPcS2aout). The nanoparticles were incubated on KB cells for 22 h at 37◦C under a 5 % CO2
humidity atmosphere. Similar to calcein, the fluorescence from RD-loaded particles in the cells
exhibits a dot-like pattern before photoactivation (Figure 6.11 a). Ten min after the photoactivation,
an evenly spread fluorescence in addition to the dot-like pattern is observed (Figure 6.11 b). The
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Figure 6.11: MSN-PS-SLB-FA nanoparticles loaded with RD (green) inside KB cells. (a) Before and (b)
10 min after photoactivation. (c) Intensity profile along the white line in a and b. Postphotoactivation
(red line) a significantly higher fluorescence signal is apparent in the positions 10-20 µm in comparison to
pre-photoactivation (black line). The scale bar represents 10 µm.
increase of the evenly spread fluorescence is apparent when measuring the intensity profile in a region
that had low fluorescence before photoactivation. Figure 6.11 c shows the fluorescence intensity
along the white line in Figure 6.11 a/b. After photoactivation, a strong increase of the fluorescence
is observed. Thus, we conclude that 10 min after photoactivation some of the RD has been released
from the MSN core and from the endosome as well and subsequently has spread through the cytosol.
For both types of cargo the release into the cytosol occurs shortly after photoactivation, emphasizing
the precise temporal control that is provided by the photoactivation approach. In addition, before
photoactivation no spreading of the cargo is observed; that is, photoactivation is required for the
release of cargo into the cytosol. As a result, our system provides a means to spatially control
the release of cargo by applying laser light at specific areas, in particular the cancer tissue. This
spatial control is available in addition to the ligand-based targeting ability of our particles and
should further reduce unintentional exposure of healthy cells to cancer therapeutics. Therefore, the
selectivity of drug release should be enhanced in comparison to the cases where only the proton
sponge effect or fusogenic/endosomolytic peptides are used.
6.4 Summary
In conclusion, we have developed a drug delivery system based on mesoporous silica nanoparticles
that addresses some of the key issues in the field of drug delivery. In particular high selectivity
and high efficacy is achieved with this system. Furthermore, a combination of the high loading
capacity of MSN, the supported lipid bilayer for controlled release, the addition of targeting ligands,
and overcoming of endosomal entrapment by photoactivation makes this system a potent drug
delivery vehicle. Employing fluorescence microscopy, we were able to demonstrate the selective
uptake of our nanoparticles by various cancer cell lines and the release of different cargos in vitro.
Furthermore, we have demonstrated that the red-light-based photoactivation approach has many
advantages compared to other approaches used in the field so far. In particular, by covalently linking
51
6 Targeted drug delivery with red light photoactivated mesoporous silica nanoparticles
the PS to the MSN surface and using a PS that can be excited by red light, negative side effects of
the PS can be minimized, and activation of the PS in vivo is feasible. Moreover, photoactivation
for cargo release enhances the spatial selectivity of where the drug is released as compared to using
targeting ligands only. With this new system we have created a platform for drug delivery based on
MSN that is flexible regarding the loaded type of drug as well as regarding the employed targeting
ligand (implying the desired cell type for drug delivery). We anticipate that the integration of
all these strategies into one multifunctional drug delivery vehicle as well as the efficient synthesis
and modification of the nanoparticles for multiple cell types will hold promise for wide-ranging
applications, especially in cancer therapy.
In the subsequent chapter we will describe a polymeric surface coating, taking advantage of its pH -
dependent solubility behavior. Similar aspects as in this chapter, like targeting and overcoming the
endosomal entrapment with and without photosensitizer will be discussed.
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This project was performed in collaboration with Dr. Stefan Niedermayer, Alexandra Schmidt and
Stefan Datz from the group of Prof. Thomas Bein; Annika Herrmann from the group of Prof.
Ernst Wagner. The particle synthesis and characterization was mainly performed by Stefan Nieder-
mayer and mice experiments by Annika Herrmann. The Chapter is adapted from and based on the
manuscript “Multifunctional Polymer-Capped Mesoporous Silica Nanoparticles for targeted Drug
Delivery” which is being prepared for submission.
In the following, a multifunctional drug delivery vehicle that combines the high loading capacity of
a mesoporous silica core with the environmental sensitivity of a pH-responsive polymer is described.
The system takes advantage of the pH-changes inside tumor tissue and especially during endocytosis
to trigger internally the release of loaded cargo. For this purpose a polymer is used that changes its
water solubility due to de-/protonation.
Polymers can be attractive for biological applications due to their biocompatibility, tuneable prop-
erties and production from sustainable sources. [288, 289] Therefore, polymers are widely used as
responsive coatings of surfaces for selective ion-permeability [290], surface patterning [278], and
drug delivery with polyplexes [258, 278, 288], hybrid dendrimers [291–293], and other drug-polymer
conjugates. [38, 294] Regarding drug-polymer conjugates, which offer relatively small particle sizes
and good biocompatibility, possible issues may arise from low loading capacities and potentially
poor stability, depending on the strength of the drug-polymer interactions. [295] The drug-polymer
interactions need to be optimized for different kinds of drugs to ensure stable drug-polymer conju-
gates.
Combining the high loading capacity and stability of mesoporous nanoparticles with the biocom-
patibility and tuneable properties of polymers offers the possibility to create stimuli-responsive
and reversible delivery systems. For instance, You et al. showed the release behavior of poly(N-
isopropylacrylamide) coated mesoporous silica at different temperatures. [118] Drug delivery vehi-
cles based on nanoparticles in a size range of around 100 nm are likely to be taken up by cells
via endocytosis. [296] During this process, the endosome is being acidified by the action of proton
pumps. [87, 297] Therefore, pH-responsive polymer coatings around mesoporous silica nanoparticles
offer the possibility to use the changes in pH during endocytosis as trigger for controlled release. For
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instance, attachment of poly(acrylic acid) [298] or poly(2-(diethylamino)ethyl methacrylate) [299]
showed the ability of pH-responsive functional polymer coatings around mesoporous silica nanopar-
ticles for release applications. Liu et al. reported on different release kinetics from mesoporous silica
by the use of poly(4-vinylpyridine) as pH-responsive shell created by multipoint anchoring. [300]
Poly(2-vinylpyridine) (PVP) has also been used for the pH-sensitive functionalization of surfaces,
due to the pronounced transition between hydrophilicity and hydrophobicity upon protonation and
deprotonation. [301]
As shown in Figure 7.1, at low pH, the protonated polymer is in a hydrophilic state and therefore,
cargo molecules are able to diffuse into and out of the mesoporous silica nanoparticle. At pH values
around 5.5 or higher, deprotonation of the polymer takes place, producing a hydrophobic state
followed by a collapse of the polymer onto the silica surface, thus preventing premature release of
the cargo. The pH-responsive switching behavior of the polymer introduces a site-specific release
mechanism to the delivery vehicle. After endocytic uptake of the particles by a cell, the endosomes
are acidified by proton pumps present in the endosomal membrane. [297] The change in pH can
automatically lead to a switch of the particle into its open state, and subsequently trigger the
release of cargo into the endosomal compartment. A major advantage of this delivery vehicle is the
reversibility of the cap system. Once the particles have been exocytosed by the cell, before having
released all of their cargo, the cap system will return into the closed state due to the environment
(pH > 7) outside of the cell. [297] To maintain colloidal dispersibility, even in the hydrophobic closed
state, poly(ethylene glycol) blocks were attached to the ends of the PVP cap system. In this context,
the use of α-, ω-bis-functionalized polymers offers the possibility for anchoring any functionality of
interest (photosensitizers, targeting ligands) step by step (Figure 7.1).
Figure 7.1: Concept of the pH-responsive delivery system. The pores can be reversibly opened and closed
through changes in the water solubility of the polymer.
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7.1 Synthesis and Characterization
According to transmission electron microscopy (TEM), the shell functionalized mesoporous silica
nanoparticles (synthesis described in the Appendix) show an average particle diameter of 90 nm with
a wormlike pore structure (Figure 7.9). The stepwise functionalization with poly(2-vinylpyridine)
and PEG was monitored with several methods and is discussed in the following (DLS, zeta potential,
TGA, nitrogen adsorption, IR and Raman spectroscopy, Figure 7.2).
Figure 7.2: Different characterization methods of MSN: a) Dynamic light scattering, b) Titration exper-
iments showing the zeta potential of MSN-PVP (black), of MSN-PVP (red) and MSN-PVP-PEG (blue),
c) TGA data for MSN-NH2 (black), MSN-PVP-NH2 (red) and MSN-PVP-PEG-NH2 d) Nitrogen sorption
and e) IR spectra of MSN-NH2 (black), MSN-PVP-Boc (brown), MSN-PVP-COOH (red), MSN-PVP-PEG
(blue), HOOC-PVP-NH2 and NH2-PEG-NH2, f) Raman spectra of MSN-NH2 (black), MSN-PVP-NH2 (red)
and HOOC-PVP-NH2 (blue).
DLS measurements revealed the need for PEG as stabilizing agent. The hydrodynamic diameter
of shell-functionalized MSN in water was 160 nm (Figure 7.2 a). MSN nanoparticles functionalized
with PVP show strong aggregation in aqueous media due to their hydrophobicity at pH 7 indicated
by an apparent size increase to 550 nm. However, the attachment of PEG blocks to the end groups
of the PVP blocks recovers the colloidal nature of the system (DLS reveals a size of around 200 nm
again). Titration experiments are shown in Figure 7.2 b. The high zeta potential (+50 mV) of
MSN-PVP at low pH reflects the polymer cap system in its fully protonated and thus open state.
At pH = 5.5, close to the pka value of protonated pyridine, deprotonation of the polymer cap system
occurs, leading to a significant drop in zeta potential with increasing pH. Together with the zeta
potential, DLS measurements were performed simultaneously at the same pH values. For MSN-PVP
the particles showed good colloidal dispersability as long as the polymer remained in its protonated
state (Figure 7.2 a). Upon deprotonation, the polymer collapses at the particle surface, forming a
hydrophobic shell around the particles, which is revealed in the increase in size due to agglomeration.
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In contrast attachment of PEG blocks tho the PVP-functionalized particles led to the suppression
of aggregation, as no changes in size were observed over the whole pH-range for MSN-PVP-PEG
(Figure 7.2).
The functionalization of the mesoporous silica nanoparticles was also monitored with TGA (Fig-
ure 7.2 c). While the shell functionalized nanoparticles (MSN-NH2) show a relative mass loss of
14.6 % (2.97 mmol per gram silica), the relative mass loss of 61.6 % for MSN-PVP-NH2 corresponds
to 0.14 mmol PVP per gram silica. Only 4.7 % of the amino-groups present at the surface have
reacted with the polymer. Based on the mass loss of 80.4 % in the sample MSN-PVP-PEG, the
amount of 1.3 mmol PEG per gram silica could be determined. This result shows that additional
attachment of PEG to the shell of the MSN must have occurred besides the attachment to the end
of the polymer cap system.
In order to show the ability of poly(2-vinylpyridine) to act as a pH responsive cap system, nitrogen
sorption measurements were performed (Figure 7.2 d, Table 7.1). To observe the open form (MSN-
PVPopen) the particles where dried from a 0.01 M HCl dispersion at 60◦C, this was expected to
keep the protonated PVP functionalized MSN in an open state. The closed state could be realized
through drying from a dispersion in Millipore water (pH 7). It can be seen that in the open state,
the pores are accessible, whereas in the closed state, the polymer completely blocks the pores. The
BET surface area of 51 m2/g in the closed state is in very good agreement with an estimated external
BET surface area of 45 m2/g of spheres with similar density and diameter. The BET surface area
of 51 m2/g for MSN-PVPclosed corresponds to a reduction in surface area of 95 % compared with
MSNs without polymer cap system (MSN-NH2), indicating that the surface of the pore walls after
blocking is not even accessible for nitrogen.
Table 7.1: Summary of nitrogen sorption measurements
Sample BET surface area NLDFT pore size NLDFT pore volume
[m2/g] [nm] [cm3/g]
MSN-NH2 1097 3.78 0.79
MSN-PVPopen 617 3.42 0.36
MSN-PVPclosed 51 - -
IR spectroscopy served to follow each step of the synthesis (Figure 7.2e). The signals at 1590 cm−1
and 1570 cm−1 correspond to the C=C stretch vibrations of the aromatic pyridine ring and can be
found in all spectra after attachment of PVP to MSN. Additionally, in these spectra the C=N stretch
vibrations of the aromatic ring can be observed at 1474 cm−1 and 1430 cm−1. After deprotection
of MSN-PVP and conversion of the amino group into a carboxy functionality with oxalic acid, a
peak at 1677 cm−1 appears which can be attributed to the asymmetric C=O stretching vibration of
MSN-PVP-COOH. This peak vanishes after the addition of poly(ethylene glycol) bisamine, which
underlines the successful attachment of PEG. In addition, Raman spectroscopy was used to monitor
the attachment of HOOC-PVP-NH2 (Figure 7.2 f, blue curve) to MSN-NH2 (Figure 7.2 f, black
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curve) resulting in MSN-PVP-NH2 (Figure 7.2 f, red curve). Bands at 3062 cm−1 (*) (C-H stretch-
ing vibration of aromatic rings (pyridine)) and 1054 & 995 cm−1(*) (ring stretching vibration of
monosubstituted pyridines) are typical for the pyridine groups of poly-2-vinylpryridine. The signals
from the polymer appear in the MSN sample after attachment of PVP to MSN and are marked with
an asterisk.
7.2 Targeting in vitro
To design an effective drug delivery system, a targeting system is highly desirable. Generally one
can distinguish between passive and active targeting. Modifications such as attaching PEG at the
surface of the delivery system provide shielding against undesired interactions, and therefore, favor
the enhanced permeability and retention effect (passive targeting). Active targeting, on the other
hand, takes advantage of the overexpression of certain receptors on diseased cells by attachment of
the corresponding targeting ligand to the delivery vehicle. [302] Accordingly, the biocompatibility
and effectiveness of the PEGylated multifunctional MSN was tested further in an in vivo setting in
mice. Moreover active targeting was shown in vitro and in vivo using the example of folic acid (FA)
receptor targeting on KB-cells.
Figure 7.3: Unspecific and receptor-mediated uptake of MSN-PVP-PEG-FA particles by KB cells. a) Incu-
bation of MSN-PVP-PEG-NH2-FA particles with FA pre-incubated KB cells for 2 h at 37◦C. b) Incubation
of MSN-PVP-PEG-NH2-FA particles with KB cells, no free FA in cell culture medium, for 2 h at 37◦C. The
KB cell membrane is shown in green (dye WGA488) and the particles in red (dye Atto633). Orthogonal
views are given to illustrate the uptake more clearly. The scale bars represent 10 µm.
The attachment of active targeting ligands is important for creating a functional drug delivery
system. [302] Folic acid was chosen as targeting ligand because it is an ideal model system for
targeting with a small molecule and is also believed to be a promising candidate for clinical applica-
tions. [303] Furthermore, the covalent binding of folic acid to the particles can be achieved with an
EDC-mediated coupling and could be easily substituted by other targeting ligands without chang-
ing the coupling chemistry. To demonstrate the functionality of the particles, they were incubated
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with KB-cells, which are known to overexpress FA-receptors. [303] In a competition experiment,
with either free folic acid to block the FA-receptors or with uninhibited FA-receptors, the uptake
of MSN-PVP-PEG-NH2-FA particles and hence the targeting abilities were monitored. For the vi-
sualization of nanoparticle-uptake, z-stacks of the cells were recorded with a spinning disk confocal
fluorescence microscope, which allows us to detect MSNs inside or outside the cells after staining
the cell membrane.
In Figure 7.3, typical confocal cuts through the cells together with the orthogonal projection are
shown. In the case of pre-incubation with free folic acid, only a few individual particles are present
inside the cells (Figure 7.3 a), and also in the full stacks the quasi-absence of nanoparticles is noted,
independent of the chosen focal plane. In contrast, incubation of MSN-PVP-PEG-NH2 -FA on KB-
cells without pre-incubation of FA resulted in significant uptake of particles (Figure 7.3 b). The
particles appear in the representative z-slice as well as trough the entire height of the cell as shown in
the orthogonal views. In the case of blocked receptors, only unspecific uptake is expected to occur,
therefore the results demonstrate the specific folate-receptor mediated endocytosis within two hours
with only a minor rate of unspecific uptake.
7.3 Externally triggered release of membrane impermeable cargo
in vitro
To verify the release properties of the particle-system several experiments were performed. First,
the pH dependency was tested in vial, in a cuvette system, at pH 7 and pH 5 (Figure 7.2 b).
Second, the particles were tested in vitro, for this purpose they were incubated with cells to clarify
if the acidification of the endosome is efficient enough to deliver the cargo. For that purpose the
MSN were loaded with membrane-permeable and membrane-impermeable cargos and incubated with
cells for several hours. Because membrane-impermeable cargos did not show endosomal escape, a
photosensitive molecule was introduced to the system in order to trigger the endosomal escape
externally. [1, 15]
In vial. The pH-responsive opening of the polymer cap system was demonstrated by quantification
of released calcein molecules with fluorescence spectroscopy (Figure 7.2 b). All intensity values
are normalized to the highest obtained fluorescent counts of the respective sample. Therefore, the
highest amount released is set to 100 % relative release. The pH-dependent release curves show
the striking capping effect of the poly(2-vinylpyridine) cap system. At pH 7, the polymer is in its
hydrophobic state and thus successfully blocks the pores of the MSN until the release is triggered
by decreasing the pH. In acidic media, the polymer changes into its water soluble hydrophilic state
through protonation, which allows the cargo to diffuse out of the pores. As seen in Figure 7.2 b, no
significant changes in release kinetics are observed through further attachment of PEG compared
with sample MSN-PVP. The total amount of cargo loaded into the MSN could be calculated to
20.4 µg dye per mg MSN. Long-term release experiments showed that even after 16 h, the premature
release is less than 4 % (see Appendix Figure 13).
In vitro. The controlled release of cargo inside the desired tissue is one of the greatest challenges
58
7.3 Externally triggered release of membrane impermeable cargo in vitro
Figure 7.4: Release curve for fluorescein out of MSN-PVP-NH2 and MSN-PVP-PEG-NH2 with a change
in pH after 2h from pH5 to pH7 (normalized fluorescence intensity).
in drug delivery. Many systems have been developed and characterized, including fusion, redox-
sensitive systems and photoactivation. [87] Some of these systems exhibit already a good temporal
and spatial control of the cargo-release. But once they are activated, the release of the cargo is
unstoppable, even if the particles leave the tissue of interest. One advantage of our newly developed
system is the reversibility of the pore opening. If the pH of the environment turns neutral again,
PVP will close the pores and the delivery system can safely circulate inside the blood system.
By photoactivation. In the first experiments, MSN-PVP-PEG particles, loaded with calcein were
incubated on HeLa cells for 20 h. The incubation time is long enough to allow the endosomal
acidification. [287] However as seen in Figure 7.5, the fluorescence colocalization of the membrane-
Figure 7.5: Fluorescence microscopy of MSN(Atto633)-PVP-PEG (25 µg/mL) nanoparticles loaded with
calcein inside HeLa cells after 20 h incubation. a) merge of brightfield image and fluorescence image. b)
fluorescence image of calcein (green) and Atto633 (red) are co-localized (yellow), no spreading of calcein can
be observed, thus no endosomal escape has occured. The scale bar represents 10 µm.
impermeable cargo calcein and the covalently bound dye Atto633 remained. Calcein is a membrane
impermeable cargo and therefore is not able to exit intact endosomal compartments without external
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trigger, but it should be released inside the endosomal compartment. For membrane-impermeable
cargos the system had to be further enhanced to induce endosomal escape. Thus the photosensitizer
AlPcS2a (PS) was covalently linked to the PEG-chains, in addition to the pH-sensitive polymer on
the particle surface. Endosomal escape was expected to occur after acidification of the endosomes
and activation of the photosensitizer with red laser light. After activation with red laser light
(639 nm, 1.2 W/mm2) singlet oxygen is produced, which can destroy the endosomal membrane.
We emphasize that the lifetime of the singlet oxygen is very short (around 2 x 10−7 s [304]),
thus its diffusion range is limited and therefore the cargo and also the cell membrane should stay
intact, due to the spatial separation of cargo, cell membrane and PS. Moreover, the red light used
for activation of the photosensitizer is in a useful region for medical applications and is already
used in photodynamic therapy. [305] For the photoactivated release experiment, MSN-PVP-PEG-
Figure 7.6: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with calcein af-
ter 18 h incubation on a HeLa cell. a-c) Calcein (green) and AlPcS2a (red) are co-localized (yellow) prior
to photoactivation. d) Intensity profile along the white line in the merged image. The red line indicates
photoactivation with 1.2 W/mm2 of red light (639 nm). e-h) after 1 min. photoactivation, i-l) 5 min. after
photoactivation, m-p) 10 min. after photoactivation. The scale bar represents 10 µm.
AlPcS2a/FA particles were incubated on HeLa cells for 18 h. As seen in Figure 7.6, calcein and PS
are co-localized (yellow spots, Figure 7.6). Directly after 1 min photoactivation with 1.2 W/mm2
of 639 nm light, calcein-spreading over the whole cell can be observed, and the calcein-fluorescence
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gets brighter over time due to de-quenching of the dye upon escape from the MSN host (Figure
7.6 e/i/m). In comparison to the emission from calcein the fluorescence of the photosensitizer stays
localized in the same dot-like pattern as prior to the photo-activation, only the intensity is reduced
because of photo-bleaching effects after the activation (Figure 7.6 f/j/n). The intensity profile along
the white line, indicated in the merged pictures, depicts the fluorescence increase due to calcein
more clearly (Figure 7.6 d/h/l/p). The cargo release can also be visualized with a constant PS-
activation and simultaneous observation of calcein fluorescence. (over a period of 8 min; Figure
Appendix 9). Strikingly, a significant part of the cargo appears to be released inside the cell already
within two minutes. The above results were compared to those of incubation experiments of cells
with a solution of free calcein and PS. As seen in Figure Appendix 9, the amount of internalized
calcein is neglible. We also observe that the free PS is spreading over the whole cell , as already
described in Chapter 6.3. If the PS is not covalently bound to an MSN, the molecules can diffuse
inside the whole cell and can cause much more damage to the cell membrane and other organelles
due to their greater proximity.
7.4 Internally triggered release of membrane permeable cargo in
vitro
To safely deliver membrane-permeable cargos like DAPI [305] or colchicine [306] inside cells with
our newly developed system the implementation of additional endosomal escape mechanisms is not
necessary. It is anticipated that the particles will be taken up in endosomal compartments, and in
the following the endosomes get acidified. This drop in pH from around 7 to approximately 5 results
in the solvation of poly(2-vinyl pyridine) and thus in release of the cargo from the pores into the
endosome, and consequently into the cytosol if it diffuses through the endosomal membrane. On
the other hand, if the particles get exocytosed the pH will increase and poly(2-vinyl pyridine) will
turn insoluble again. In this case the cargo will stay inside the particles and the latter can circulate
again and possibly find a new target cell. DAPI and colchicine were used as model systems to
examine the delivery of membrane permeable cargo. DAPI preferentially stains dsDNA and thereby
produces a fluorescence enhancement of around 20-fold. [307] Figure 7.7 shows the staining of the
nucleus after several time intervals. Shortly after incubation only a weak staining of the nucleus can
be seen, after 15 h the nucleus is clearly visible and after 46 h even the region of the endoplasmic
reticulum gets stained. Because of the slowly increasing and very strong DAPI-fluorescence signal
after several hours of incubation, it could be excluded that the staining is due to free DAPI in the
particle solution. In the case of free DAPI in the solution, the staining would be expected to be
detectable shortly after addition, as the typical incubation time for nucleus staining with free DAPI
in solution is only between 1-5 minutes. The second cargo colchicine hinders the polymerization
of microtubuli as it binds to free tubulin. [306] It is blocking the formation of the mitotic spindle
but not the mitosis itself. For this study stable GFP-transfected liver carcinoma cells (HuH7) were
used, such that GFP is attached to the tubulin network. In Figure 7.8a a picture of untreated HuH7
cells with GFP tagged on the tubulin network is depicted; one can clearly see the fibrous tubulin
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Figure 7.7: Fluorescence microscopy of HeLa cells incubated with MSN-PVP-PEG nanoparticles loaded
with DAPI (blue) and labeled with Atto633 (red) after a) 15 min b) 15 h and c) 46 h incubation with the
cells. The nucleus region is indicated with dashed white lines. The scale bar represents 10 µm.
network. As shown in Figure 7.8 b, MSN-PVP-PEG particles loaded with colchicine were incubated
Figure 7.8: Fluorescence microscopy of HuH7 cell expressing tubulin GFP (green). a) untreated cells. b)
MSN-PVP-PEG nanoparticles loaded with colchicine and labeled with Atto633 (red) after 18 h incubation
with the cells. The scale bar represents 10 µm.
for 18 h, and as clearly seen, the fibrous structure has vanished completely, because the formation
of the tubulin network is hindered.
7.5 Stability
Stability tests in artificial cell media.
The stability of the MSN was tested i) in bio-fluids and ii) for storage purposes in order to get an idea
for the shelf-lifetime. Biostability assays were performed to test whether the polymer cap system
will prevent the mesoporous silica nanoparticles from degradation. This was done using Dulbecco’s
Modified Eagle’s Medium (DMEM) at 37◦C at two different pH values (5 and 7). As a widely used
basal medium for growing many mammalian cells, DMEM contains various amino acids, vitamins
and inorganic salts, amongst others and is used here to simulate a biological environment. Samples
were removed after specific times, washed and dried. The nanoparticles were then characterized with
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Figure 7.9: TEM images showing a) as synthesized MSN-NH2, and MSN after 24 h incubation in DMEM
media: (b) MSN pH 7, (c) MSN-PVP-PEG pH 7, (d) MSN-PVP-PEG pH 5. Nitrogen sorption isotherms
(left) and pore size distributions (right) for different immersion times in DMEM at pH 5.
Figure 7.10: Dynamic light scattering of MSN-PVP-PEG as synthesized (black curve) and after drying the
particles followed by redispersion in water (red curve). There is only a small size increase from around 142 nm
to around 164 nm, which is in the range of measuring inaccuracy and demonstrates a good redispersion.
transmission electron microscopy and nitrogen sorption. TEM images show significant degradation
of the nanoparticle structure for unfunctionalized MSN after 24 h immersion at pH 7 (Figure 7.9),
which is in good agreement with results of similar expirements reported earlier. [38] In contrast,
nanoparticles functionalized with PVP offer very good stability in DMEM at pH 7. At this pH,
the polymer cap system forms a tight, hydrophobic, and therefore impermeable envelope for water,
proteins and salts around the MSN.
Additionally, the polymer shell improves the stability of the MSN in DMEM at pH 5, where the cap
system is in its open state. In comparison with uncoated nanoparticles, MSN-PVP particles show
less degradation, which was also confirmed by nitrogen sorption experiments (Figure 7.9). In both
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Figure 7.11: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with calcein
inside KB cells, particles have been stored three weeks at 4◦C. a-c) Calcein (green) and AlPcS2a (red) are
co-localized (yellow) prior to photoactivation. The red line indicates photoactivation with 1.2 W/mm2 of
red light (639 nm). d-f) after 1 min. photoactivation, h-i) 5 min. after photoactivation, j-l) 10 min. after
photoactivation. The scale bar represents 10 µm.
cases, in the open and the closed state of the cap system, no changes in the pore size distribution
were observed, indicating that the pores are not affected by the medium. In order to test the
stability of the MSN regarding storage possibilities the functionality of 4-week-old particles (stored
at 4◦C) could be verified with in vitro release experiments(Figure 7.11). After storage in water and
(therefore in a closed state of the PVP) the particles retain the same calcein release behavior in
cells as was already seen in Figure 7.6. Drying and re-dispersion of MSN-PVP-PEG-NH2 in water
exhibits no significant agglomeration of the particles or any other visible change of their solution
behaviour (DLS measurements in Figure 7.10). According to the redispersibility of the nanoparticles
after drying a long shelf lifetime of the nanoparticles can be expected.
Cell experiments also revealed the good stability of the system. Even after storage of the ready-for-
use particles for four weeks at 4◦C the release behavior stays the same as can be seen in Figure 7.11.
This test is in good agreement with the stability tests that are described above. It clearly demon-
strates the good shielding of the silica core by the polymer layer.
7.6 Experiments in vivo
Biodistribution and biocompatibility upon intravenous injection in mice. In a next step,
the biodistribution of unfunctionalized MSNs and MSNs functionalized with FA and the cap system
was evaluated in vivo. Cy7-loaded MSNs were injected in mice (n=3) via the tail vein. Near infrared
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fluorescence imaging revealed short circulation times for both particle types. Preferred accumulation
in the liver was observed for several days (Figure 7.12). Importantly, both particle types were well
tolerated by the mice. To rule out toxic effects of the Cy7-loaded MSN clinical chemistry parameters
Figure 7.12: Intravenous administration of MSN in mice examined through near infrared fluorescence
imaging. Time dependent distribution of 100 µg per animal Cy7-loaded MSN-PVP-PEG-NH2-FA or un-
functionalized MSN (MSN-NH2) over 48 h. Upper panel: ventral position. Lower panel: dorsal position.
Experiments were performed in triplicates; a representative mouse of each group is shown.
were investigated. Serum parameters of 3 mice per group are shown in Figure 7.2. Treatment with
functionalized and unfunctionalized particles showed no deviations from the alanine transaminase
(ALT) and aspartate transaminase (AST) levels compared to the control group treated with pure
HBG indicating intact liver function. Besides, serum creatinine levels and blood urea nitrogen (BUN)
were also unaffected, confirming that kidney function was not compromised by the treatment.
Additionally, histopathological examinations of liver, lung, spleen and kidney were carried out and
there were no histological disturbances for both particle types compared to the HBG treated group
(Figure 7.13).
Prolonged retention in (subcutaneous) tumors of mice. In first experiments we tested tar-
geting to a MDA-MB-231-tumor model in mice after systemic application. The tumor231 is known
to overexpress FA-acid receptors as was already shown in literature. [308, 309] In this experiment
tissue sections of the tumor, liver, spleen, lung and kidney were imaged with confocal microscopy to
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Table 7.2: Clinical chemistry parameters of mice 48 h after treatment with HBG (control), MSN-PVP-
PEG-NH2-FA or unfunctionalized MSN. Values shown: alanine transaminase (ALT); aspartate transaminase
(AST); creatinine; blood urea nitrogen (BUN).
Treatment group ALT (U/I) AST (U/l) Creatinine BUN (mg/dl)
± SD ± SD (mg/dl) ± SD ± SD
control 33.9 ± 12.9 54.7 ± 14.1 0.3 ± 0.0 47.3 ± 8.5
MSN-PVP-PEG-NH2-FA 43.2 ± 13.6 59.2 ± 12.1 0.3 ± 0.0 43.9 ± 6.7
MSN-NH2 32.5 ± 2.5 51.9 ± 2.1 0.3 ± 0.0 47.4 ± 6.5
Figure 7.13: 48 h after treatment with HBG (control), MSN-PVP-PEG-NH2-FA or unfunctionalized MSN
the organs were dissected and fixed in formalin, embedded into paraffin and stained with eosin and hema-
toxylin. Images were taken on an Olympus BX41 microscope. Histopathological sections of: a) liver of the
control (HBG), b) animals treated with functionalized MSN and c) treated with unfunctionalized MSN; d)
lung after treatment with HBG, e) functionalized MSN or f) unfunctionalized MSN; g) spleen after treat-
ment with HBG, h) functionalized MSN or i) unfunctionalized MSN; j) kidney after treatment with HBG,
k) functionalized MSN or l) unfunctionalized MSN
evaluate the distribution of MSN after intravenous injection. Additionally the particles were loaded
with calcein in order to monitor model-drug release. But the detection of calcein inside the tissue
sections was not possible due to auto-fluorescence of the tissue below 600 nm. [310] As can be seen
in Figure 7.14 the particles can be found mainly inside the spleen and liver, also in the lung but
almost no particles are found in the kidney. MSN-PVP-PEG-NH2/MSN-PVP-PEG-FA particles
are able to reach the tumor tissue, presumably because of the EPR-effect. If also active targeting
takes place is hard to distinguish out of the performed experiments, as the uptake of the particles
into the cells is not clearly evaluable.
For a clear result studies with therapeutic loading have to be performed. Then the effect of ther-
apeutic loaded particles can be compared to unloaded particles and to free therapeutics. If the
targeting works the therapeutics loaded particles should give the best results.
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Figure 7.14: Systemic administration of MSN in MDA-MB-231-tumor (tumor231) bearing mice. The cell
nuclei are stained with DAPI (blue), MSN-PVP-PEG-NH2 are labeled with Atto633 (red). 3 mice per
group, one representative mouse of each group is shown. The mice were injected with HBG as control
(upper panel), MSN-PVP-PEG-NH2 (middle) and with MSN-PVP-PEG-FA (lower panel). Accumulation
inside spleen and liver can be clearly detected, also inside the lung, but almost no particles can be found in
the kidney. The scale bar represents 50µm.
7.7 Summary
In this work, we have developed a multifunctional drug delivery vehicle based on polymer- function-
alized mesoporous silica nanoparticles. This system combines attractive features such as the high
loading capacity of MSNs with the tunable functionality of a polymer. The use of bis-functionalized
polymers blocks allowed us to covalently attach step-by-step many functionalities of interest. We
demonstrate that covalently bound poly(2-vinylpyridine) in combination with a PEG-block acts as
a pH-responsive cap system for MSN. With this system, we show the successful delivery of dif-
ferent cargos into cells. Membrane permeable cargos were delivered without any external trigger,
because such cargos could penetrate the endosomal membrane. Covalent attachment of a red-light-
photosensitizer offered the possibility to open the endosome through irradiation with laser light,
and to deliver membrane-impermeable cargos. Effective targeting of folic acid receptor expressing
cells was enabled by the covalent attachment of folic acid. Stability tests revealed the effectiveness
of poly(2-vinylpyridine) not only as cap system, but also as a highly effective protecting agent for
MSNs against aggressive body fluids. In addition good storage stability for the dried particles can
be expected. Biodistribution experiments in vivo revealed no particle agglomeration and showed
preferred liver accumulation. The modified and unmodified MSN particles were well tolerated in
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mice without causing side effects. First in vivo targeting experiments revealed passive targeting of
MSN to a tumor mouse model providing a huge range of further investigations on cancer treatment.
With this new system we have developed a multifunctional toolbox based on MSNs that is able to
open and close its cap sysstem depending on the environment. One major advantage of our system
derives from the covalent attachment of all components which allows the system to operate for
several cycles. We anticipate that the possible integration of almost any functionality of interest, as
well as the efficient synthesis make this system promising for wide-ranging biological and medical
applications, especially in cancer therapy.
In the following chapter again the decrease in endosomal pH will be used to achieve endosomal
release, but this time the proton-sponge effect will be investigated.
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cargo - proton sponge effect
This project was performed in collaboration with Dr. Stephan Mackowiak and Adriano de Andrade
Torrano from the group of Prof. Bräuchle, Christian Argyo and Tim Gatzenmeier from the group
of Prof. Thomas Bein and Claudia Strobel from the group of Prof. Ingrid Hilger. Whereby the
Particle Synthesis and Characterization was mainly performed by Christian Argyo, [311] cytotox-
icity studies by Claudia Strobel and the quantification of particle uptake by Adriano de Andrade
Torrano. The Chapter is adapted from the publication “Investigation of the Endosomal Escape via
the Proton Sponge Effect with Dendron-Functionnalized Mesoporous Silica Nanoparticles”, which
is in preparation for submission.
In a recent publication, the problem of endosomal entrapment has already been investigated in a joint
project of Bräuchle, Bein and coworkers, showing no efficient cytosolic delivery of the cargo cysteine
after endocytosis for multifunctional MSNs designed for a redox-driven disulfide cleavage based drug
release system. [86] In order to overcome this barrier, photo-induced endosomal release via excitation
of co-incubated photosensitizer was employed causing rupture of the endosomal membrane upon
singlet oxygen generation. The system was further improved by adding “on-board-photosensitisers”
(cf. Chapter 6). Compared to the photoactivation pathway, requiring an external stimulus to induce
endosomal escape and the pH-responsive polymer approach presented in Chapter 7, the proton
sponge effect isanother promising “automatic” strategy to achieve endosomal release of nanocarriers.
The proton sponge effect describes an intrinsic osmotic swelling induced by the buffering capacity
of the modified nanocarriers, and consequently results in rupture of the endosomal membrane. [89]
In detail, after endocytosis of cationic polymers these act like a proton trap preventing a drop
in pH. [93] The intracellular trafficking of endosomal vesicles to late endosomes or endolysosomes
normally leads to an acidification of the endosomal compartment by proton pumps (H+-ATPase)
causing a decrease of the internal pH value from 7.4 to 5.5. [90] However, when cationic polymers
are present, the overall increased protonation level leads to a continuous inflow of protons coupled
simultaneously to a passive influx of chloride anions to maintain electron neutrality within the
compartment. Subsequently, an osmotic swelling and rupture of the endosomal membrane is caused
by the substantial increase of the ion concentration within the endosome.
Several cationic lipids and polymers [91, 92], such as poly (ethyleneimine) (PEI), with high buffering
capacities were examined as potential proton sponges, whereupon poly-(amidoamines) (PAMAM)
dendron structures have attracted great interest due to their high amino group content, simple
and variable synthesis as well as biomimetic structure. [291, 312–314] Dendrons represent a struc-
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tural component of a parent dendrimer structure, which are highly ordered, monodisperse, three-
dimensional, tree-like polymers comprising specific size and shape characteristics. [315] Due to their
high positive surface charge at physiological pH, PAMAM dendrimers exhibit extraordinary stabil-
ity forming complexes with DNA. In vivo experiments demonstrated that the use of high PAMAM
dendrimer generations (G7-10) as transfection agent for DNA is highly efficient. [316, 317] The result-
ing transfection was explicitly attributed to an activated proton sponge mechanism. Experiments
on PAMAM coating of carbon nanotubes further indicate that PAMAM structures are substan-
tially beneficial for cellular uptake and provide a reduction of cytotoxicity compared to uncoated
nanotubes. [318] Lin and co-workers investigated a gene transfection nanocarrier system based on
MCM-41-type mesoporous silica nanospheres containing covalently attached second generation (G2)
PAMAM dendrimers. [319] An intracellular delivery of plasmid-DNA complexed by the PAMAM
dendrimers and a fluorescent dye encapsulated in the mesopores could be observed. But as the dye is
not covalently bound inside the pores and the plasmid DNA is complexed with the dendrimeric shell,
the systems provides only an endosomal escape route, but a controlled release cannot be expected.
The stability of the system over multiple hours or even in the blood flow is doubtful.
Figure 8.1: Schematic illustration of the proposed proton sponge effect. MSN-D3 approach a cell and are
uptaken into endosomes. Endosome acidification leads to intrinsic osmotic swelling caused by the buffering
capacity of the dendrimer-coated MSN. Finally endosomal rupture takes place and the cargo can be set free
in the cytosol (reducing milieu).
In the present work, we established newly designed multifunctional core-shell MSNs coated with poly
(amidoamine) (PAMAM) dendron structures on the outer surface, which feature a high buffering ca-
pacity acting as a potential trigger for endosomal escape. Covalent binding sites (mercapto groups)
exclusively inside the mesopores can form disulfide bridges for immobilization of cargo molecules.
Cytotoxicity studies suggest good biocompatibility of this system. Subsequently, this nanocarrier
system offers controlled cargo release upon redox-driven cleavage of disulfide bridges when enter-
ing the reductive milieu of the cytosol. Additionally, the external PAMAM dendron shell of the
nanocarriers offer high buffering capacity to generate a pH-dependent intrinsic endosomal escape
mechanism via the proton sponge effect (Figure 8.1). Further attachment of the targeting ligand
folate at the outer periphery of the nanocarriers results in specific receptor-mediated cellular uptake.
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Our nanocarrier system can be modified at the very last synthesis stage with various ligands for
a specific targeting of cancer cells. It is anticipated that the combination of all these important
requirements for an efficient drug delivery makes the mesoporous silica nanocarriers a promising
platform for specific cancer therapy.
8.1 Synthesis and characterization
The synthesis of PAMAM dendron-coated MSNs was carried out in three steps. First, propargyl-
PAMAM dendron in the third generations (D3) was obtained by iterative steps of Michael additions
and amidations following a previously described procedure. [320] The synthetic route using the
reagents methyl acrylate and 1,2-ethylenediamine alternatingly for a stepwise creation of increasing
PAMAM dendron generations is shown in the Appendix, Figure 20.
For a convergent synthesis route to covalently attach the PAMAM dendrons at the external MSN
surface, a PAMAM dendron silane precursor was synthesized in a second step. The PAMAM dendron
silane was synthesized by performing a Huisgens click reaction to attach azidopropyl trimethoxysi-
lane to the propargyl-PAMAM dendrons. According to a previous report, [321] the azidopropyl
trimethoxysilane was synthesized and subsequently reacted with alkyne-PAMAM dendrons to gain
triazole-linked PAMAM moieties by using azide-alkyne click chemistry. In a last step, this silane
linker was used in a delayed co-condensation approach to create core-shell functionalized MSNs
via a sol-gel process, as described previously. [37, 38] Specifically, bifunctional MSNs (MSN-SHIN -
D3OUT ) equipped with dendrons generation 3 on the external surface was prepared via a delayed
co-condensation approach. The MSNs consisted of a thiol-functionalized particle core and addition-
ally PAMAM dendrons were present exclusively on the outer particle surface. The nitrogen sorption
measurements showed type IV isotherms indicating a mesoporous structure of the nanoparticles
with typical inflection points at about 0.3 p/p0 (Figure 8.2 a). At higher partial pressures (about
Figure 8.2: a) Nitrogen sorption isotherms and b) DFT pore size distribution of functionalized MSNs.
MSN-SHIN -N3OUT (black), and MSN-D3 (blue).
0.9 p/p0) a second hysteresis loop arose for both samples, which can be related to interparticle tex-
tural porosity. For the reference sample MSN-SHIN -N3OUT a relatively high BET surface area and
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pore volume was observed (data summarized in Table 8.1). The structural parameters of MSN-D3
are significantly reduced compared to MSN-SHIN -N3OUT . This is attributed to an increasing sample
mass due to the non-porpos organic polymer. Furthermore, there is the possibility that the large
PAMAM dendron caused clogging of some pore entrances at the low measurement temperatures
(−196◦C) of the nitrogen sorption measurements. The slight decrease in pore size could be related
to a partial pore blocking caused by the PAMAM dendron. Also we assume that the mesopores
are still accessible for the incorporation of cargo molecules. Transmission electron microscopy im-
Table 8.1: Structural parameter of functionalized MSNs.
a Pore volume is calculated up to a pore size of 8 nm to remove the contribution of interparticle porosity.
b DFT pore size refers to the range of the pore size distribution with sufficient percentage.
Sample BET surface area Pore volumea DFT pore sizeb
(m2/g) (m3/g) (nm)
MSN-SHIN -N3OUT 1190 0.74 2.5 - 5.0
MSN-D3 497 0.24 2.0 - 4.0
ages showed spherically shaped nanoparticles with sizes of about 70 nm in diameter for PAMAM
dendron-coated MSNs (Figure 8.3 c, MSN-D3). Furthermore, a worm-like porous structure consist-
ing of radially grown mesoporous channels was present for all samples. Additionally, dynamic light
scattering (DLS) measurements were performed to determine obtained particle sizes for the samples
and the particle size distribution is shown in Figure 8.3 a. Both samples featured a narrow size
distribution with an average particle size of about 122 nm. This indicated good colloidal stability
and no tendency for agglomeration in aqueous solution was observed. Zeta potential measurements
showed drastic changes in the surface charge of PAMAM dendron-coated MSNs (Figure 8.3 b). At
acidic pH values highly positive surface charge was observed for MSN-D3, a zeta potential of about
+60 mV at pH 2 was obtained. This sample exhibited high amino group content leading to such
a high positively charged particle surface. PAMAM dendron-coated MSNs showed a significant
difference of the zeta potential values compared to the reference sample MSN-SHIN -N3OUT . Here,
the isoelectric point (IEP) was close to pH 2, which resulted in a negatively charged particle surface
over the full pH range. Furthermore, MSNs functionalized with aminopropyl groups (MSN-SHIN -
NH2OUT ) featured only slightly positive surface charge with an IEP of about 4.2. The IEPs for the
PAMAM derived particles were significantly shifted to higher pH values (about 6.7). These highly
positively charged particle surfaces in acidic milieu gave evidence for a high proton acceptance of
the polymer shell resulting in a high buffering capacity.
For a more detailed investigation of the buffering capacity of PAMAM dendron-coated MSNs, both
samples were titrated against an aqueous solution of NaOH (0.01 M). As depicted in Figure 8.4,
PAMAM derived samples featured a significant increase in required volume of NaOH solution to be
neutralized (pH 7). This suggested a high tendency for proton uptake MSN-D3 indicating a great
potential to act like a proton sponge showing optimal buffering behavior in the pH range 5.5 to 6.5
which perfectly fits the endosomal acidification range. In general, a high buffering capacity in the
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Figure 8.3: a) Dynamic light scattering (DLS) measurements, b) Zeta potential measurements, c) Trans-
mission electron micrograph, and d) IR spectroscopy of functionalized MSNs. MSN-SHIN -N3OUT (black),
MSN-D3 (blue), and MSN-SHIN -NH2OUT (brown). The TEM image belongs to MSN-D3. For clarity
reasons, the curves of IR spectroscopy are shifted along the y-axis by 0.2 units.
physiological range (pH 5 - 7) is desirable to enable endosomal release via proton sponge effect. In
the literature, titrations of amino-terminal PAMAM generations with 0.1 M HCl gave sharp breaks
at pH 3.86 and pH 6.85, respectively.[312] This provided information about the pKa values for the
tertiary amino groups (pH ∼ 5) and for the terminal primary amino groups (pH ∼ 9). Conclusively,
the tertiary amino groups are significantly less basic than the terminal primary amino groups,
which were completely protonated already at pH 7.4. In contrast, the tertiary amino groups were
unprotonated at neutral pH values. Acidification (pH ∼ 5.5) causes an almost exponential increase of
the buffering capacity with the number of PAMAM generations. [322] In consequence, the buffering
activity of PAMAM dendrimer or dendron structures in the pH region of interest (pH 7 - 5) is
mainly provided by the tertiary amino groups. Elementary analysis provided information about the
quantitative organic functionalization degree of modified MSNs. The measured data is shown in
Table 8.2 (aminopropyl functionalized MSNs (MSN-SHIN -NH2OUT ) have been used as a reference).
The nitrogen content (wt% N) of the samples directly correlates with the amount of PAMAM
functionalization, since nitrogen atoms were only present in the PAMAM dendron structures. The
measured values for PAMAM dendron coated MSNs were significantly higher compared to the
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Figure 8.4: Titration data of functionalized MSNs. MSN-SHIN -N3OUT (black)and MSN-D3 (blue).
reference samples MSN-SHIN -N3OUT and MSN-SHIN -NH2OUT . These high nitrogen contents may
allow a high protonation level in acidic milieu. In terms of IR spectroscopy, organic functional groups
Table 8.2: Elemental analysis data for functionalized MSNs.
Sample MSN-SHIN -N3OUT MSN-D3 MSN-SHIN -NH2OUT
wt% N 0.860 2.47 0.350
were determined (Figure 8.3, for full range IR spectra see also Appendix Figure 3). All samples
featured typical bands of the silica framework appearing at 1240 - 1050 cm−1 (asymmetric stretching
vibration of Si-O-Si), and at 964 and 796 cm−1 (asymmetric bending and stretching vibration
of Si-OH). The reference sample MSN-SHIN -N3OUT showed a characteristic signal at 2111 cm−1
which was related to the azide vibration mode (asymmetric stretching vibration of - N=N+=N−).
Additionally, a band at 1629 cm−1 indicated the bending modes of physisorbed water. This band
was present in all spectra but was partially covered by other, more intensive bands for the PAMAM
dendron-coated particles. The nanoparticles MSN-D3 showed two additional bands at 1644 cm−1
(C=O stretching vibration) and 1554 cm−1 (N-H deformation and C-N stretching vibration), which
were attributed to the amide bonds of the PAMAM dendron moieties. An increase in intensity
of these signals was observed with increasing PAMAM dendron generations indicating increasing
amounts of functional groups within the samples. Further characterization of the attached functional
groups was performed by 13C solid state NMR analysis (Appendix Figure 18). MSN-SHIN -N3OUT
showed distinct signals for the propyl chains of the mercaptopropyl- and azidopropyl- moieties which
have been incorporated into the silica framework during the co-condensation approach at 53 ppm
(-CH2-N3), 27 ppm (-CH2-SH), 22 ppm (CH2-CH2-CH2-), and 10 ppm (Si-CH2-). Additional peaks
of high intensity at 58 ppm (O-CH2-CH3) and 15 ppm (O-CH2-CH3) were present in all samples and
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were related to ethoxy groups resulting from the extraction steps in ethanolic solution. PAMAM
dendron functionalized MSNs featured characteristic peaks for the amide groups of the PAMAM
dendrons at 173 ppm (C=O). Furthermore, weak signals at 144 ppm and 125 ppm derived from
the two carbon atoms in the triazole ring which provided evidence for a successful click reaction of
the PAMAM dendron silane precursor. Various strong signals in the range between 60 to 10 ppm
corresponded to different types of methylene groups which belong to the PAMAM moieties (52 and
40 ppm (N-CH2-R), 21 and 10 ppm (R-CH2-R)).
From all these results, we conclude a successful synthesis of core-shell functionalized MSNs with
the third generation of PAMAM dendron (D3) via the delayed co-condensation approach. The
PAMAM moieties are exclusively located at the external particle surface resulting in an organic
polymer coating of MSNs featuring a high buffering capacity. The sample MSN-D3 showed optimal
properties and might have a great potential to generate the proton sponge effect. Therefore, we
investigated the MSN-D3 particles in the following for cargo release, cytotoxicity, cell uptake and
cell targeting experiments.
8.2 Release - in vial
Figure 8.5: Redox-responsive release kinetics of 5(6)-carboxy-X-rhodamine (MTS-ROX) before (black) and
after (red) addition of dithiothreitol (DTT) to simulate the reductive milieu of the cytosol. Before medium
change, MSN-D3 shows no premature release of the fluorescent cargo molecules, which are attached to the
mesopores via disulfide bridges. Only in a reductive milieu a significant increase in fluorescence intensity
can be observed, demonstrating a redox-responsive release behavior of the MTS-ROX due to cleavage of the
disulfide bridges.
To prove a stimuli-responsive cargo release behavior of the PAMAM dendron-coated MSNs we per-
formed time-based release experiments of the fluorescent model drug 5(6)-carboxy-X-rhodamine
(ROX). The thiol-functionalization of the particle core offers the possibility to covalently attach
cargo molecules to the internal pore surface via disulfide bridges. In a reductive milieu (simula-
75
8 Dendrimeric shell and disulfide binding of cargo - proton sponge effect
tion of the cytosol), disulfide bridges can be cleaved causing a release of the cargo molecules from
the mesopores. [86] A derivative of the fluorescent dye ROX (containing the thiol-reactive group
methanethiosulfonate, MTS) was covalently attached to the particle core in a one-step synthesis at
mild conditions (1 h, room temperature, dark). The presence of non-bound dye was excluded due to
extensive washing steps before the release experiments. A custom-made two-compartment release
set-up was used to perform the in vial release experiments (Figure 8.5), as previously described. [40]
The PAMAM dendron-functionalized MSNs with immobilized MTS-ROX in the mesopores showed
no cargo release in aqueous solution under oxidative conditions within the first hour. The cargo
molecules were covalently attached via disulfide bridges preventing premature leakage of the dye.
Only upon addition of a reducing agent (dithiothreitol, DTT) an increase in fluorescence intensity
was shown. This indicateed a redox-responsive cleavage of the disulfide bridges and subsequently a
specific stimuli-responsive release of the fluorescent model drug occurred. In conclusion, the redox-
responsive behavior provides great potential for a specific cargo release once the mesoporous silica
nanocarriers have escaped from the endosomes and entered the cytosol of the targeted cell.
8.3 Cytotoxicity
Figure 8.6: Cellular uptake kinetics of PAMAM dendron-coated MSNs. Panels (a-c) show representative
3D images of single cells (in gray) and intracellular MSNs (in red) after 3 h, 24 h and 48 h. (d) The absolute
number of nanoparticles internalized by single cells increases steeply within the first 24 h and reaches more
than 13000 nanoparticles. Remarkably, the number decreases to around 10000 PAMAM dendron-coated
MSNs per cell after 48 h. The histogram depicts the mean ± standard error of two independent experiments
(n = 15).
The decision which dendrimer generation we used was partially based on the result of cytotoxicity
studies. It was shown, that high generation denrimers (starting with the fourth generation), due to
their high cationic charge, exhibit a high toxicity, whereby low generation denrimers are believed
to be more biocompatible. [323] In order to elucidate for the first time the toxicity of PAMAM
dendrimers in combination with MSN we determined the uptake kinetics and the relative cellular
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dehydrogenase activity(rcDH, in order to asses the cell viability) of immortalized human microvas-
cular endothelial cells (HMEC-1), modeling an important cell barrier after intravenous application.
Figure 8.7: Relative cellular dehydrogenase activity of human microvascular endothelial cells (HMEC-1)
after exposure to PAMAM dendron-coated MSNs. PAMAM dendron-coated MSNs revealed no cytotoxic
impact. n = 3 independent experiments.
To gain detailed information about the dose of MSNs effectively internalized by cells at defined incu-
bation times, we investigated the nanoparticle uptake kinetics (Figure 8.6). HMEC-1 were exposed
to a concentration of 100 µg/ml PAMAM dendron-coated MSNs for 3 to 48 h and subsequently
imaged by live-cell fluorescence microscopy. Confocal stack images of single cells (stained plasma
membrane, WGA488) interacting with fluorescent-labeled nanoparticles were acquired and evalu-
ated with Particle_in_Cell-3D, a custom-made ImageJ image analysis method [324]. In order to
reach an absolute quantification of nanoparticle, the intensity of each object (nanoparticle or ag-
glomerate) is compared to the intensity of a single nanoparticle previously measured in a calibration
procedure. Image analysis revealed that around 2500 nanoparticles are inside each cell after just
three hours. This number increases and reaches more than 13000 nanoparticles per cell after 24 h.
Interestingly, intracellular particles are diluted by the natural cell division process [325], and the
number decreases to approximately 10000 MSNs after 48 h. This interpretation is in line with the
reported doubling time of HMEC-1 cells, 28.6 h [326]. The relative cellular dehydrogenase activity
(rcDH) of HMEC-1 cells after exposure to PAMAM dendron-coated MSNs is presented in Figure 8.7.
Although the cells were shown to internalize thousands of nanoparticles, PAMAM dendron-coated
MSNs revealed no adverse effects over all investigated concentrations (10 fg/ml to 100 µg/ml) and
exposure times (3 to 72 h). For data interpretation the cytotoxic threshold giving by DIN EN ISO
10993-5:2009-10 was used. Therefore, PAMAM dendron-coated MSNs can be considered as highly
biocompatible.
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8.4 Release of different cargos - in vitro
We investigated the potential of freshly prepared PAMAM dendron-coated MSNs to achieve en-
dosomal escape via the proton sponge effect by performing in vitro cell experiments. Fluorescent
live-cell imaging with high-resolution spinning-disk confocal microscopy is a versatile technique to
examine the cellular uptake of nanocarriers and the intracellular cargo release. (cf. Chapter 5)
For the cell experiments we tried four drug-models, propidium iodide (PI), a rhodamine deriva-
tive (ROX), colchicine and DAPI, that all can be chemically modified with the thiol-reactive group
methanethiosulfonate (MTS) in order to create disulfid-bridges with the thiol-functionalization of
the MSN. Here PI and ROX are not able to to cross intact endosomal membranes, Colchicine and
DAPI molecules in contrast would be able to diffuse through the cell-membrane in case they are not
particle-bound. All four molecules exhibit features that makes them good model cargos for small
drugs. Propidium iodide is a positively charged fluorescent dye that binds to nucleic acids and its
fluorescence is increased 20-30 fold after intercalation therein. [271] DAPI is just as PI a stain for
nucleic acids and usually used to stain the cell nucleus of living/fixed tissues or cells. [262] Both dyes
are very useful as they exhibit an enhancement in fluorescence after intercalation into nucleic acids
and they can stain a MSN-free region inside the cell (nucleus), which is favorable as in this way also
dim fluorescence can be detected without cross-talk from the MSN-label. Rox however could be used
to demonstrate the delivery of the cargo inside the whole cytosol, as it isn’t supposed to cross an
intact cell membrane. It would only spread inside the cytosol after release, and is also good to use in
in vial experiments, as it doesn’t need a binding partner for fluorescence enhancement. Colchicine
is a non-fluorescent molecule, used in medicine as treatment against gout, which binds to tubulin
subunits and therefore hinders the polymerization of the tubulin-network. [327, 328] As the tubulin
network can be easily stained with commercial available kits, it is easy to monitor the delivery of
colchicine into the cytosol, as just the structure of the tubulin network hast to be monitored. We
excluded the possibility of free colchicine or DAPI molecues inside the particle solution (as they
would be membrane permeable) with extensive washing steps and always used the last supernatant
from the washing procedure to test its freedom of free molecules with cell experiments.
After endocytosis, the loaded nanocarriers need access to the reductive cytosol, which provides
efficient redox potential to cause cleavage of the covalent linkage and successful cargo release. Today,
due to limited understanding of cellular redox compartmentalization leads to controversial discussion
about the redox potential of the endosomal environment in literature continue. [329]
FRET experiments with disulfide-bridged folate-dye conjugates showed a time-dependent reduction
of the fluorescence signal after cellular uptake to KB cells suggesting to some extent a reductive
milieu in the endosomes. [330] In contrast, Austin et al. showed that the pathway of endocytosis for
antibody-drug conjugates, containing disulfide bridges, to breast carcinoma cells (SKBr3) provides a
oxidizing environment and hence no significant disulfide cleavage could be observed. [331] Since the
acidic milieu of lysosomes and late endosomes is not favorable for reducing agents such as glutathione
(GSH), endolysosomal content could be mainly degraded by means of thiol reductases. [332] These
enzymes are able to cleave disulfide bridges of free drug conjugates, but are too large to access the
porous system of MSNs. Therefore, we assume that our nanocarrier system only provides efficient
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cargo release only after endosome rupture, when the particles are freely distributed in the cytosol
Propidium iodid
The first dye we used was propidium iodide, as it was already shown in our groups, that it can be
delivered with MSN. [1] The MTS-functionalization was attached over an amino-group. First we
Figure 8.8: HeLa cells incubated for (a) 5 h with PI loaded MSN-D3 (same result for 40/72 h), (b) 16 h
with pure PI and photoactivated release of PI from endosomes. In case of free PI staining of the nucleoli
inside the nucleus (dashed white line) can be observed. The scale bar represents 10 µm.
tested the functionalized propidium iodide, if it is still functional after attachment of the reactive
group. For this purpose HeLa cells were incubated with the dye and free photosensitizer AlPcS2a
for 16 h. The photosensitizer was used in order to provide endosomal escape route as PI can not
pass the membrane of living cells. After 26 h the PS was excited as already described (Section 5.3).
As can be seen in Figure 8.8 b the nucleoli of HeLa cells are clearly visible and we can presume
that the dye is not damaged due to the binding procedure. Nevertheless, the dye-loading of the
dendrimer-functionalized particles was not successful. In Figure 8.8 a again HeLa cells are depicted.
In this case the cells are incubated for 5 h with PI-loaded MSN-D3. Contrary to the free PI/AlPcS2a
the cell and nuclei remained unfluorescent and only the MSN can be excited whereas the nucleus
remains dark. 40 and 72 h of incubation with PI-loaded MSN-D3 resulted in the same pictures. We
assume that due to the positive charges of the dendrimer and the positive charges in the PI only a
inefficent drug loading was possible and therefore no drug release could be detected.
ROX
The next dye we tested was a methanethiosulfonate-functionalized rhodamine derivative (MTS-
ROX). After an incubation time of 72 h of KB cells with MTS-ROX loaded MSN-D3 we could only
observe a slight cell membrane staining (Figure 8.9 a), in this case we increase the contrast in a
way that the particles seem overexposed. As it was possible, that the buffer capacity of MSN-D3
was not big enough to induce endosomal escape we added a second proton sponge inducing agent to
the denrimer functionalization over an EDC amidation, polyhistidine (polyHIS). Again after 72 h of
incubation a slight membrane staining could be observed (Figure 8.9 b). In Section 6.3 we already
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Figure 8.9: KB cells incubated for 72 h. (a) with ROX-loaded MSN-D3, (b) with ROX-loaded MSN-D3-
polyHIS and (c) with pure ROX. In all three cases a slight staining of the membrane can be observed. The
scale bar represents 10 µm.
observed the delivery of a rhodamine derivative into the cytosol after photoactivation. In this
case the rhodamine derivative spreaded inside the cytosol, but the membrane was not fluorescently
labeled through the released dye. Because of this we also incubated a small amount of free MTS-
ROX for 72 h and we could also observe the slight membrane-staining (Figure 8.9 c). It seems, that
the release of the dye is very slow and not enough dye could be release in order to detect it over the
background of the cell and the bright fluorescence of the MSN, also because of photobleaching.
Colchicine
We also tested membrane-permeable cargos. Membrane permeable cargos would not need a delivery
system to access the cells. But our goal is deliver the drug into a localized compartment and not
in every available cell. The memrbane-permeable cargos therefore are also attached into the MSN
pores over disulfide bonds. It is therefore believed, that it needs first endosomal escape, provoked
through the proton sponge effect, and afterward cleavage of the dsulfide bond inside the cytosol
in order to deliver the cargo. So the membrane permeability of the cargo itself is not believed to
influence the experiment.
The intracellular release of the cell membrane-permeable anticancer drug colchicine causes inhibition
of the microtubuli polymerization due to irreversible binding to tubulins. [333] The depolymerization
of the microtubules, which are basic structural components of the cellular cytoskeleton, is still
proceeding ultimately leading to cell death.
MTS-modified colchicine was immobilized at the inner mesoporous surface of the PAMAM dendron-
coated silica nanoparticles and subsequently these loaded drug delivery vehicles were incubated with
tubulin-GFP-transfected HuH7 cells. In Figure 8.10 a, the fluorescently-labeled microtubule network
(green) of untreated HuH7 cells is depicted for comparison. After 9.5 h of incubation the tubulin
network in this case is destroyed for MSN-D3 as well as for MSN-D3-polyHIS. A reproduction of this
experiment with the same particles (after a storage time of the particles of one week at 4 ◦C) was not
possible. Also experiments with the genetically modified HuH7 tubulin GFP cells were challenging,
as they were infected with mycoplayma and after the treatment with antibiotics showed problems
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Figure 8.10: Fluorescence image of HuH7 tubulin GFP cells. a) untreated cells expressing GFP to the
tubuline-network. b-c) HuH7 tubulin GFP cells incubated with MTS-Colchicine loaded MSN for 9.5 h. b)
MSN-D3-polyHIS particles on the cells, tubuline network is destroyed. c) MSN-D3 particles on cells, tubulin
network is also destroyed. The scale bar represents 10 µm.
with the GFP fluorescence. That’s why we changed the cell line finally to KB cells and GFP-
stained the tubulin-network with an commercially available transfection reagent. Additionally, as
we couldn’t detect a difference in polyHIS modified MSN-D3 to unmodified MSN-D3 we exclusively
used MSN-D3 for the experiments.
For the following experiments we always used particles not older than one week in order to be
sure, that no alteration of the system had taken place. Again the MTS-modified colchicine was
immobilized at the inner mesoporous surface of the PAMAM dendron-coated silica nanoparticles
and subsequently these loaded drug delivery vehicles were incubated with tubulin-GFP-transfected
KB cells. Already after 2 h of particle incubation (MSNs have been additionally labeled with
Atto633, red), endocytosis occurred to a high degree (Figure 8.11 b). Importantly, the microtubule
network seemed to be still intact, suggesting that no release of colchicine had occurred at this time
point. A partial destruction of the microtubule network could be observed, measured after 7 h of
incubation (Figure 8.11 c). After 22 h of incubation, cell death finally occurred which was indicated
by vanishing of the tubulin structure, blurred green fluorescence signal and a round form of the cells.
A delivery of free colchicine was excluded due to reference experiments with the sample supernatant
after particle separation by centrifugation showing no effect to the microtubule network for 22 h
(Figure 8.12). This destruction of the cytoskeleton due to colchicine has been observed by our groups
before. Cauda et al. could show an efficient cell death triggered by colchicine after endocytosis of the
drug-loaded MSN nanocarriers sealed with a supported lipid bilayer. [39] Despite of the enhanced
therapeutic effect compared to free drug molecules, concerns about premature leakage from the
lipid bilayer-coated nanocarriers may arise since colchicine features membrane permeability. In the
study of Cauda et al. [39] colchicine leads to the destruction of the tubulin network after only 2 h
of incubation. As the release mechanism in the previous study is believed to be simple diffusion out
of the SLB and endosomal membrane, as no controlled release mechanism is included, it is in good
agreement that in the present study, with a controlled release mechanism, it takes up to 22 h until
the tubulin network is destroyed. Thus, an immobilization of the drug molecules to the internal
mesoporous surface via stimuli-responsive cleavable linkers (e.g. disulfide bridges) as done in the
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Figure 8.11: Fluorescence microscopy of a/e) KB cells with GFP tagged tubulins (green). The cells were
incubated with MSN-D3 loaded with immobilized colchicine (MTS-Col) inside the mesopores and labeled
with Atto633 (red) for b/f) 2 h, c/g) 7 h and g/h) 22 h. e-h) Zoom in on representative microtubule
structures. A time-dependent destruction of the tubulin network can be observed finally causing cell death.
The scale bar represents 10 µm.
Figure 8.12: Fluorescence microscopy of KB cells with GFP tagged tubulins (green). a/c) The cells were
incubated with MSN-D3 loaded with covalently attached colchicine (MTS-Col) in the mesopores and labeled
with Atto633 (red) after 22 h incubation on the cells. b/d) Cells are incubated with sample supernatant after
particle separation by centrifugation for 22 h. c-d) Zoom in on representative micrutubule structures. A
destruction of the tubulin network can only be observed for particle-incubated cells. The scale bar represents
10 µm.
present work promises further improvement for a spatial-controlled cargo release. Conclusively, the
present cell experiments suggest a time-dependent intracellular release of immobilized colchicine
from the mesoporous drug delivery vehicles. We anticipate that the acidification of the endosomal
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compartment while trafficking initiated the proton sponge effect. The high buffering capacity of
the PAMAM dendrons caused high internal osmotic pressure subsequently leading to rupture of the
endosomal membrane and access to the cytosol. Reducing agents present in the cytosol were able
to cleave the disulfide bridges and colchicine has been efficiently released.
DAPI
We further investigated the in vitro release of 4’,6-diamidino-2-phenylindole (DAPI) on HeLa can-
cer cells. DAPI preferentially stains the nuclei of cells. The intercalation to dsDNA leads to a
significantly enhanced fluorescent signal, which can be detected by fluorescence live-cell imaging
microscopy (20-fold increase). [240, 334] PAMAM dendron-coated MSNs were immersed in a solu-
tion containing in situ synthesized DAPI derivatives with thiol-reactive methanethiosulfonate groups
(MSN-D3-MTS-DAPI), which were subsequently covalently attached to the mercapto-functionalized
mesopores of the silica nanoparticles. These established covalent disulfide bridges should be cleaved
only when the proton sponge effect has achieved endosomal escape and the nanocarriers have reached
the reductive milieu of the cytosol. HeLa cells were incubated with MSN-D3-MTS-DAPI for 5, 10
Figure 8.13: Fluorescence microscopy of HeLa cells incubated with MSN-D3 nanoparticles loaded with
immobilized DAPI (MTS-DAPI, blue) inside the mesopores and labeled with Atto633 (red) after a) 5 h, b)
10 h and c) 22 h incubation on the cells. The nuclei are indicated with dashed circles. Time-dependent
nuclei staining can be observed suggesting triggered release of the cargo molecules from the nanocarriers
after endosomal escape via the proton sponge effect and excess to the cytosol. The scale bar represents
10 µm.
and 22 h. Figure 8.13 shows an efficient cellular uptake behavior of the nanoparticles labeled with
Atto633 (red) already after 5 h. Moreover, only weak staining of the nuclei (blue) has been ob-
served at this time point. In contrast, free DAPI molecules are able to permeate through the cell
membrane causing efficient nuclei staining already within a few minutes (1-5 min), as described by
standard nucleus staining protocols. [262] Reference experiments with the sample supernatant after
particle separation by centrifugation showed only a marginal staining of the nuclei which proves
that only a small amount of free dye molecules was present in the particle solution. Therefore, we
assume that the DAPI was released from the MSNs upon cleavage of the disulfide anchors. Over the
entire time range a successive increase in fluorescence intensity of the DAPI-stained nuclei could be
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observed. We attribute this time-dependent release behavior of DAPI to the relatively slow process
of the proton sponge effect which was caused by the PAMAM dendron content of our nanocarri-
ers. Consequently, endosomal escape was provided for an efficient cytosolic delivery of the cargo
molecules.
Figure 8.14: Nuclei staining kinetics of the DAPI delivery to HeLa cells from MSN-D3-MTS-DAPI (black),
MSN-NH2-MTS-DAPI (blue), and the supernatant (red) of the MSN-D3-MTS-DAPI solution (after particle
separation). The fluorescence intensity of distinct regions of interest (stained nuclei) has been evaluated
after different time points of sample incubation. Data represents average fluorescence intensity ± standard
deviation. A time-dependent increase of fluorescence intensity can be observed for MSN-D3-MTS-DAPI
suggesting an efficient DAPI release from the nanocarriers. In contrast, the fluorescence intensity remains
constant at a marginal level for the reference samples. This indicates that negligible DAPI release occurred
for MSN-NH2-MTS-DAPI and almost no free DAPI molecules have been present in the particle solution
(supernatant).
For further monitoring of the proton-sponge induced cargo delivery, bare MSNs without dendron
functionalization on the external surface have been loaded with DAPI (MSN-NH2-MTS-DAPI) for
reference experiments. These nanoparticles only exhibit amino groups at the external surface. We
monitored their release behavior in comparison to the sample MSN-D3-MTS-DAPI and its solution
after particle separation (by centrifugation), denoted as supernatant (for fluorescence microscopy
images refer to Appendix 19). HeLa cells have been incubated with the samples for a total time
period of 61 h. The fluorescence intensity of DAPI-stained nuclei dependent on the incubation time
has been investigated for all three samples (MSN-D3-MTS-DAPI, MSN-NH2-MTS-DAPI, and su-
pernatant of MSN-D3-MTS-DAPI). The experimental findings are summarized in Figure 8.14 The
nuclei areas have been selected as distinct regions of interest (ROI) and the fluorescence intensity
has been evaluated at different time points for all samples. Sample MSN-D3-MTS-DAPI revealed a
significant increase in fluorescence intensity over time, as has been discussed before (cf. Figure 8.13).
This proves an efficient DAPI delivery to the cells shown by fluorescent nuclei staining. The su-
pernatant of sample MSN-D3-MTS-DAPI exhibited no temporal increase of fluorescence intensity
proving that only a small amount of free dye was present in the solution which was already completely
incorporated into the nuclei after 5 h (first data point). Conclusively, DAPI needs to be released
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from the mesopores of the dendron-coated silica nanoparticles. Importantly, the fluorescence in-
tensity for the reference sample MSN-NH2-MTS-DAPI also remained constant at a marginal level
comparable to the supernatant of sample MSN-D3-MTS-DAPI. Almost no nuclei staining could be
observed for sample MSN-NH2-MTS-DAPI indicating that negligible amounts of DAPI have been
released from these nanocarriers. This comparison demonstrates that the PAMAM dendron content
of our drug delivery vehicles is crucial to achieve successful cargo delivery to cancer cells.
Table 8.3: Overview over cargos used for release experiments with MSN-D3.
Cargo Membrane permeability Cellular observation Cell line
PI non membrane-permeable no release HeLa
ROX non membrane-permeable membrane staining KB
Colchicine membrane-permeable de-polymerizes tubulin structure HuH7tub, HuH7, KB
DAPI membrane-permeable staining of nuclei HeLa
Conclusively, these in vitro release experiments with different cell lines and different cargo molecules
(overview given in Table 8.3) incorporated into the mesoporous system of PAMAM dendron-coated
silica nanoparticles suggest an efficient endosomal escape followed by intracellular delivery caused by
the proton sponge effect. In contrast to the recent literature we were able to show the time-dependent
release of drug-models out of dendrimer-functionalized MSN, whereas other papers mainly show
knockdown of certain genes with PAMAM gene-complexes after one defined time-point. [319, 335–
337]
8.5 Targeting in vitro
Another key feature for a capable drug delivery vehicle is specific targeting of the desired tissue,
mainly cancer cells. Many cancer cell lines were found to overexpress diverse cell membrane receptors
due to increased metabolic activity. In contrast, healthy tissue features only small concentrations
of such receptors on the cell membrane surface. A preferential targeting of cancer cells can be
achieved by exploiting a receptor-mediated cellular uptake of the nanocarriers. Targeting ligands,
such as folic acid, can be attached to the periphery of the PAMAM dendron-coated MSNs. The
covalently bound FA moieties interact with the folic acid receptor FR-α resulting in a fast and
specific endocytosis. [15, 54] Amino group terminated PAMAM dendrons offer the possibility to
covalently attach folate via a short bifunctional PEG-linker. Atto633-labeled MSNs equipped with
the folate targeting ligand were incubated for 5+h with KB cells to investigate a receptor-mediated
endocytosis. In Figure 8.15 membrane-stained KB cells (WGA488, green) are depicted. Two cellular
uptake experiments were performed simultaneously. On the one hand, KB cells were pretreated with
free folate to gain full saturation and blocking of the cell receptors before particle incubation. Here,
unspecific cell uptake could be observed only to a minor degree (Figure 8.15 b), which is commonly
expected to take much longer than receptor-mediated endocytosis. Indication of the particle location
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Figure 8.15: a) Receptor-mediated and b) unspecific endocytosis of MSN-D3 with targeting ligand folate
(MSN-D3-FA, red) by KB cells (membrane staining, green). A specific receptor-mediated cell uptake can be
observed for MSN-D3-FA with KB cells (not FA-preincubated) after 5 h incubation at 37◦C (a). Incubation
of MSN-D3-FA with FA-preincubated KB cells for 5 h at 37◦C (b) shows significantly less internalized
particles compared to (a). The scale bar represents 10 µm.
(inside or outside the cell) can be received by evaluation of cellular z-stacks with a spinning disk
confocal fluorescence microscope. A significantly higher efficiency of particle internalization to the
cells occurred for KB cells without pretreatment with free targeting ligands (Figure 8.15 a). Here,
the fast cellular uptake is attributed to the receptor-mediated endocytosis of MSNs with folate
(MSN-D3-FA) which can also be seen in the orthogonal views.
8.6 Summary
In summary, the synthesis of PAMAM dendron-coated MSNs combines advantageous structural pa-
rameters such as high loading capacity and tunable functionality with the high tendency of PAMAM
dendrons for proton absorption. The novel synthesis strategy, primarily creating PAMAM dendron
silane precursors, which have been subsequently used in a delayed co-condensation approach, re-
sulted in core-shell functionalized MSNs containing PAMAM dendron moieties exclusively at the
external particle surface. Cytotoxicity tests suggest a very good bio-tolerabitly, since no adverse
effects of the PAMAM dendron-coated MSNs on the cellular dehydrogenase activity of the cells
were observed. Remarkably, under comparable experimental conditions, single cells were shown to
be overloaded with more than ten thousand intracellular nanoparticles.
We could show that these multifunctional mesoporous silica nanocarriers provide triggered and
efficient release of the fluorescent dye DAPI and the anticancer drug colchicine to cancer cells
which is achieved by the high buffering capacity of the external PAMAM dendron shell causing
the proton sponge effect. Conclusively, our drug delivery vehicles provide an intrinsic endosomal
escape pathway for efficient intracellular release of immobilized cargo molecules. This technique
prevents endosomal entrapment of nanocarriers and will also provide access for impermeable cargos
to the cytosol or other targeted cell compartments. Furthermore, they feature optional attachment
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of various cargos inside the mesopores via disulfide bridges and binding of different targeting ligands
to the outer periphery of the nanoparticles which can be precisely tuned to target specific cancer
cell lines. The multifunctional MSNs are viewed as a general platform for controlled drug delivery
in various biomedical applications, in particular for cancer therapy.
In the following chapter another strategy in using the decreasing pH-value inside endosomes is
investigated. We uses the pH-dependend binding of a enzyme-inhibitor pair for closing the pore
entrance of the MSN.
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9 Enzyme based pH-sensitive cap system for
MSNs
This Chapter is based on work in cooperation with: Christian Argyo [311], Michael Gattner, Stefan
Datz, Thomas Carell, Thomas Bein, and Christoph Bräuchle. The particle synthesis and char-
acterization was mainly performed by Christian Argyo and Stefan Datz, and carbonic anhydrase
functionalization by Michael Gattner. The Chapter is adapted from the manuscript “Carbonic
Anhydrase-Based pH-Responsive Cap System for Mesoporus Silica Nanoparticles” which is in prepa-
ration for submission.
Beside surface coating and internal pore modification, particle pore gating is another possibility for
controlled release mechanism from MSNs. As already described in Chapter 3.2 diverse molecules
can be used for particle pore gating. Besides SPIONs, [111, 125] Au-NPs, [112, 126] 18-crown-
6 [124] and [2]-pseudorotaxane, [131] biological relevant molecules such as DNA, [110, 120–122]
glycoprotein, [123] lysozyme [150] and ATP dependent aptamers, [162–164] provide high potential
as bulky gatekeepers.
The idea is to use molecules that are already present in the blood stream or inside cells and ther-
fore offer the opportunity of increased biocompatibility and improved prevention of a immune
response. The influence of surface coatings of nanoparticles on the immune response is part of
current research. [338] In this Chapter we investigated carbonic anhydrase (CA) as a cleaveable
capping structure for MSNs. CA is a ubiquitous enzyme in animals, as it catalyzes the hydration
of CO2/dehydration of bicarbonate, and is therefore a promissing candidate.
The attachment of CA to MSNs was achieved by using benzene sulfonamide (phSA) groups as a
functionalization of the external particle surface. Benzene sulfonamide groups are well described in
the literature as inhibitors for CA. The binding behavior of phSA to the active site of CA is pH-
dependent. [339] With this inhibitor-enzyme system we wanted to obtain a pH-sensitive gatekeeping
system. Both, CA and phSA are often used as model systems for biophysical and physical-organic
studies of proteins and protein-ligand binding. CA is a monomeric single chain protein of intermedi-
ate molecular weight (ca.30 kDa), its inexpensive, the amino acide sequence is known and it provides
a excellent stability under laboratory conditions. [339] The inhibitors aryl-sulfonamides can be easy
synthesized and posses a high binding affinity to CA (1 µM to sub-nM) to the catalytic center. [339]
In a pH region > 7 the carbonic anhydrase is reversibly bound to benzenesulfonamide which are
covlaently attached at the external particle surface and therefore show high potential to block the
pore entrances of the MSNs. A decrease in pH causes a cleavage of the coordination bond of the
inhibitor to the active site of the enzyme. As the hydrodynamic diameter of CA is about 5.4 nm
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Figure 9.1: a) Covalent attachment of sulfonamide groups (green) at the outer MSN surface. In a second
step, carbonic anhydrase (CA) enzymes (yellow) bind to the sulfonamide groups at pH > 7 and consequently
block the pore entrances. b) Carbonic anhydrase modified with norbonene binds also to the functionalized
MSN surface. c) Decreasing the pH to slightly acidic values (pH < 7) leads to a cleavage of the capping
system and incorporated cargo molecules can be released.
and the MSN pores are around 4 nm the gatekeeper is in a suitable size range for closing the MSN
pores efficiently.
With this system the incorporated cargo molecules should be concealed inside the MSN pores until
the particles reach a region (e.g. late endosomes or lysosomes) with a slightly acidic pH values.
Consequently the acidic enviroment triggers the cleavage of the capping system and the cargo can
efficiently be released.
Beside this highly controllable release mechanism, the system can be further improved with targeting
ligands, by a specific modifcation of the carbonic anhydrase. Therefore a unnatural amino-acid
(norbonen-lysine) was introduced into the amino acid sequence. [340, 341] With the help of the
unnatural amino-acid it is possible to attach one targeting molecule to one carbonic anhydrase. As
the unnatural amino acid was placed on the opposite side of the catalytic center, the targeting ligand
is presented exactly at the outer periphery of our drug delivery vehicles. The system described in
this Chapter represents a novel pH-sensitive capping system additionally providing the possibility
to attach targeting ligands at a defined exposed place of the carbonic anhydrase. We anticipate
that these multifunctional nanocarriers offer high potential for applications such as controlled drug
delivery.
90
9.1 Synthesis and characterization
Figure 9.2: a) Nitrogen sorption isotherms.b) DFT pore size distributions of functionalized MSNs. c)
Infrared (IR) data of functionalized MSNs. MSN-SH (black), MSN-phSA (red), and MSN-phSA-CA (green).
For clarity reasons, the curves are shifted along the y-axis by 0.2 units. d) Dynamic light scattering (DLS). e)
Zeta potential measurements of functionalized MSNs. f) Raman spectroscopy data of functionalized MSNs.
MSN-SH (black), MSN-phSA (red), and MSN-phSA-CA (green). For clarity reasons, the curves are shifted
along the y-axis by 0.1 units.
9.1 Synthesis and characterization
The synthesis of pH-responsive MSNs consisting of biomolecular valves based on the enzyme carbonic
anhydrase (CA) was achieved in a two-step approach. First, MSNs containing thiol-functionality
exclusively at the external particle surface were established, following a previously described de-
layed co-condensation approach. [37] In brief, the silica source tetraethyl orthosilicate (TEOS) and
the template cetyltrimethylammonium chloride (CTAC) were mixed at elevated temperatures in an
aqueous solution including the base triethanolamine (TEA) which additionally serves as a structure
directing agent to form colloidal nanoparticles. A mixture of TEOS and mercaptopropyl triethoxysi-
lane (MPTES) was added at the very last step of the silica framework formation to achieve a very
thin external functional shell consisting of thiol groups (MSN-SH). This organic moiety offers the
possibility to attach further functionality exclusively on the outer surface of the MSNs and not affect-
ing the porous system. In a second step, benzene sulfonamide (phSA) groups have been covalently
attached to the silica nanoparticles via a short bifunctional crosslinker (maleimide-C6-NHS) at mild
reaction conditions (MSN-phSA). The particle sizes of functionalized MSNs has been determined
with dynamic light scattering (DLS) measurements (Figure 9.2 d). All samples featured narrow
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particle size distribution implying a good colloidal stability. No agglomeration occurred due to the
additional attachment of organic moieties to the particle surface. Samples MSN-SH and MSN-phSA
show a maximum for particles sizes at 122 and 142 nm, respectively. For enzyme-coated particles
MSN-phSA-CA a slight shift to higher values can be observed (190 nm) due to the additional organic
shell based on carbonic anhydrase macromolecules.
Furthermore, the first-order reflection of the mesoporous material observed with small-angle X-
ray diffraction (XRD) suggests a non-ordered mesoporous structure (cf. Appendix Figure 21).
The surface charge of silica nanoparticles, measured by zeta potential, is changed due to stepwise
attachment of organic moieties (Figure 9.2 e). The isoelectric point (IEP) of MSN-SH (pH 3.6) is
shifted to a more acidic pH values (<2) for MSNs containing the benzene sulfonamide groups on the
outer surface. The tendency for sulfonamide groups to be protonated is relatively low due to the
stabilizing resonance effect, consequently causing a more negative surface charge since the influence
of silanol groups is increased. After attachment of the carbonic anhydrase a drastic change can
be observed. This enzyme consists of various amino acid residues which can be easily protonated,
including arginine, histidine and lysine. Therefore, a highly positive surface charge occurs over the
whole acidic pH range. MSN-phSA-CA features an IEP at neutral pH values (pH ˜ 7).
Table 9.1: Porosity parameters of functionalized MSNs.
a Pore volume is calculated up to a pore size of 8 nm to remove the contribution of interparticle porosity.
b DFT pore size refers to the peak value of the pore size distribution.
Sample BET surface area Pore volumea Pore sizeb
(m2/g) (m3/g) (nm)
MSN-SH 1170 0.83 3.8
MSN-pSA 1004 0.72 3.7
MSN-pSA-CA 99 0.07 -
Vibrational spectroscopy, including infrared (IR, Figure 9.2 c) and Raman (Figure 9.2 f) spec-
troscopy, were performed to investigate specific vibrational bands originating from organic groups.
IR data for all samples show typical vibration bands of the silica framework (Figure 9.2 c). A broad
peak in the range between 1300 and 1000 cm−1 can be assigned to Si-O-Si stretching vibration
modes. Two additional bands at 900 and 780 cm−1 are related to asymmetric stretching and bend-
ing vibrations of Si-OH groups, respectively. Furthermore, a group of bands in the range between
3000 and 2800 cm−1 can be observed which indicates C-H stretching vibration of methylene and
methyl groups from the propyl chain of organosilane moieties and residual ethoxy silane groups.
Sample MSN-SH features a band at 1633 cm−1 which can be assigned to the bending modes of ph-
ysisorbed water. This band is present in all spectra but partially overlapped by other more intensive
bands for the coated particles. MSNs containing the benzene sulfonamide groups show additional
C=O stretching vibration bands at 1700 and 1627 cm−1 which can be referred to the carbonyl
groups of the short maleimide-C6-NHS linker (maleimide and amide, respectively). Furthermore, a
peak of weak intensity at 1340 cm−1 is present in the spectrum of sample MSN-phSA which belongs
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to the typical asymmetric SO2 stretching vibration modes derived from the sulfonamide groups.
For the sample MSN-phSA-CA amide vibration bands (Amide I: 1639 cm−1, C=O stretching vi-
bration; Amide II: 1535 cm−1, N-H deformation and C-N stretching vibration) of high intensity
are all-dominant present in the range between 1700 and 1500 cm−1 which are typical for enzymes.
Raman spectroscopy provides complementary data to IR spectroscopy (cf. Appendix).
Nitrogen sorption measurements show type IV isotherms for MSN-SH and MSN-phSA confirming
mesoporosity of the silica nanoparticles. The corresponding nitrogen sorption isotherms are depicted
in Figure 9.2 a showing inflection points at p/p0 = 0.3. Another hysteresis loop at about 0.9 p/p0
is present for all samples which can be attributed to interparticle textural porosity. Relatively high
surface areas (up to 1200 m2/g) and pore volumes (0.8 cm3/g) can be observed for MSN-SH and
MSN-phSA (Table 9.1).
The slight reduction in these porosity parameters for benzene sulfonamide-functionalized MSNs can
be assigned to the increase of sample weight by additional non-porous organic moieties. Furthermore,
the DFT pore size distribution (Figure 9.2 e) still shows accessible pores. The porous system is not
affected by the attachment of the benzene sulfonamide linkers and no incorporation of organic groups
inside the mesopores can be observed which is confirmed by a constant pore size distribution. The
attachment of the bulky enzyme carbonic anhydrase results in a drastic reduction of the surface area
and pore volume for sample MSN-phSA-CA. Enzyme-coated MSNs feature a type II isotherm which
corresponds to non-porous materials. The carbonic anhydrase enzymes act like bulky biomolecular
valves which are able to efficiently block the mesopores even towards the access of small nitrogen
molecules.
Figure 9.3: In vial release kinetics of fluorescein molecules from the enzyme-coated MSNs at different pH
values. (a) Sample MSN-pSA-CA feature no premature release of the fluorescent cargo molecules in HBSS
buffer solution at pH 7.4 (closed state, black curve). After 3 h the medium has been changed to slightly
acidic milieu (CAP buffer, pH 5.5, red curve) resulting in a significant increase in fluorescence intensity. The
gatekeepers are detached from the particle surface upon acidic pH values causing an efficient and precisely
controllable release of the fluorescein from the mesoporous system. (b) Long-term stability of the capping
system was investigated in HBSS buffer (pH 7.4, black curve) and cell medium (blue curve). No unmeant
cargo release was observed within about 16 h.
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With all these data, we assume a successful synthesis of carbonic anhydrase coated MSNs via benzene
sulfonamide linkers. In order to investigate the pH-responsive secession of the bulky gatekeepers
from the particles, in vial cargo release experiments were performed. We used a custom-made two-
compartment system to analyze the time-based release of the fluorescent model drug fluorescein. [40]
After incorporation of fluorescein molecules into the mesoporous system, carbonic anhydrase was
added to block the pore entrances. An efficient sealing of the pores and no premature release of the
cargo can be observed for the sample MSN-phSA-CA dispersed in HBSS buffer (pH 7.4) at 37◦C
(Figure 9.3 a, closed state, black curve). After 3 h the solution has been exchanged and the particles
have been dispersed in CAP buffer (pH 5.5). The change to acidic milieu, which should simulated the
acidification of endosomes, causes a significant increase in fluorescence intensity over time reaching
its maximum after 18 h (open state, red curve). Furthermore, we could show a long-term stability
of the capping system for more than 16 h in HBSS buffer and cell medium at pH 7.4 (Figure 9.3 b).
These in vial release experiments demonstrates an efficient sealing of the pores with the carbonic
anhydrase as bulky gatekeepers preventing premature cargo release and a stimuli-responsive release
behavior upon acid-sensitive detachment of the capping system.
Figure 9.4: Enzyme activity assay of CA catalyzing the hydrolyzation of the chromogentic substrate p-
nitrophenyl acetate measured by UV-Vis spectroscopy (absorbance at 400 nm). Non-catalyzed (green) and
non-inhibited (blue) reaction and after addition of MSN-SH (black) or MSN-phSA (red).
Enzyme activity assays provide information about the binding affinity of carbonic anhydrase on the
surface of sulfonamide-functionalized MSNs (Figure 9.4). The enzyme activity assay investigates
the hydrolyzation of a chromogenic substrate (p-nitrophenyl acetate, NPA) in the presence of the
enzyme generating nitrophenol in TRIS-buffered solution. By UV-Vis spectroscopy the resulting
absorption maximum at 400 nm can be measured. Figure 9.4 shows the resulting curve for the
non-catalyzed (no carbonic anhydrase) reaction which can be taken as baseline. The slight slope
for this curve is due to the hydrolysis rate of the pure substrate in aqueous solution in the absence
of catalytic enzymes. In presence of 100 nM enzyme (non-inhibited) the maximum conversion of
the substrate can be obtained. By addition of 50 µg of MSN-SH particles a slight decrease in
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conversion efficiency can be observed due to marginal reduction of enzyme activity in presence of
silica nanoparticles. We assume that this effect corresponds to minor unspecific attachment of the
carbonic anhydrase to the silica nanoparticles causing inaccessibility of the active site to some extent.
In comparison, the addition of inhibitor-containing particles (MSN-phSA) a significant decrease of
the slope of the resulting curve can be observed. Conclusively, the sulfonamide-functionalized MSNs
are able to inhibit the enzyme carbonic anhydrase. At neutral pH values, the enzyme is specifically
attached to the sulfonamide-functionalized particle surface resulting in an inhibition of the enzyme’s
active site. This leads to a drastic decrease in enzyme activity. With this, we further anticipate the
confirmation of the pH-responsive gatekeeping concept of our mesoporous silica nanocarriers.
9.2 Dye release - in vitro
The in vitro release behavior of the sample MSN-phSA-CA was investigated with fluorescent live
cell imaging. Instead of fluorescein (used in vial) we used 4’,6-diamidino-2-phenylindole (DAPI) as
cargo and studied the release behavior on HeLa cancer cells. Since DAPI and fluorescein molecules
are of comparable size, the encapsulation behavior can be estimated the same. As already described
in Chapter 8, DAPI is used for nucleic staining, is cell membrane permeable and the fluorescence
intensity is about 20 fold enhanced after intercalation to DNA. [240] In order to keep track on the
particles they were, additional to the DAPI loading, covalently labeled with Atto633. To seal the
pores, the human carbonic anhydrase was added to the MSN solution after loading of DAPI. The
Figure 9.5: Fluorescence microscopy of HeLa cells incubated with Atto 633-labeled MSN-phSA-CA (red)
after a) 24 h on GFP-early endosome (green) tagged cells, b) 21 h incubation on GFP-late endosome (green)
tagged cells, and c) 21 h on GFP-lysosome (green) tagged cells. Co-localization (yellow) could be primarily
observed for late endosomes and lysosomes (indicated with arrows) suggesting that the multifunctional
MSNs are located in acidic compartments after endocytosis. The scale bar represents 10 µm.
first step in testing the in vitro release behavior of carbonic anhydrase capped MSNs was to explore
their fate inside HeLa cells. Therefore the early, late endosomes or lysosomes were stained with a
fusion-constructs of green fluorescent protein (GFP) and the corresponding cell component marker.
The cells were incubated simultaneously with the fusion construct and the Atto633 labeled, DAPI
loaded MSNs for 21-24 h.
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After 21-24 h the cells were imaged and co-localization between the GFP-marked cell compartments
and the MSNs was investigated. In Figure 9.5 an exemplary section is depicted. After 24 h of
incubation almost no co-localization (yellow) between early endosomes (green) and MSNs (red,
Atto633) can be found (Figure 9.5a). After uptake of the particles they should be delivered relatively
fast within minutes to a few hours to late endosomes. [303] The few yellow spots can be explained
by endocytosis of MSNs at later time points which were not delivered to late endosomes so far.
It can also be observed, that the MSNs are localized in the perinuclear region, which was already
observed for other nanoparticles after an incubation time around 24 h. [342, 343] The co-localization
Figure 9.6: Colocalization of MSN-phSA-CA with GFP-stained lysosomes. The intensity profiles along
the dashed white line in (c) is plotted for (a) MSN and (b) GFP-stained lysosomes, intensity maxima which
occur in both profiles are marked with red lines. (c) Fluorescence microscopy of HeLa cells incubated with
MSN-phSA-CA nanoparticles loaded with DAPI (blue) and labeled with Atto633 (red) after 21 h on GFP-
lysosome (green) tagged cells. The white spots indicate co-localization between MSNs and lysosomes. A
successful DAPI delivery is clearly visible by efficient nuclei staining (blue). The scale bars represent 10 µm.
(yellow) between late endosomes/lysosomes (green, Figure 9.5b/c) and MSNs (red) after 21 h of
incubation in contrast is clearly visible. The yellow spots are also indicated by arrows. In Figure 9.6
a more detailed analysis on the co-localization between lysosomes and MSNs is given. Along the
dashed white line the intensity profiles of the MSNs (Figure 9.6a) and lysosomes (Figure 9.6 b) are
graphically presented. The peaks (maxima) of all MSN can be assigned to a peak in the lysosome-
profile, which is also indicated with red bars for a clear allocation. At some areas the lysosomes
can not be clearly distinguished from another, because they lie very close together, in this cases
no clear statement about co-localization can be drawn. Also not every lysosome contains MSNs,
hence not every lysosome-peak has a corresponding MSN-peak. In Figure 9.6 c the same cells as
in Figure 9.5 c is depicted, but in this case the released cargo DAPI (blue) is also included. We
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summarize, that the MSNs are located in acidic compartments.
In a next step we took a closer look at the time-dependent release-behavior of DAPI from the CA
capped MSNs. Therefore, we incubated HeLa cells with the particles for a total time period of
24 h. In Figure 9.7 exemplary cells after 7, 15 and 24 h (Figure 9.7 a-c) of incubation are depicted.
Additionally the supernatant (after centrifugation) of the particle solution was incubated with the
cells in order to exclude free DAPI molecules in the solution (Figure 9.7 d). After 7 h of incubation
Figure 9.7: Fluorescence microscopy of HeLa cells incubated with MSN-phSA-CA nanoparticles loaded
with DAPI and labeled with Atto633 (red) after (a/e) 7 h, (b/f) 12 h and (c/g) 24 h of incubation on the
cells. The delayed nuclei staining with DAPI (blue) is caused by a time-dependent release of DAPI based
on the need for an acidic environment. (d/h) As a reference, the incubation with the supernatant solution
(without MSNs) showed no staining of the nuclei with DAPI after 24 h suggesting no free DAPI molecules
in the particle solution. The nuclei are indicated with dashed circles. (a-d) Merge of brightfield image,
MSN-fluorescence and DAPI. (e-h) Merge of MSN-fluorescence and DAPI. The scale bar represents 10 µm.
the particles were efficiently uptaken by the cells, which is evident from the localization in the cells in
the merge of particle fluorescence with brightfield images. However, a lack of nuclei staining after 7h
indicates that the release needs some time to start(Figure 9.7 a/e). Only after 15 h (Figure 9.7 b/f) of
incubation, the DAPI (blue) was efficiently released form the nanocarriers resulting in an significant
nuclei staining (even more intensive after 24 h; Figure 9.7 c/g). These experiments in combination
with the lack of DAPI fluorescence after incubation with the supernatant (particles separated by
centrifugation; Figure 9.7 d/h) demonstrate a time-depended release behavior without free cargo
molecules in solution. Thus we anticipate, that the acidification process inside the endosomes
destabilizes the binding between CA and particles and therefore efficiently releases the cargo DAPI
which leads to a delayed nucleic staining.
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9.3 Targeting - in vitro
For an efficient cell targeting a targeting ligand needs to be implemented. As the particle surface is
covered with bulky enymes (CA), the targeting moieties have to be attached directly onto the enzyme
in order to be available for receptors. Furthermore, the site of targeting attachment on the enzyme is
of key importance. It should be on the opposite of the acitve/binding site of the enzyme, to prevent
blocking of the active site. However, site specific chemical modifications of proteins was found to
be quite challenging. Different methods, such as the reaction of thiol groups with maleimide or
lysine chains with activated esters, lack of specificity. A more precise method is the incorporation of
unnatural amino acids (AS) into the protein. [340] The incorporation of unnatural AS bearing side-
chains with alkyne, trans-cyclooctene, cyclooctyne or norbornene can be found in the literature. To
Figure 9.8: Norbornene functionalized carbonic anhydrase (HCA H36Norb) with indicated functionaliza-
tion site (red) and active site (blue) is able to react in a revversed-electron-demand Diels-Alder reaction
with a folic acid-PEG2000-tetrazine derivate to HCA-FA.
incorporate the genetically encoded non-natural amino acids bioorthogonal tRNA/rRNA-synthetase
pairs are used. Especially the pyrrolysen systems is well studied. Previously aMethynosarcina mazei
PylRS triple mutant (norb-PylRS:Y306G, Y384F, I405R) which accepts norbornene-containing Pyl
analogue was identified by the group of Carell. [340, 341] The functionalization with norbonene is
of interest as they react selectively with tetrazine.
The synthesis of the norbornene functionalized carbonic anhydrase was accomplished similar to the
previously described procedure by the Carell-group [340, 341] gaining a human carbon anhydrase II
(HCA) with H36Norb. The norbornene modified HCA then was reacted with a folic acid-PEG2000-
tetrazine derivate as is schematically depicted in Figure 9.8. With this bio-orthogonal reversed-
electron-demand Diels-Alder reaction we were able to gain a folic acid functionalized CA. The
functionality of this modified enzyme as capping system was confirmed by another release experiment
in vial and in vitro (data not shown).
The efficiency of the as synthesized targeting system was again tested as already described in the
previous Chapters on KB-cells with free/blocked FA-receptors. In Figure 9.9 the result is shown.
The cell membrane of the KB cells is stained with WGA488 (green) and the particles are labeled with
Atto633 (red). In the first row (Figure 9.9 a-c) the folic acid receptor blocked cells are incubated 2-
8 h. With increasing incubation time only a few particles get internalized. In contrast, the cells with
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Figure 9.9: a-c) Unspecific and d-f) receptor-mediated endocytosis of MSN-HCA-FA (red) by KB cells
(WGA488 membrane staining, green). A specific receptor-mediated cell uptake can be clearly observed
for MSN-HCA-FA with KB cells (not FA-preincubated) after 5 and 8 h incubation at 37◦C (e/f), whereby
after 2 h of incubation no big difference to folic acid pre-incubated particles can be seen (d). Incubation of
MSN-HCA-FA with FA-preincubated KB cells for 2, 5, 8 h at 37◦C shows only a low amount of unspecific
cellular uptake over all incubation times (d-f). The scale bar represents 10 µm.
available folic acid receptor on their surface (Figure 9.9 d-f) exhibit an increasing uptake behavior
and more important have many particles internalized and not only a few as in the case of blocked
receptors.
9.4 Summary
In summary, we conclude that the novel capping system concept based on pH-responsive detachment
of carbonic anhydrase is a suitable candidate for a highly controllable drug release from porous
nanocarriers. Our drug delivery system provides an on-demand release mechanism shown by in
vial and in vitro cargo release experiments. The multifunctional MSNs are capable for efficient
endocytosis by cancer cells and are subsequently located in acidic cell compartments including late
endosomes and lysosomes. The acidic milieu caused cleavage of the coordination bond between the
sulfonamide linkers and the bulky gatekeepers and a successful cargo release occurred which has
been proven by the appearance of a strong fluorescent nuclei staining with DAPI. Also the specific
attachment of targeting moieties on a modified human carbonic anhydrase II provides possibilities
for applications in vivo, since the targeted delivery of drugs to the desired tissue is one of the critical
parameters especially in cancer therapy. With this systems the drug could be selectively aimed at
the desired tissue and only inside the cells the drug would be released. Consequently, spreading of
chemotherapeutics in the organism is restrained and systemic side-effects can be further reduced.
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A detailed investigation of this valuable characteristic is part of future work. This newly developed
concept for pH-responsive gatekeepers provide a promising basis for future work on mesoporous
silica particles as a more powerful and versatile drug delivery platform.
In the last chapter the difficulties in increasing the pore size of MSN are discussed as well as nature
derived strategies to overcome endosomal escape, namely fusion processes.
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In the following Chapter some other modifications of mesoporous silica nanoparticles for drug deliv-
ery are described, which are based on the systems presented so far. First investigations on particles
with increased pore size are presented. Furthermore, the incorporation of fusiongenic petides into
supported lipid bilayers around MSN was investigated.
10.1 Large pore MSN
This Chapter is based on the work in cooperation with: Alexandra Schmidt, Martina Licht-
necker [344], Katharina Braunger, Thomas Bein, and Christoph Bräuchle. The synthesis and char-
acterization of the large pore system was mainly performed by Martina Lichtenecker.
In the previous Chapters promising post-synthesis functionalization methods for colloidal mesosporous
silica nanoparticles, with pore sizes between 4 and 5 nm, are described in detail. These investigated
systems are able to deliver membrane-permeable cargos as well as membrane-impermeable cargos to
specific cells and release their cargo on external and internal stimuli. Often, the pore size of the MSN
is the limiting factor for various cargos (e.g enzymes). With a pore size around 4 nm of standard
silica nanoparticles (Chapter 6 - 9) only small molecules can be delivered, proteins normally need
more space due to size and charge. Therefore it is desirable to develop MSNs with reproducible
larger mesopores. [169, 184, 205, 345]
One of the most prominent mesoporous material is the Santa Barbara Amorphous 15 (SBA-15),
introduced in 1998 in the group of Stucky. [190] Their pore size of this material can be modified in
a broad size range (4.6-30 nm), but a particle size of 80 µm [190, 346], and are already tested in
various application fields like adsorption, host for (immobilized) catalysis or optical applications and
drug delivery. [347–352] In addition to the above mentioned pore size, the partilce size itself is of
high importance for drug delivery applications. If the particles are to small (below 5-6 nm) they will
most likely be cleared renal [12], in case of big particles (> 200 nm) they are very likely taken up by
the reticuloendothelial system (RES). [13] Because of this, SBA-15 particles can not be considered
for drug delivery systems inside living systems, even though their synthesis is reproducible and their
are well characterized.
Other approaches which were tested by Gao et al. [353] achieved smaller particles with pore sizes
of around 20 nm and particle size between 70-300 nm. A dual surfactant system, consisting of the
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triblock copolymer Pluronic F127 and Fluorocarbon Surfactant FC-4, together with the micellar
expander TMB was employed at low temperatures. It was shown that FC-4 limits the particles
growth whereas F127 acts as template for the mesoporous network. Additionally. the effect of
distinct hydrothermal treatment steps was investigated. Until now, all mentioned LP-MSN systems
lack introduced functionalization which is mandatory for the post-synthesis functionalization of the
NPs (e.g. attachment of capping systems). In the following controlled release experiments with
large-pore mesoporous slica nanoparticles (LP-MSN) synthesized in the Bein group are presented.
10.1.1 Synthesis and characterization
The LP-MSN particles investigated in this section were synthesized based on the modified procedure
of Gao et al.. [353] The reaction to create LP-MSN was performed under mild acidic conditions
at low temperatures (30◦C/ 10◦C) in the presence of the dual surfactant system Pluronic® F127
and FC-4 (high and low amount). A co-condensation approach was pursued to introduce organic-
functionalization within the mesoporous framework. (cf. details in Appendix Chapter 5.1) The
Figure 10.1: (a) TEM micrographs of LP-MSN-NH2/-Ph (10◦C, TEOS:FC-4 high (left) and low (right))
after size-separation centrifugation. The scale bar represents 50 nm (left) and 30 nm (right). (b) DLS data
of LP-MSN-NH2/-Ph (10◦C, TEOS:FC-4 high, black) and LP-MSN-NH2/-Ph (10◦C, TEOS:FC-4 low, red),
measured after size-separation centrifugation. (c) Nitrogen sorption isotherms at 77 K and (d) calculated
NLDFT pore size distribution of sample LP-MSN-NH2/-Ph (black, 10◦C, TEOS:FC-4 high) and LP-MSN-
NH2/-Ph (red, 10◦C, TEOS:FC-4 low) For clarity reasons the isotherms are shifted along the y axis by a
value of 200. (e) Zeta potential of sample LP-MSN-NH2/-Ph (10◦C, TEOS:FC-4 high, black) and LP-MSN-
NH2/-Ph (30◦C, TEOS:FC-4 low, red).
transmission electron microscope (TEM) imgage of the LP-MSN (LP-MSN-NH2/-Ph, TEOS:FC-4
high and low, after size-separation-centrifugation) shows spherical particles with a fairly homogenous
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particle size distribution within a size range of 100-200 nm (or around 60 nm for low FC-4) and
significantly larger pore size of 7-9 (or 8-14) nm (Figure 10.1 a). LP-MSN-NH2/-Ph synthesized
with higher amount of FC-4 feature a larger pore size (8-14 nm) compared to the low amount
FC-4 synthesized particles (7-9 nm), in both cases the pores are evenly distributed over the entire
nanoparticle. The particles with higher amount of FC-4 also exhibit a higher order in pore structure
and lower average particle size. Both particle types posses suitable pore size for the intended
application.
DLS measurements were performed to examine the particle size distribution after size separation
centrifugation (Figure 10.1 b). Sample LP-MSN-NH2/-Ph (TEOS:FC-4 low) features particles with
a size around 80 nm, LP-MSN-NH2/-Ph (TEOS:FC-4 high) around 300 nm. We attribute the slight
increase compared to TEM measurements to the development of hydrodynamic shell.
Nitrogen sorption data of high and low FC-4 LP-MSN-NH2/-Ph revealed IUPAC type IV isotherms
typical for mesoporous materials (see Figure 10.1 c/d). Sample LP-MSN-NH2/-Ph (TEOS:FC-4
low) exhibits a higher pore volume (0.8 cm3/g) and pore size (maximum at 13.0 nm) compared to
LP-MSN-NH2/-Ph (TEOS:FC-4 high) with 0.6 cm3/g and 8.1 nm. The obtained data are in good
agreement with the TEM measurements. Textural porosity or a small amount of impurities in both
samples are probable causes for the lack of a saturation plateau of the isotherms at high p/p0 values.
But the N2 adsorption measurements also reach their limitation within the large pore diameter of
our LP-MSN-NH2/-Ph.
For charge-determination, zeta potential measurements were performed (Figure 10.1 e). Due to
amino moieties present in both samples exhibit a positive zeta potential between pH 2-4. At pH 5-7
the NH2 groups are deprotonated and the potential turns negative. This behavior is typical for
amino-functionalized nanoparticles and indicates the successful functionalization of LP-MSN by
co-condensation.
To achieve a controlled endosomal release system with LP-MSN the particles were post-synthetic
modified with stimuli-responsive molecules, PVP/SLB for capping and AlPcS2a for endosomal es-
cape. As capping systems we tested supported lipid bilayers (SLB) and the pH-dependend polymer
poly(2-vinylpyridine) (PVP), which were already described with our established core-shell particles
in Chapter 6 and 7. The LP-MSN were loaded with a selection of cargo molecules of a varying size,
they are listed in Table 10.1. The release behavior was tested in vial and in vitro. Whereby for
the PVP-capped LP-MSN only the cargo calcein was used. The release of small molecules (calcein,
propidium iodide) was repeated in order to compare them with already performed experiments of
core-shell particles (with smaller pores, 4-6 nm) in our groups. [1, 15] The larger dextran molecules
(fluorescently labeled polysaccarides) were not used as model drugs so far, as their size exceed the
capacity of conventional MSN.
Supported lipid bilayer capped LP-MSN
In a first set of in vial release experiments the release behavior at physiological temperatures (37◦C)
of calcein (Figure 10.2 a) or FITC-dextran (3000-5000 Da, Figure 10.2 b; 10000 Da, Figure 10.2 c)
without internal release mechanisms was monitored with the already described fluorescent release
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Table 10.1: Properties of applied cargos in different size ranges.
size range cargo molecular hydrodynamic
weight [Da] radius [nm]
small size calcein 623 ca. 0.6
propidium iodide 668 ca. 0.6
medium size FITC-dextran 3.000 - 5.000 ca. 1.2 - 1.4
Alexa-Fluor-Phalloidin 1590 ca. 1.5
large size FITC-dextran 10.000 ca. 2.3
Alexa-Fluor-dextran 10.000 ca. 2.3
setup. The goal of this experiments was first to proof that the formation of the supported lipid
bilayer works also with increased pore size and therefore decreased real surface volume. Second
the incorporation of small, medium and large size cargos should be demonstrated. In a next step
LP-MSN with covalently attached photosensitizer AlPcS2a and cargo calcein were investigated (Fig-
ure 10.2 d).
The SLB was disrupted in all cases after 3 h of monitoring the closed system. The release trigger
for LP-MSN covered with SLB was the addition of Triton-X, which disintegrates the SLB. [39]
This delay time is important to rule out free fluorescence molecules and secondly in case of wrong
SLB-formation the fluorescence increase could be detected without inducing release. In the case
of attached photosensitizer the release trigger was light activation and resulting singlet oxygen
formation which then leads to membrane rupture. [15]
In case of calcein loading no premature release could be detected (Figure 10.2 a), indicating a
successful capping of the particles with the SLB. In case of the FITC-dextrans premature release up
to 20% could was visible (Figure 10.2 b/c). This could be either indicating an insufficient washing
step, so that free cargo molecules are in the solution or an insufficient sealing of the particles. In case
of free cargo molecules in the solution only a limited amount of fluorescent molecules should pass
the cuvette membrane, since the majority should be encapsulated inside the MSN by the supported
lipid bilayer. In case of an insufficient SLB-formation the fluorescence would increase constantly,
independent of the release trigger. Especially the small plateau that is reached after three hours in
the case of the 10000 Da FITC-dextran (Figure 10.2 c) indicates the presents of free dye molecules,
as otherwise the fluorescence would increase the entire time. Also the strong increase in fluorescence
after the triggered release indicates a successful formation of the supported lipid bilayer. We assume
that the polysaccharides of the dextranes interact with the SLB and can not be separated easily
thereof.
To overcome the endosomal entrapment the red light sensitive photosensitizer AlPcS2a was attached
onto the surface of LP-MSN. The functionality of the system in order to rupture the SLB was
demonstrated with the in cuvette-release experiment (Figure 10.2 d). By formation of a sulfonamide
bond, AlPcS2a was covalently attached to LP-MSN-NH2/-Ph. To remove excess AlPcS2a, the
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Figure 10.2: Dye release kinetics of SLB@LP-MSN-cargo as a function of time. After a three-hour release
experiment (37◦C) with SLB sealed LP-MSN-calcein, Triton-X (a/b/d) or photoactivation (c) was applied,
resulting in a burst of dye release. (a) SLB@LP-MSN-calcein. 100 % was set for the amount released after
8 h. (b) SLB@LP-MSN-FITC-dextran (3000-5000 Da). The inflection of the curve after 11 h presumably
is a result of photobleaching of FITC. The curve was normalized to 100 % for the amount released after
11 h. (c) SLB@LP-MSN-AlPcS2a-calcein. Photosensitizer AlPcS2a was activated by red laser light (639 nm,
1 min, 5.4 W/cm2). Saturation of released calcein was reached after 12 h. The release curve was normalized
to the value obtained after 12 h. (d) SLB@LP-MSN-FITC-dextran (10.000 Da). Saturation of released
FITC-dextran was reached after about 9 h. The curve was normalized to 100 % for the amount released
after about 9 h.
particles were extensively washed with a DMSO/H2O mixture (1:1 vol%) after the synthesis.
The supernatants of the washing steps were investigated with UV-VIS, as small amounts cannot be
detected by eye, but in spectroscopy/microscopy. For characterization of the attachment nitrogen
sorption measurements were performed and the BET area was calculated for each sample. The
results are given in Table 10.2. After attachment of AlPcS2a the BET-surface area increased slightly.
Table 10.2: Summary of nitrogen sorption measurements.
Sample BET surface area pore volume pore size
[m2/g] [cm3/g] [nm]
LP-MSN-NH2/-Ph 177 0.8 13.0
LP-MSN-AlPcS2a 246 0.9 13.0
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Presumably the large steric hindered AlPcS2a molecules resulting in interstitial pore volume. The
pore size was not effected by the synthesis, indicating that the mesoporous framework was not
affected by the reagents and that the attachment occured predominantely on the outer surface of the
LP-MSN. The amount of attached AlPcS2a was determined with thermogravimetric analysis of the
samples LP-MSN-NH2/-Ph and LP-MSN-AlPcS2a (Figure 10.3 a). The additional mass loss of 4.5 %
for the sample LP-MSN-AlPcS2a is high, considering that the amount of organo-functionalization
(APTES/PTES) was only 0.5 mol%. The amount of attached AlPcS2a was calculated to 64 µmol
per g LP-MSN-NH2/-Ph.
Figure 10.3: (a) IR spectra of LP-MSN-NH2/-Ph (black) and LP-MSN-AlPcS2a (red), normalized to silica
peak (1087 nm), in blue: IR spectrum of AlPcS2a (normalized to the strongest peak). The spectrum of
LP-MSN-AlPcS2a was shifted along the y axis by a value of 0.25 and the spectrum of AlPcS2a by a value
of 0.5 for clarity reasons. (b) Thermogravimetric analysis of the samples LP-MSN-NH2/-Ph (black) and
LP-MSN-AlPcS2a (red). The curves are normalized at 130◦C. The mass loss is not easily evaluated as high
temperatures can cause side reactions like dehydroxylation of the silanol-groups. For mass loss calculations
the mass value at 900◦C was used.
Infrared spectroscopy (Figure 10.3 b) also confirmed a successful attachment of AlPcS2a. Peaks
between 2959 and 2838 cm−1 can be attributed to symmetric and asymmetric CH2 stretching
vibrations. The peak at 1678 cm−1 with medium intensity can be attributed to the O-H vibration
of small amounts of water in the sample. The aromatic stretching vibration of AlPcS2a is outlined
at 1456 cm−1 (dashed line) and can be found in both spectra (LP-MSN-AlPcS2a and AlPcS2a).
At 1377 cm−1 (second dashed line) the asymmetric SO2 stretching vibration of the newly formed
sulfonamide bond is visible in the spectrum of LP-MSN-AlPcS2a. Below 1300 cm−1 the vibrations of
the silica framework arises with strong intensity, whereas the aromatic vibrations below 1000 cm−1
could not be detected.
To conclude, the successful synthesis of large pore mesoporous silica nanoparticles could be demon-
strated. Also the formation of a supported lipid bilayer around the particles was shown, and the
covalently attachment of photosensitizer to LP-MSN as photoactivable release stimulus was achieved.
In contrast to the standard MSN which are described in Chapter 6, the use of a PEG-spacer between
LP-MSN and AlPcS2a was not necessary in order to prevent pore clogging.
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Post-synthesis modified LP-MSN with PVP capping
Additionally to the supported lipid bilayer approach a polymeric capping system was tested with
LP-MSN. The synthesis route was equal to the one described in Chapter 7. For all experiments the
cell-membrane impermeable cargo calcein was used, making the employment of a photosensitizer
for endosomal escape mandatory. (cf details in Appendix Chapter 5.1)
Figure 10.4: (a) IR spectra of LP-MSN-NH2/-Ph (black), LP-MSN-PVP-Boc (blue), LP-MSN-PVP-NH2
(red), LP-MSN PVP-Ox (purple), LP-MSN-PVP-PEG-NH2 (green) and LP-MSN-PVP-PEG-AlPcS2a (ma-
genta). All spectra are normalized to the silica peak. The dashed lines indicate the C=C and C=N stretching
vibration of the pyridine rings. The asterisked peak in the spectrum of LP-MSN-PVP-Boc can be attributed
to the asymmetric CH3 bending vibration of the Boc protecting group, the asterisked peak in the spectrum
of LP-MSN-PVP-Ox can be assigned to the C-O stretching vibration. (b) Thermogravimetric analysis of
the samples LP-MSN-NH2/-Ph (black), LP-MSN-PVP-NH2 (red), LP-MSN-PVP-PEG-NH2 (green) and
LP-MSN-PVP-PEG-AlPcS2a (magenta), all curves were normalized at 130◦C. The mass losses of the green
and magenta curves are not easily evaluated as both curves are descending between 800◦C and 900◦C. This
might be caused by side reactions like dehydroxylation of the silanol-groups.
In order to characterize the reaction TGA measurements and IR spectra were recorded. TGA
measurements were performed for each reaction step to calculate the additional mass loss (Fig-
ure 10.4 a). From the mass loss of 7.5 % of LP-MSN-NH2/-Ph (Figure 10.4 a, black curve), the
amount of aminopropyl moieties can be estimated at 0.56 mmol/g silica under the assumption that
the molar ratio of aminopropyl to phenyl-moieties in the sample is 1:1 as employed during syn-
thesis. After the attachment of the PVP polymer an additional mass loss of 8.2 % was measured,
which equates to an estimated PVP-functionalization density of 6.9 µmol/g silica (Figure 10.4 a,
red curve). This indicates that 1.2 % of all NH2-residues on the surface of LP-MSN have reacted
with poly(2-vinylpyridine). This result can be explained by the large molecular dimension of the
polymer (in coiled form) and the mutual shielding of the long polymeric chains. From the additional
mass loss of 14.1 % of the sample LP-MSN-PEG-NH2 (Figure 10.4 a, green curve) the amount of
bound PEG can be estimated to 80 µmol/g silica. This implies that after attachment of oxalic acid
about 14 % of all carboxy-groups within the LP-MSN have reacted with PEG. Thus it is assumed
that the attachment of oxalic acid and PEG not only occurred at the N-terminal residues of PVP,
but also on the amino moieties on the surface of LP-MSN. As the additional mass loss of LP-MSN-
PVP-PEG-AlPcS2a was 3 % (Figure 10.4 a, magenta curve), the amount of attached AlPcS2a can
107
10 Outlook: Modifications of surface coated MSN
be calculated to 42 µmol per gram silica.
Figure 10.5: Time-based dye release kinetics of calcein loaded LP-MSN-PVP-NH2 particles at pH 7.34
(SSC buffer, 1:40, particles completely closed by PVP) and pH 5.0 (McIlvaine buffer, PVP chains protonated,
open state) 37◦C.
IR spectra of all samples were measured for further analysis of the functional groups on the obtained
samples (Figure 10.4). The peaks between 2950 cm−1 and 2837 cm−1 can be assigned to the
symmetric and asymmetric CH2-stretching vibration of the vinyl groups in PVP and are present in
all samples after the attachment of the polymer. A shoulder with very weak intensity is also visible
in the spectrum of LP-MSN-NH2/-Ph due to the presence of propyl groups. The vibrations at
1455 cm−1 and 1376 cm−1 (dashed lines) can be attributed to C=C and C=N stretching vibrations
of the pyridine rings. They appear in all spectra of PVP-containing samples. The asymmetric CH3
bending vibration of the Boc protecting group is visible at 1438 cm−1 in the spectrum of LP-MSN-
PVP-Boc (asterisked peak), and disappears after de-protection with TFA. The peak at 1324 cm−1 in
the spectrum of LP-MSN-PVP-Ox (asterisked peak) can be assigned to the C-O stretching vibration,
which disappears after the attachment of the PEG-linker. However, the C=O stretching vibration,
which should arise within the range of 1685-1640 cm−1, could not be detected. In the spectrum
of LP-MSN-PVP-PEG-AlPcS2a broad shoulders are visible in the range of 1573-1396 cm−1 that
presumably result from an overlay of aromatic ring stretching vibrations in AlPcS2a and C=C and
C=N stretching vibrations of the pyridine rings. The peak at 1635 cm−1 is visible in all spectra
and can be attributed to residual water within the samples. Below 1300 cm−1 the vibrations of the
silica framework appear with strong intensities.
DLS measurement revealed a size increase after attachment of PVP (from 190 nm to 295 nm) and
an additional increase after addition of the PEG-linker (to 342 nm). These results are in good
accordance with the previously described system and are explained there (Chapter 7) After the
successful synthesis calcein was adsorbed into the mesopores of the sample LP-MSN-PVP-NH2 at
acidic pH and a time-based release experiment at 37◦C was performed (Figure 10.5). In the first
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three hours the pH was set to pH 7.34 (SSC buffer) to measure the LP-MSN in closed state. After
3 h, the nanoparticles were separated by centrifugation and re-dispersed in McIlvaine buffer (pH5 .0)
resulting in a protonation of the polymer chains, resulting in an opening of the pores. Immediately,
a second release experiment was performed for additional 13 h.
The pH-dependent calcein-fluorescence was calibrated with the help of emission scans of a serial
dilution of calcein in both buffers and the measured cps at pH 5.0 were multiplied with the obtained
intercept of 1.35. The release experiment showed a small amount of premeature calcein release. This
most likely can be attributed to free calcein molecules that were attached to the polymer chains
and then are diluted in the buffer. After the protonation of PVP at pH 5.0 a strong fluorescence
increase could be observed.
10.1.2 LP-MSN-AlPcS2a: removal of free photosensitizer
In Chapter 6 it was alread discussed, that the washing procedure is highly important after attach-
ment of AlPcS2a to MSN. It was also shown, that free AlPcS2a is uptaken into cells and the release
out of single endosomes can be monitored, followed by staining of the whole cell afterward with
photosensitizer (Figure 6.9) .
Figure 10.6: UV-Vis data taken from the supernatants of the washing procedure of the sample LP-MSN-
AlPcS2a. No free photosensitizer could be detected in supernatants 9 and 10.
With the help of UV-VIS measurments the washing procedure of LP-MSN-AlPcS2a was monitored
by subsequent measurements of the supernatants. The resulting spectra were compared with the
standard MSN after AlPcS2a-functionalization (Figure 6.10). The obtained results are similar,
therefore the washing of LP-MSN-AlPcS2a is assumed to be sufficient.
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Nevertheless in all following cell experiments a spreading of the photosensitizer (AlPcS2a) occurred
after photo-activation (639 nm). As free photosensitizer was eliminated as cause, another possibil-
ity could be photochemical cleavage of the sulfonamide bonds. [354] In cell tests performed with
standard-MSN this cleveage couldn’t be observed [15], but the attachment was slightly different
(additional PEG-spacer). Another possibility would be the ending of the SLB@LP-MSN-AlPcS2a
inside lysosomes (pH around 4) resulting in a degradation.
The cause of this side effect has to be cleared, as free photosensitizer spreading inside the cell is
unfavorable and causes immediate cell death.
10.1.3 Delivery of different sized cargos with LP-MSN
Fluorescence live cell imaging of photo-activable supported lipid bilayer capped LP-MSN
After the successful characterization of LP-MSN-AlPcS2a, cargo loaded SLB@LP-MSN-AlPcS2a
were incubated on HeLa cells. The first cargo was calcein. Therefore, calcein loaded SLB@LP-
MSN-AlPcS2a were incubated for 21 h to allow an sufficient cell uptake via endocytosis. With
spinning disc confocal fluorescence microscopy confocal cuts throug the cells were recorded before
and after activation of AlPcS2a with 639 nm light (Figure 10.7).
Figure 10.7: Fluorescence microscopy of SLB@LP-MSN-AlPcS2a loaded with calcein after 21h incubation
on HeLa cells. (a-c) AlPcS2a (red) and calcein (green) are mainly co-localized (yellow) prior to photoac-
tivation. The red line indicates photoactivation with 0.6 W/mm2 of red light (639 nm). (d-f) 1 min after
photoactivation, (g-i) 6 min after photoactivation. The scale bar represents 10 µm.
Before activation of the PS (Figure 10.7 a-c) the fluorescence of AlPcS2a (red) and calcein (green) are
co-localized to a good amount and exhibit a dot-like pattern. This indicates, that the cargo calcein
is still enclosed inside the mesopores and internalized by photoactivation. In the red channel a small
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amount of photosensitizer is already spread inside the cells, which could be attributed to activation
by daylight and out-of-focus fluorescence. After activation of the photosensitizer spreading of calcein
inside the cell could be detected. Through the photoactivation singlet oxygen was produced, which
caused disintegration of the SLB and the endosomal membrane and subsequent release of calcein
out of the mesopores into the cytosol.
Figure 10.8: Intensity profiles of the calcein (green) and AlPcS2a (red) fluorescence along the dashed white
lines in the activation series of calcein loaded SLB@LP-MSN-AlPcS2a (see Figure 10.7) for t = -1 min, t =
1 min and t = 6 min with t = 0 min denoting the point of photosensitizer activation.
Along the dashed white line inside Figure 10.7 c/f/i the intensity-profiles for AlPcS2a and calcein
were determined. As a result an increase in calcein intensity could be observed over a distinct time,
as calcein de-quenches through the dilution inside the cell compartments. The intensity of AlPcS2a
stays more or less the same, but it could be observed, that not only calcein spreads over the whole
cell but also AlPcS2a. This spreading leads to a damage of the cell, which can already be seen after
6 min in the formation of bubbles on the cell membrane. The formation is an indication for cell
death. In a next set of experiments the delivery of the cargo propidium iodide (PI) was investigated.
Propidium iodide was already tested with the dendrimeric system in this work and was succesfully
delivered by our groups before. [1] PI is a fluorescent, cell-membrane impermeable dye to stain
nucleoli, as it interacts with the nucleic acids of ribosomal RNA. The particles were incubated for
21 h on HeLa cells. After that time period they were imaged. In this case the pictures do not show
single confocal planes but an average of the intensity over multiple slices to improve the signal-to-
noise ratio. Before photoactivation no staining of the nucleoli is visible (Figure 10.9 a/c). Due to the
photoactivation a strong decrease in fluorescence occurs because of photobleaching (Figure 10.9 d-
f). 10 min after the activation the nucleoli are visible (Figure 10.9 j/l). In the region of the six
clearly visible nuclei (white boxes in Figure 10.9 a/d/g/j) the fluorescence intensity was measured
and plottet, setting the fluorescence intensity at time point -1 min to 100 % (Figure 10.10).
In the plot depicting the intensity’s of the nucleoli it can be seen, that the fluorescence is increasing
with increasing time after activation with a strong photo-bleaching derived fluorescence-decrease
(Figure 10.10). Again a spreading of AlPcS2a could be observed. The obtained measurements
suggest a successful encapsulation and delivery of the small sized cargo’s calcein and propidium
iodide. As model for a bigger cargo Alexa-Fluor-Dextran 488 (AFD488, MW 10.000) citeAFD488
was testet. The hydrodynamic radius of this molecule is roughly 2.3 nm. Again HeLa cells were
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Figure 10.9: Fluorescence microscopy of SLB@LP-MSN-AlPcS2a loaded with propidium iodid after 21 h
of incubation on HeLa cells. Several z-planes were averaged for each image in order to improve the signal-
to-noise ratio, especially for the propidium iodide fluorescence. (a-c) Propidium Iodide (green) and AlPcS2a
(red) before photoactivation. The red line indicates photoactivation with 1.2 W/mm2 of red light (639 nm).
(d-f) after photoactivation, (g-i) 5 min and (j-k) 10 min after photoactivation. Fluorescence intensity for
the nucleoli indicated with white circles was measured, after photoactivation strong photobleaching effects.
The scale bar represents 10 µm.
Figure 10.10: Propidium iodide intensities for the time points -1, 0, 5 and 10 min for the six different
nucleoli. They are measured in the region of the nucleoli (within the outlined squares in Figure 10.9 ). The
intensity at time point -1 min was normalized to 100 %. The decrease in intensity percentage at 0 min is
caused by photo-bleaching due to photoactivation.
incubated with particles for 23 h, in this case AFD488 loaded SLB@LP-MSN-AlPcS2a, and an
activation series comparable to the PI loaded SLB@LP-MSN-AlPcS2a was performed. Again not
single confocal cuts but z-projections of the entire height of the cells out of confocal cuts are depicted
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Figure 10.11: Fluorescence microscopy of SLB@LP-MSN-AlPcS2a loaded with AFD488 after 23 h incu-
bation of HeLa cells. The channels represent z-projections of the entire height of the cells out of confocal
cuts. (a-c) AFD488 (green) and AlPcS2a (red) are in the same regions (yellow) prior to photoactivation.
The red line indicates photoactivation with 1.2 W/mm2 of red light (639 nm). (d-f) after photoactivation,
(g-i) 5 min and (j-l) 10 min after photoactivation. Along the white lines intensity profiles were measured.
The scale bar represents 10 µm.
(Figure 10.11). The scaling was chosen in order to visualize the spreading of dextrans in the
cytoplasm in regions without particles. Therefore the particle fluorescence seems to be overexposed.
The spreading of the dextran is not easy to visualize, due to the lack of self-quenching, also no de-
quenching effect can be observed and the Alexa dye is bleaching relatively fast compared to other
dyes which were used in this thesis.
Again the signal of the cargo (AFD488) and AlPcS2a is located in the same region which suggest
a packing of the cargo inside the endosomes (Figure 10.11 a-c). After photoactivation a slight
spreading of the cargo inside the cytoplasm could be observed (Figure 10.11 c/g/j). For a clearer
demonstration the intensity profile through two cells in a region without big particles was measured
along the dashed white line and plotted in Figure 10.12. For a greater visibility a black line was
drawn in the region of the main fluorescence in the beginning.
Only a slight increase in AFD488-dextran fluorescence could be detected, which can be also seen in
the intensity profiles plottet along the dashed white lines (Figure 10.12). Compared to the intensity
of the particles a low amount of cargo seemed to be release inside the cell. We assume that the
diffusion of the large cargo needs more time for diffusing out of the pore, due to steric or charge
effects.
We also tried to deliver fluorescent-labeled phalloidin. But although it was already shown with even
smaller pores in the MSN [1] it was not possible in our case. It seems that already the loading isn’t
efficient enough, as the fluorescence of the phalloidin labeling inside the particles was very weak.
But taken together we were able to demonstrate the release and delivery of small to large cargo
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Figure 10.12: Intensity profiles of AFD488 fluorescence along the dashed white lines in the activation series
of AFD488 loaded SLB@LP-MSN-AlPcS2a (see Figure 10.11) for t = -1 min, t = 0 min,t = 5 min and t =
10 min with t = 0 min denoting the point after photosensitizer activation. A slight fluorescence increase in
the region of the cytosol was observed.
molecules out of SLB@LP-MSN-AlPcS2a. This opens new application areas for the particles as
now also small proteins can be delivered. In addition to the above observations, the spread of
free photosensitizer was detected in the channel of AlPcS2a. As mentioned above, the cause of the
formation of free photosensitizer has to be investigated in more detail in future studies.
Photoinduced cargo release from post-synthesisis modified LP-MSN with PVP capping
Also the functionality of LP-MSN-PVP-PEG-AlPcS2a particles was tested in vitro. As cargo again
calcein was used and the red light photosensitizer AlPcS2a was attached to enable endosomal escape.
HeLa cells were incubated with calcein-loaded LP-MSN-PVP-PEG-AlPcS2a for 21 h. After 21 h
the cells were imaged with constant activation and monitoring. In Figure 10.13 a-c a confocal
cut through the cells is depicted and a high degree of co-localization between calcein (green) and
AlPcS2a (red) is visible (yellow). With increased activation time the cargo is released out of the
endosomes. After the incubation time of 21 h the particles should have ended up in acidic cell
compartments and the cargo calcein set free inside the endosome. Due to the acidification PVP
was already protonated inside the endosome and calcein released. So that the photosensizer only
has to open endosomal membranes. After 5.5 min of activation (Figure 10.13 d-f) calcein is clearly
visible inside the cytoplasm and nucleus. The fluorescence intensity inside the nucleus was measured
over the whole activation time and plotted in Figure 10.14. In the fluorescence images as well as
in the plotted intensities it can be seen that the calcein intensity decreases again after an increase
over around 5.5 min. This decrease is attributed to photobleaching effects, as calcein is not very
photostable. But the strong increase untill 5.5 min is attributed to de-quenching effects as the dye
is diluted out of the mesoporous system into the cell.
The constant but slow increase of AlPcS2a, in the plotted intensity over time, can be attributed to
spreading of the photosensitizer as the fluorescence is measured inside the nucles region, an area
which could not be entered by the whole MSNs. This spreading is also visible in the cell pictures
themselves. Beside the problem of AlPcS2a de-attachment the functionalization with PVP-PEG
moieties was successful.
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Figure 10.13: Fluorescence microscopy of LP-MSN-PVP-PEGAlPcS2a loaded with calcein after 21 h in-
cubation of HeLa cells. Constant monitoring and therefore activation of the cells with 0.6 W/mm2 of red
light (639 nm). (a-c) calcein (green) and AlPcS2a (red) are co-localized (yellow) in the beginning of the
measurement. With increasing time the AlPcS2a gets activated and calcein is released (d-f) 5.5 min, (g-i)
11 min and (j-l) 16 min after the start of the measurement. The intensitys inside the nucleus was measured
for calcein and AlPcS2a (white box). The scale bar represents 10 µm.
Figure 10.14: Fluorescence intensity of calcein (green) and AlPcS2a (red) inside the dashed white square
in the activation series of calcein loaded LP-MSNPVP-PEG-AlPcS2a (see Figure 10.13) with constant but
lower laser intensity (0.6 W/mm2; 639 nm) photosensitizer activation. Decrease of calcein fluorescence is
due to photobleaching.
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10.2 Membrane-fusion inducing peptides - reduced SNARE
peptides
This Chapter is based on the work in cooperation with: Alexandra Schmidt, Katharina Braunger,
Thomas Bein, Christoph Bräuchle and with Harshal Zope and Alexander Kros. The synthesis of
MSN for fusiongenic applications was mainly performed by Alexandra Schmidt and the reduced
SNARE peptides were provided by the group of A. Kros.
In order to increase the application area of our supported lipid bilayer MSNs we wanted to include
other possibilities to overcome the endosomal entrapment. One possible solution could be the
incorporation of fusion inducing proteins inside the SLB. In the group of Prof. Kros a reduced
SNARE (soluble N-ethyl-maleimide-sensitive fusion (NSF) protein) attachment protein model for
membrane fusion was developed. [277]
In all living system membrane fusion is a key process for facilitating transport between and within
cells, for example in vesicle transport, cell division and chemical synaptic transmission. [355] SNARE
proteins play an important role in this processes as they mediate the fusion process. [355, 356] The
interaction between two membrane bound SNAREs and a cytoplasmic SNARE leads to the formation
of a four-helical bundle complex, which zip up and simultaneously induces bilayer fusion. [277, 355]
As the exact mechanism is still unclear, reduced SNARE proteins were developed. The complex
designed in the Kros group consists of a lipid, a short PEG-linker and the oligopeptide hybrids
(LPK/LPE, see also Figure 10.15). This peptides are able to induce fusion between liposomes. In
order to demonstrate this ability, they used liposomes with incorporated reduced SNARE peptides,
either LPE or LPK. After mixing of these two liposomes an increase in the size could be observed and
a content mixing between the different liposomes has been shown. Figure 10.15 shows a schematic
Figure 10.15: (a) Model of the natural SNARE-protein (left) and of the the minimal model (right). Both
systems are based on the same principle, in the minimal model only the key features were adopted (b)
Schematic illustrations of G(EIAALEK)3-NH2-PEG12-DOPE (LPE) and (KIAALKE)3GW-NH2-PEG12-
DOPE (LPK). (c) After mixing of Liposomes with either LPE or LPK, coiled-coil formation occurs, which
induces close proximity and thus fusion. Figure was taken from Ref [357].
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representation of the the natural SNARE-protein-based model in comparison to the minimal model.
The minimal model mimics the coiled-coil forming motif and consist of a DOPE (or a cholesterol) tail,
a PEG12 linker and the amino acid sequence. For LPE the sequence is G(EIAALEK)3-NH2 (peptide
E) and for LPK (KIAALKE)3GW-NH2 (peptide K). Between peptide E and K the formation of
coiled coil motives leads to membrane fusion. [277] The lipid (or cholesterol) tail can be diffused into
membranes, the PEG12 linker has the function of a spacer and the amino acid sequence for forming
coiled-coil-motives. [358] Besides the PEG12-linker, the usage of PEGylation should be avoided,
since it can inhibit the fusion process as it prevents close proximity of the membranes. [359]
To combine these two projects, the fusion peptide and SLB coated MSNs, a collaboration between
the groups of Prof. Bein, Prof. Bräuchle and Prof. Kros was started. In this collaboration, we
wanted to show in real time and on a single nanoparticle level the fusion process between MSN with
an SLB and one reduced SNARE-peptide and giant vesicles or cells functionalized with the other
reduced SNARE-peptide.
Table 10.3: Various synthesis approaches for introducing SNARE-peptides into the SLB of MSN. With
dioleoyl-sn-glycero-3-phosphocholine (DOPC), dioleoyl-trimethylammonium propane (DOTAP), dioleoyl-
phosphatidylethanolamine (DOPE), cholesterol-PEG-peptide E/K (CPE/CPK), DOPE-PEG-peptide K
(LPK), carboxyfluorescein (cf).
# SLB-composition SNARE-peptide method
1 DOPC/DOTAP 70/30 wi CPE-cf diffusion, 2/6 h
2 DOPC/DOTAP 70/30 wi CPE-cf mixing
3 DOPC/DOTAP/cholesterol 80/10/10 wi CPE-cf diffusion, 2 h
4 DOPC/DOTAP/cholesterol 80/10/10 wi CPK+E-cf diffusion, 2 h
5 DOPC/DOTAP/cholesterol 80/10/10 wi CPE-cf, 1 % mixing
6 DOPC/DOTAP/cholesterol 80/10/10 xi CPE-cf, 1 % mixing
7 DOPC/DOTAP 70/30 wi DOPE-lr, 1 % diffusion, 4/24 h
8 DOPC/DOTAP 70/30 wi LPK + E-cf diffusion, 37◦C, 24 h
9 DOPC/DOTAP 70/30 wi LPK + E-cf diffusion, 23◦C, 24 h
The incorporation of the reduced SNARE peptide into the SLB was performed analogous to the
diffusion of DSPE-PEG-TL into the SLB (Chapter 6). In first attempts we used cholesterol as tail,
which was proved to incorporate into cell membranes and liposomes in the Kros group. [360] In
Table 10.3 the different approaches are listed. The incorporation of the cholesterol tail was not
successful, neither the diffusion approach, nor mixing of the lipids with the construct before SLB-
formation. Also changes in the SLB composition did not succeed. The incorporation of the according
construct was proved by cover-slip measurements with fluorescent labeled MSN and addition of
fluorescent labeled (corresponding) peptide to the particles after synthesis. If the incorporation
would have worked out co-localization would be visible.
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As the cholesterol-tail could not be successfully incorporated into the SLB we tested the incorpo-
ration of fluorescent labeled DOPE into the SLB by the diffusion method. Since this approach was
successful, we subsequently used DOPE as tail for the reduced SNARE motive. For the incorpora-
tion of the reduced SNARE motive into cell membranes further on cholesterol was utilized. The best
Figure 10.16: (a) SLB@MSN-SHin-Atto633out (red) with LPK-Ecf (green) diffused into the SLB. Co-
localization (yellow) results from successful incorporation. (b) Brightfield image and (c) fluorescence image
of HeLa cells incubated for 1 min with CPE and K-cf (green) each, staining the cell membranes. (d)
Brightfield image and (e) fluorescence image of HeLa cells incubated for 1 min with K-cf (green), no staining
of the cell membranes but fluorescence in the cell medium. The scale bar represents 10 µm.
attempt for incorporation of the reduced SNARE peptide into SLB@MSN-SHin-Atto633out was us-
ing LPK and diffusion on a shaker at room temperature for 24 h. In Figure 10.16 the co-localization
(yellow) between MSN-SHin-Atto633out (red) and carboxy-fluorescein labeled peptide E bound to
LPK is depicted. After the incorporation of LPK into the SLB was achieved, the incorporation of
CPE into HeLa cells was tested. Firstly the cell membrane was functionalized with the reduced
SNARE motive (CPE) by incubation for 1 min. Afterwards, the corresponding labeled peptide
K-cf was added and the cells were washed. The cell-membrane staining demonstrates a successful
incorporation of the construct into the membrane (Figure 10.16 c). As control experiment we also
incubated the fluorescent K-cf with the cells, according to the staining step. Here again we washed
the cells after incubation, but in this case no staining of the cell membrane could be observed. The
cell boundaries are nevertheless visible, because K-cf is still present in the cell medium (Figure 10.16
e).
We already observed during the creation of the SLB around the NPs that the temperature in the
diffusion step seems to play a role for the functionality of LPK. Hence we stored a small amount of
LPK at 37◦C and one at RT, the normal storage is at −20◦C, to prove our assumption. After one
day, comparable to the diffusion time in the synthesis, we incubated HeLa cells with this LPKs and
E-cf for subsequent staining. In Figure 10.17 the result is depicted. The cell membrane staining in
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Figure 10.17: HeLa cell incubated with LPK-E-cf and E-cf as functionality test. (a) Brightfield image and
(b) fluorescence image of HeLa cells incubated for 1 min with LPK (stored for 1 d at RT) and E-cf (green)
each, staining the cell membrane. (c) Brightfield image and (d) fluorescence image of HeLa cells incubated
for 1 min with LPK (stored for 1 d at 37◦C) and E-cf (green) each, staining the cell membrane less than
RT-stored LPK. (e) Brightfield image and (f) fluorescence image of HeLa cells incubated for 1 min with
E-cf (green), no staining of the cell membrane but fluorescence in the cell medium. The scale bar represents
10 µm.
the case of LPK (RT) was stronger than with LPK (37◦C), but both constructs exhibit a weaker
staining than the cholesterol-construct. This result suggest a temperature-dependence of peptides.
Also it could be concluded, that it is useful to use different anchor groups for SLB and cell membrane
incorporation.
Figure 10.18: HeLa cell incubated with CPE and LPK-SLB@MSN-SHin-Atto633out. (a-d) LPK-
SLB@MSN-SHin-Atto633out loaded with calcein and incubated for 2 h. (e-h) LPK-SLB@MSN-SHin-
Atto633out, SLB stained with bodipy and incubated for 6 h. The scale bar represents 10 µm.
The last step was to investigate if fusion could be observed for reduced SNARE motive functionalized
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HeLa cells and MSN. For visualization we used two different approaches. First the incorporation of
a membrane-impermeable cargo (calcein), which should be able to diffuse into the cell after fusion of
the MSN with the cell (Figure 10.18 a-d). Second we used a bodipy-labeled lipid, mixed into the SLB
(Figure 10.18 e-h). In the case of fusion on the cell membrane the cell membrane should be stained.
If the fusion needs a pH change and the fusion takes place inside the endosomes a separation between
the endosome and the particles should be observable. The cell experiments revealed problems with
the incorporation of calcein, as can be seen only a few particles were internalized (Figure 10.18 c),
but many calcein-filled endosomes can be detected which do not contain MSN (Figure 10.18 b).
Nevertheless also no release of the cargo was detectable. The fusion process was believed to take
place within a few minutes, but even after several hours no release of calcein or fusion detectable
with bodipy was observed. As the pH, temperature, serum proteins or the used cell line can influence
the fusion behavior, it has to be investigated which factor is the determining one.
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10.3 Membrane-fusion inducing peptides - fusion peptide
H5WYG
This Chapter is based on the work in cooperation with: Alexandra Schmidt, Katharina Braunger,
Thomas Bein, and Christoph Bräuchle. The synthesis of MSN for fusiongenic applications was
mainly performed by Alexandra Schmidt.
In nature, membrane-fusion is not only used within one organism, but also for virus entry. To
induce fusion the natural distance between membranes, caused by electrostatic repulsion and steric
interactions, of 10 - 20 nm has to be overcome. Viruses overcome this hurdle by using fusion
proteins. [357] One example is the influenza virus, the envelope of the virus particles consists to
a large extend of the glycoprotein hemagglutinin. Hemagglutinin posseses two domains, one is
responsible for membrane binding (HA1) and the other to induce the fusion process (HA2). [361]
In Figure 10.19 a the general principle of the fusion process is shown. After binding of subunit
HA1 to siliac acid receptors (not shown) the protein undergoes a conformational change in the
acidic environment of the endosomes. The illustration displays the pre-fusion conformation in the
first step, in a second step at low pH the extended intermediate is forming, and the fusion peptide
(green) interacts with the target bilayer. In the next two steps the intermediate collapses and
therefore brings the membranes together. [357]
Figure 10.19: a) Schematic representation of full fusion protein hemagglutinin. First the pre-fusion state,
second formation of a extended intermediate (fusion peptide (green) inside target membrane), and finall
collapse of the intermediate and fusion of the membranes. [357] b) Schematic representation of the possible
mechanism for fusion induced by a fusion peptide incorporated into the SLB of MSN.
As the full fusion protein would induce a immune response [362], much effort was put into mimic this
system in order to circumvent endosomal entrapment. The fusion domain on the N-terminus of HA2
was identified to be a good candidate to overcome the endosomal entrapment. The fusion domain
forms a α-helix structure which is capable of insertion into membranes. [363] Based on the sequence of
this fusion domain (23 N-terminal amino acids) the so called fusion peptides were developed. Beside
the peptide with HA2-analogous structure, peptides with slightly improved amino-acid sequences
were developed, for example INF1-4, INF7, E5 or H5WYG. They all vary in a few amino acids from
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the original amino acid structure, the sequences for the original segment and H5WYG, which we
used, are listed in Table 10.4. H5WYG performes a confomartional change from random coil to α
Table 10.4: Sequence of fusion peptide H5WYG and N-terminal segment of the subunit HA2. [364]
amino acid sequence
H5WYG GLFHAIAHFIHGGWHGLIHGWYG
HA2, N-terminal GLFGAIAGFIEGGWTGMIDGWYG
helix in a pH range between 5 -6.5 due to protonation of the histidines, finally leading to membrane
rupture. [364, 365] But, because of the protonation capacities mainly of the histidines, there is also
the hypothesis, that H5WYG is buffering the pH inside the endosomes, similar to PEI, causing
osmotic swelling and finally leading to endosomal destabilization. [365] The goal of experiments
with this so called fusion peptide was to investigate the working mechanism.
To incorporate the fusion peptide into SLB@MSN-SHin-NH2out we used amino-functionalized H5WYG
(H2N-H5WYG-GGC-COOH) and either DSPE-PEG2000-Mal or DOPE-PEG4-Mal to obtain DSPE-
PEG2000-H5WYG / DOPE-PEG4-H5WYG. We tested two different linkers and lipids, because these
factor can influence the incorporation into the SLB, especially because of the poor water solubility
of H5WYG. The lipid constructs then were incorporated similar to targeting ligands or reduced
SNARE constructs into the SLB by simple diffusion. In Figure 10.20 the co-localization (yellow)
between FITC-labeled H5WYG (green) and Atto633 (red) labeled MSN is displayed. In both cases
the incorporation should have worked, but with DOPE-PEG4-H5WYG we obtained the more repro-
ducible results and so it was chosen over DSPE-PEG2000-H5WYG, also because the co-localization
is slightly better.
Figure 10.20: Co-localization (yellow) between FITC-labeled H5WYG (green) and Atto633 (red) labeled
MSN (a-c) FITC-H5WYG-PEG2000-DSPE-SLB@MSN (d-f) FITC-H5WYG-PEG4-DOPE-SLB@MSN.
(a/d) FITC fluorescence, (b/e) Atto633 fluorescence, (c/f) merge of FITC and Atto633 fluorescence. Scale
bar represents 10 µm.
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In a first attempt the functionality of the entire process should be tested. For this purpose, we
loaded calcein into the pores of covalently Atto633 labeled MSN and incubated the SLB-sealed and
H5WYG-functionalized particles on HeLa cells. But as can be seen in Figure 10.21, neither after
4 h, nor after 22 or 65 h any release of clacein into the cells could be observed. On the contrary,
free calcein could be detected, as only fluorescence derived from calcein could be detected in several
endosomes (green, especially in Figure 10.21 a).
Figure 10.21: HeLa cells incubated with calcein (green) loaded H5WYG-PEG4-DOPE-SLB@MSN (red)
for (a) 4 h (b) 22 h (c) 65 h. Especially after 4 h a high amount of calcein without MSN fluorescence was
detected. Scale bar represents 10 µm.
It was also observed, that the co-localization between the particles and the cargo seems to increase
over time. This effect is attributed to fusion of endosomes among themselves on their way to become
lysosomes at the end. The greater aggregation behavior of the particles could possible arise from an
unstable SLB formation, which would also explain the high amount of free calcein, which was not
observed without incorporation of fusion peptides (see also Figure 6.7 where the co-localization was
almost 100 %).
The influence of serum proteins on the fusion behavior of these kind of peptides is also discussed in
the literature. It is stated, that for H5WYG the presence of serum proteins inside the cell culture
medium has no influence. [364] But as the binding to PEG reduces the activity to more acidic
environments [365] it was also considered to influence the system. But also measurements in serum
free environments has not resulted in better co-localization between calcein and MSN or release of
calcein inside cells.
In a different approach, we did not use adsorbed calcein, but tested the integrity of the SLB with
bodipy-labeled lipid (DOPC) during the experiment (Figure 10.22). As can be seen a high amount
of free bodipy is visible already on the coverslip (Figur 10.22 a). In case of H5WYG-free par-
ticles less unbound bodipy is visible, but also fewer particles are available (Figure 10.22 d). The
cell experiments revealed a slight staining of the cell membrane especially in the case of H5WYG
containing MSN (Figure 10.22 c/f), but free bodipy is also able to incorporate into cell membranes.
A conclusion on the mechanism of fusion therefore was not yet possible.
Additionally, we tested the combination of the pH-dependend polymer PVP (see Chapter 7) and
fusion peptides. The fusion peptide hereby was covalently attached to a PEG to the NH2 group
of H5WYG. The MSN in this case were only loaded with calcein. On the coverslip many evenly
distributed particles were observed (Figure 10.23 a). Incubation on cells didn’t show any release of
calcein into the cytosol, even after 41 h of incubation (Figure 10.23 c). Co-localization experiments
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Figure 10.22: (a) Bodipy (green) labeled H5WYG-PEG4-DOPE-SLB@MSN (red) (d) Bodipy (green) la-
beled SLB@MSN. (b) Brightfield and (c) fluorescence image of HeLas cells incubated for 1.5 h with H5WYG-
PEG4-DOPE-SLB@MSN. (e) Brightfield and (f) fluorescence image of HeLas cells incubated for 1.5 h with
SLB@MSN. Scale bar represents 10 µm.
Figure 10.23: (a)MSN-PVP-PEG-H5WYG loaded with calcein imaged on a coverslip. (b) Brightfield
and (c) fluorescent image of HeLa cells incubated for 4 1h with MSN-Calcein-PVP-PEG-H5WYG. and
(d) Brightfield and (e) fluorescent image of HeLa cells incubated for 41 h with MSN-Calcein-PVP-PEG-
H5WYG (green) and Lysotraker Red (red). High amount of co-localization can be detected (yellow). Scale
bar represents 10 µm.
with a lysosome staining (Figure 10.23 e) dye revealed that the particles were already transported to
the lysosomes and therefore were transported to acidic compartments, but the lysosome membran
seems to stay intact despite the presence of the fusion peptide. This could be either an indication
for a buffering capacity of the fusion peptide, as the polymer needs an acidic pH in order to release
cargo, or the need of two lipid membranes to induce fusion.
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In this thesis it was demonstrated, that mesoporous silica nanoparticles exhibt a great platform for
targeted drug delivery applications. Various different capping and release systems were investigated
and their functionality in vitro (including live-cell experiments) was proven. Drug delivery systems
are desired in order to safely hide non-membrane-permeable cargos as well as membrane-permeable
cargos inside the nanoparticle in order to prevent the cargo or the body from damage.
The first system (chapter 6) presented a combination of the high loading capacity of MSN, the
supported lipid bilayer for controlled release, the addition of targeting ligands, and overcoming
of endosomal entrapment by photoactivation. This system exhibits an ideal platform as cargo
molecules, targeting ligands and the photosensitzier can be varied easily.
In the second system (chapter 7), the pH-responsive polymer PVP was investigated as drug
delivery platform. Beside supported lipid bilayers, the employment of stimuli-responsive polymers
is a new promising capping approach for MSN. In addition to its ability to encapsulate membrane-
permeable cargos within the mesopores, the features of our previous developed system (attachment of
photosensitizer and targeting ligands) could be successfully employed to this approach. Additionally,
the biocompatibilty of our novel drug delivery platform was investigated in vivo (mouse model) and
proved to be nontoxic.
The third system (chapter 8) is an example for internal pore modifications. In contrast to the
systems presented so far, the mechanism to overcome endosomal entrapment is not relied on a
photosensitizer, but on inducing the proton sponge effect. For this purpose the shell of the MSN
is modified with a dendrimeric polymer which is known to induce a proton sponge effect. Osmotic
swelling finally leads to membrane rupture and subsequent cargo release. Cytotoxicity tests suggest a
very good bio-tolerabitly of these kind of particles. Targeting could be achieved by binding targeting
ligands to the outer periphery of the MSNs.
A fourth system (chapter 9) was an example of particle pore gating, as we used a bulky enzyme to
close the pores. The release trigger in this case was internally as we attached an enzyme inhibitor on
the particle surface which binds pH-dependent to the enzyme. By incorporating unnatural amino
acids into the enzyme we were also able to incorporate targeting moieties. Again we achieved a a
versatile drug delivery platform.
Increasing the pore size of the MSN (fifth system) in order to gain greater variation possibilities
for cargo loading is one important point, in order to further enhance the surface coating approach
we discussed in this work. We demonstrated the release of different sized cargos out of large pore
MSNs with two different, but for standard pore sizes already established, capping systems. The
used capping systems were the supported lipid bilayer and the pH-dependend polymer PVP. In
both cases successful release was demonstrated. Nevertheless, the systems raised new questions, as
the binding of a photosensitizer to the large pore system is not as straight forward as the addition
of capping systems and the delivery of cargos of different sizes.
Furthermore we incorporated fusiogenic peptides into the SLB (sixth and seventh system) in
order to expand our platform presented in the first system to an internal trigger. Especially for
membrane-impermeable cargos the supported lipid bilayer offers an easy method to cap MSNs,
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and the systems can be simply modified afterward, e.g. with targeting moieties. The first step,
the successful incorporation of fusion inducing peptides into the SLB was demonstrated. Two
different fusiogenic peptides were investigated. First a influenza virus-derived peptide (H5WYG) was
examined with the aim to clarify the working mechanism. And second a minimal model of the cellular
“SNARE” proteins was applied to the SLB coated MSN and the cells. The successful incorporation
of the peptides into the cell membrane could be demonstrated and the working direction outlined.
After the successful implementation of targeting ligands and stimuli responsive pore and endour
some opening mechanisms the next step now should be testing the particle behavior in vivo with
real chemotherapeutica. Our studies demonstrate various drug delivery platforms, in which the
particles can be modified in many parameters. Therefore good chances exist to adapt the system to
the challenges arising in in vivo studies.
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This chapter is adapted from the publication “Multifunctional Mesoporous Silica Nanoparticles as a
Universal Platform for Drug Delivery”, published in Chemistry of Materials, written in collaboration
with C. Argyo from the group of T. Bein. [14]
Colloidal MSNs have attracted great attention as potential drug delivery systems for cancer cell
targeting and as bioimaging devices. In addition to their biocompatibility and biodegradability,
they can be selectively modified at their inner and outer surface. Guest molecules can be efficiently
encapsulated in their tunable pore system. Furthermore, it is possible to functionalize their outer
surface with targeting ligands, biomimetic and other pore gating molecules, fluorescent dyes, and
biocompatible polymers. Compared to most other prominent organic carriers, such as liposomes and
polyplexes, MSNs offer several advantages including high loading capacity, high stability, and the
ability to protect the guest molecules from various biochemical attacks causing degradation of the
bioactive cargo molecules. Extensive in vitro studies on the controlled release of therapeutics and
the evaluation of cytotoxicity have proven the feasibility of multifunctional MSNs for a sustainable
and efficient drug delivery to cancer cells.
Today’s challenge is the investigation of pharmacokinetics and pharmacodynamics of mesoporous
silica nanoconstructs for in vivo diagnostic and therapeutic applications. Issues and opportunities
have been recently reviewed by several groups. [184, 186, 366, 367] The biological effects of MSNs at
different levels ranging from molecules, cells, and blood to tissue and organs, involving cytotoxicity,
biodegradability, blood compatibility, biodistribution, and excretion, are currently under investiga-
tion. Oral administration and injection into the bloodstream of such nanocarriers require specific
properties for long-term stability during circulation in the organism, specific targeting of the desired
location, and controllable release of the loaded drugs to obtain the desired therapeutic outcome.
Controlling all these requirements is important to avoid side effects harming healthy tissue. Re-
searchers are still faced with many challenges, especially in vivo applicable stimuli-responsive re-
lease mechanisms, targeting specificity, and biosafety issues, which need to be fully understood to
achieve efficient and safe drug delivery. A complete understanding of the mechanisms for intracellu-
lar uptake, trafficking, and the fate of multifunctional MSNs in the body would be highly desirable.
Up to now, only a few in vivo studies of the pharmacokinetics of multifunctional MSNs including
biodistribution, biodegradation, and excretion and clearance have been performed, and additional
work in this area is clearly needed. [228, 368–371] Additional functional groups such as PEG chains
on the external surface of MSNs seem to be important for achieving the EPR effect; they were
shown to decrease the clearance through the RES. [47, 228] Selected strategies and model systems
are needed to gain insights into such complex processes before reaching the stage of clinical trials.
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Comprehensive reviews address the state of the art regarding preclinical studies. [184, 367] Model
systems for investigations on the way to clinical trials are being discussed, including chorioallantoic
membrane, zebrafish embryo, and mouse, among others. [372–374]
The pharmacokinetics of nanomaterials are closely related to in vivo toxicity, biocompatibility, and
retention. The issue of potential toxicity to cells or organisms caused by nanocarriers seems to be
strongly influenced by several particle properties including size, morphology, and surface function-
ality. [215] Studies on the dissolution of silica nanoparticles concerning retention and clearance in
the body showed that the silica was adsorbed or excreted in the urine in the form of silicic acid or
organic silica species. [228]
Finally, recent studies focus on the ultimate combination of diagnostic and therapeutic capabilities in
the multifunctional mesoporous nanoparticles, such that the nanocarrier uses diagnostic information
to control or tune its therapeutic actions. One such approach could be the detection of the presence of
multiple receptors indicating specific target tissue, where the logical combination of this information
leads to release of drug only at this location. And another one could be the detection of several
enzymes that together constitute the signature of a target tissue. Therefore the future is bright for
multifunctional mesoporous nanoparticles in diagnostics and therapy.
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abbreviation explanation
AFD alexa fluor dextran
AlPcS2a Al(III)phthalocyanine chloride disulfonic acid
ALT alanine transaminase
AOTF acousto-optical tunable filter
AST aspartate transaminase
ATP adenosine triphosphate
BET brunauer-emmett-teller
BP band pass
BUN blood urea nitrogen
(H)CA (human) carbonic anhydrases
CAPS 3-(Cyclohexylamino)-1-propanesulfonic acid
CD cyclodextrin
CPE cholesterol - PEG12 - peptide K
CTAC cetyltrimethylammonium chloride
DAPI 4’,6-diamidino-2-phenylindole
DFT density functional theory
DLS dynamic light scattering
DMEM dulbecco’s modified eagle’s medium
(ss)DNA (single-stranded) desoxyribonucleic acid
DOPC dioleoyl-sn-glycero-3-phosphocholine
DOPE dioleoyl-phosphatidylethanolamine
DOTAP dioleoyl-trimethylammonium propane
DOX doxorubicin
DPBS dulbecco’s phosphate-buffered saline
DSPE 1,2distearoyl-sn-glycero-3-phosphoethanolamine
DTT dithiothreitol
D3 PAMAM dendron 3rd generation
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
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abbreviation explanation
E-cf peptide E - carboxyfluorescein
EGF(R) epidermal growth factor (receptor)
EPR enhanced permeability and retention effect
EMCCD electron-multiplying charge-coupled device
FA folic acid
FBS fetal bovine serum
FC-4 fluorocarbon Surfactant
FITC fluorescein isothiocyanate
FRET fluorescence resonance energy transfer
(E)GFP (enhanced) green fluorescent protein
GSH glutathion
HBG HEPES with 5% glucose
HBSS hank’s balanced salt solution
HeLa cervix adenocarcinoma cell line
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(poly)HIS (poly)histidine
HMEC-1 immortalized human microvascular endothelial cells
HuH7 human hepato cellular carcinoma cell line
H5WYG endosomolytic peptide
ICG indocyanine green
IEP isoelectric point
IR infrared
KB HeLa derived cell line
K-cf peptide K - carboxyfluorescein
LDH layered double hydroxides
LPE DOPE - PEG4 - peptide E
LPK DOPE - PEG4 - peptide K
LP-MSN large-pore mesoporous silica nanoparticles
MCM-41 Mobil Crystalline Materials
MDR multiple drug resistance
MPTES (3-mercaptopropyl)-triethoxysilane
MSN mesoporous silica nanoparticles
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abbreviation explanation
MTS methanethiosulfonate
NA numerical aperture
(P)NIPAM (poly)N-isopropylacrylamide
NIR near-infrared
(ss)NMR (solid state) nuclear magnetic resonance
NSF N-ethyl-maleimide-sensitive fusion
PAMAM poly(amidoamine)
(D)PBS (dulbecco’s) phosphate buffered saline
PCI photochemical internalization
PDT photodynamic therapy
PEG polyethylene glycol
PEI polyethyleneimine
PFA paraformaldehyde
PI propidium iodide
PMO periodic mesoporous organosilicas
PS photosensitizer
PVP poly(2-vinylpyridine)
QD quantum dot
RD 5(6)-carboxy-X-rhodamine
(r/si/t)RNA (ribosomal/small interfering/transfer) ribonucleic acid
RGD Arg-Gly-Asp amino acid sequence
RES reticuloendothelialsystem
phSA benzene sulfonamide
rcDH relative cellular dehydrogenase activity
ROI region of interest
ROS reactive oxygen species
ROX 5(6)- carboxy-X- rhodamine
RPMI roswell park memorial institute 16440 medium
RTES organotriethoxysilane (R represents an organic moiety)
SBA-15 Santa Barbara Amorphous type material
SKBr3 breast carcinoma cells
SD spinning disc
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List of abbreviations
abbreviation explanation
SD standard deviation
SLB supported lipid bilayer
SNARE soluble N-ethylmaleimide-sensitive factor attachment protein receptor
SPION superparamagnetic iron oxide nanoparticle
SP94 targeting peptide
TEA triethanolamine
TEM transmission electron microscopy
TEOS tetraethyl orthosilicate
TFA trifluoroacetic acid
TGA thermogravimetric analysis
TL targeting ligand
TRIS tris(hydroxymethyl)-aminomethan
UV-VIS ultraviolet-visible spectroscopy
WGA wheat germ agglutinin
XRD Xray diffraction
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1 Synthesis details for Chapter 6: Targeted drug delivery in
cancer cells with red light photoactivated mesoporous silica
nanoparticles
Experimental procedure for the shell reactions shown in Scheme 6.2
Figure 1: Shell reactions of MSN-SHinCOOHout nanoparticles. 1) PEGylation reaction and 2)covalent
attachment of photosensitizer AlPcS2a.
The carboxylic acid moieties of the colloidal mesoporous silica nanoparticles (MSN) obtained through
hydrolysis of the cyano groups of the sample MSN-SHin-CNout (II) are PEGylated with a short
bisamino polyethylene glycol linker via an EDC amidation. To avoid crosslinking of the nanoparti-
cles an excess of the PEG-spacer was used. In a second reaction step, the Al(III) phthalocyanine
chloride disulfonic acid (AlPcS2a) photosensitizer was covalently attached to the outer surface of
the particle via a sulfonamide bond.
Experimental procedure for Lipid-EGF construct
To utilize EGF as another targeting ligand beside folic acid, we synthesized a lipid-EGF construct,
where the EGF (50 µg) is covalently attached to the lipid DSPE-PEG2000-maleimide (Scheme 2).
In a first step, the N-terminus of the targeting peptide was modified via the Traut’s reagent (2-
Iminothiolane, 2 equiv., 16 nmol) in an aqueous solution by stirring for 1 h at room temperature.
This resulted in a terminal thiol group which can be used for further functionalization. Subsequently,
the modified EGF was covalently attached to the lipid DSPE-PEG2000-maleimide (3.5 µL of a
10 mg/mL 60/40 H2O/EtOH v%). The final DSPE-PEG2000-EGF construct can be further utilized
to use as targeting ligand on the nanoparticle as described below.
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Figure 2: Chemical modification of the EGF targeting ligand via the Traut’s reagent (2-iminothiolane) to
achieve thiolation of the N-termius of EGF. In a second step the lipid DSPE-PEG2000-maleimide covalently
binds to the modified EGF
Transmission electron microscopy
Figure 3: a-b)TEM images of the template-extracted core-shell MSN-SHin-CNout (I). c-d)TEM micro-
graphs of the sample MSN-SHin-PEGd8NH2out (III).
All samples were investigated with a FEI Titan 80-300 operating at 300 kV with a high-angle
annular dark field detector. A droplet of the diluted MSN solution in ethanol absolute was dried on
a carbon-coated copper grid. The TEM micrographs in Figure 3 show template-extracted mesporous
core-shell silica particles of the type MSN-SHin-CNout. All nanoparticles are of perfect spherical
shape, highly monodisperse and uniform with a size of around 70 nm, which is consistent with the
dynamic light scattering data (see Figure 6.3 b). Furthermore, the worm-like mesoporous network
is clearly visible in the micrographs, indicating a radial growth of the MSN.
Figure 3 c/d shows TEM images of the sample MSN-SHin-PEGd8NH2 (III). The homogeneity of the
sample and the meso-structure of the MSN are preserved during the hydrolysis of the cyano-groups
and the PEGylation step. The size of around 70 nm is in good agreement with the results from the
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dynamic light scattering experiments. In comparision to Figure 3a/b , the mesoporous structure of
the nanoparticles is hardly detectable due to the additional organic layer attached to the MSN shell.
The mild white-greyish halo is a focus artifact caused by electron beam exposure and ultrahigh
vacuum.
Nitrogen Sorption measurements
Figure 4: Nitrogen sorption isotherms for the samples MSN-SHin-CNout (black squares), MSN-SHin-
COOHout (red circles), MSN-SHin-PEGd8NH2out (green up triangles) and MSN-SHin-PEGd8-AlPcS2aou
(blue down triangles). For clarity reasons curves for MSN-SHin-COOHout, MSN-SHin-PEGd8NH2out, and
MSN-SHin-PEGd8-AlPcS2aout are shifted along the y-axis by a value of 500 each.
Nitrogen sorption measurements were performed on a Quantachrome Instruments NOVA 4000e. All
four samples (15 mg each) were heated to 393 K for 12 h in vacuo (10 mTorr) to outgas the samples
before nitrogen sorption was measured at 77 K. For calculations of pore sizes and volumes a non-local
density functional theory (NLDFT) equilibrium model of nitrogen on silica was used. The nitrogen
sorption isotherms of the samples MSN-SHin-CN−out (I, black squares), MSN-SHin-COOHout (II,
red circles), MSN-SHin-PEGd8NH2out (III, green up triangles), and MSN-SHin-PEGd8-AlPcS2aout
(IV, blue inverted triangles) can be seen in Figure 4a, exhibiting a typical type IV isotherms for
mesoporous materials.
The Brunauer-Emmett-Teller (BET) surface areas for each sample are calculated from the corre-
sponding nitrogen sorption isotherm in the range p/p0 = 0.05 - 0.2 and are summarized in Table 4b.
All samples feature a high specific surface area typical for our MSN. We assume that the reduced
BET surface area in the sample MSN-SHin-COOHout (II) in comparison with MSN-SHin-CNout (I)
comes from the more condensed silica network and pore shrinkage resulting from the hydrolysis of
the cyano-moiety in hydrochloric acid. The decrease of the specific surface area in the sample MSN-
SHin-PEGd8NH2out (III) can be explained by the addition of non-porous PEG and the blocking of
some pores by frozen PEG-linker in the surface layer of the MSN.
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Table 2: Particle size, specific BET surface area, pore size and relative mass loss derived from Figure 6.3 b,
Figure 4 and Figure 6.4 b
Sample Particle size BET surface area Pore size Relative mass
[nm] [m2*g−1] [nm] loss [%]
MSN-SHin-CNout 69 934 5.2 17
MSN-SHin-COOHout 125 746 5.1 12
MSN-SHin-PEGd8-NH2 98 615 5.6 18
MSN-SHin-PEGd8-NH2 98 615 5.6 18
MSN-SHin-PEGd8-AlPcS2aout 294 918 5.5 31
DOPC/DOTAP-SLB@MSN 160 n.a. n.a. n.a.
This effect is relatively small due to the short length of the flexible spacer. In contrast, the BET
surface area of the sample MSN-SHin-PEGd8-AlPcS2aout is with 918 m2/g significantly higher than
the BET surface area for MSN-SHin-COOHout (II) and MSN-SHin-PEGd8NH2out (III). We suppose
that this effect comes from interstitial pore volume occurring upon attachment of AlPcS2a onto the
particle shell. Considering phthalocyanines are large, sterically hindered molecules that lack the
flexibility of a PEG-linker, a covalent attachment of them to the MSN surface will result in voids
at liquid nitrogen temperatures. The pore size distributions derived from NLDFT calculations are
given in Figure 6.2 and are summarized in Table 2. The pore size changes little upon PEGylation and
photosensitizer attachment, indicating that the mesopores are still accessible for guest molecules.
Furthermore, it proves the selective functionalization of the particle shell.
Dynamic Light Scattering
Dynamic light scattering (DLS) measurements were performed on a Malvern Zetasizer-Nano in-
strument equipped with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. The hy-
drodynamic radius of the particles was determined by dynamic light scattering in ethanolic sus-
pension. For this purpose, 100 µL of an ethanolic suspension of MSN particles (ca. 10 mg/ml)
was diluted with 3 mL of ethanol prior to the measurement. The data for the samples MSN-
SHin-CNout, MSN-SHin-COOHout, MSN-SHin-PEGd8NH2out, MSN-SHin-PEGd8-AlPcS2aout, and
DOPC/DOTAP@MSN-CARGOin-PEGd8-AlPcS2aout can be seen in Figure 6.3 and are summarized
in Table 2. A shorter measurement time was used for the samples MSN-SHin-PEGd8-AlPcS2aout
and DOPC/DOTAP@MSN-CARGOin-PEGd8-AlPcS2aout in order to avoid generation of singlet
oxygen.
Zeta potential measurements
Zeta potential measurements of the samples were performed on a Malvern Zetasizer-Nano instrument
equipped with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. For determination of
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the zeta potential curves, two drops of the ethanolic MSN suspension ( 3 % wt.) was mixed
with 1 mL commercial Hydrion Buffer solution of the appropriate pH prior to measurement. The
Figure 5: Zeta potential measurements of the samples MSN-SHin-CNout (black squares), MSN-SHin-
COOH−out (red circles), MSN-SHin-PEGd8NH2out (green up triangles).
cyanopropyl groups of the sample MSN-SHin-CNout (I, black squares) are uncharged at high or low
pH values, resulting in a zeta potential curve that is similar to the one of unfunctionalized MSN. The
successful attachment of NH2-PEGd8-NH2 to the sample MSN-SHin-COOHout results in a higher
zeta potential value due to protonation of the amino groups at low pH values (green). The sample
MSN-SHin-PEGd8-AlPcS−2aout (IV) couldn’t be measured because the laser wavelength of 633 nm
leads to an excitation of the photosensitizer, resulting in oxygen production with bubble formation
on the electrode. Shorter measurement times did not lead to sufficient results.
IR Spectroscopy
All measurements were performed on a Bruker Equinox 55 FTIR/FTNIR Spectrometer in ab-
sorbance mode (spectra were background substracted). The CH2 stretching vibrations from the or-
ganic functionality (mercaptopropyl- and cyanopropyl) are visible between 2800 cm−1 and 2850 cm−1.
Furthermore, several peaks at 2900 cm−1 (C-H stretching vibrations) and at 1400 cm−1 (C-H bend-
ing vibrations) are visible. The intensity of these vibrations decreases after the carboxylation of the
cyanide groups. Further condensation of the silica framework was achieved through the hydrolysis
of the cyano-moiety and therefore the content of ethoxygroups was reduced. The cyanide vibration
at 2253 cm−1 for the species I disappears completely after hydrolysis while the new -COOH vibra-
tion at 1707 cm−1 (MSN-SHin-COOHout) arises. After PEGylation by EDC amidation the C=O
stretching vibration mode is moved to higher vibrational energies (1616 cm−1) resulting from the
newly formed amide bond. Also the N-H bending vibrations appear at 1530 cm−1. The band be-
tween 1300 cm−1 and 900 cm−1 can be attributed to silica framework vibrations and is visible in all
spectra. The peak at 1332 cm−1 represents the asymmetric stretching of the -SO2 group in AlPcS2a.
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Figure 6: IR spectra of MSN-SH−in-CNout (black), MSN-SHin-COOHout (red),MSN-SHin-PEGd8NH2out
(green) and MSN-SHin-PEGd8-AlPcS2aout (blue). For clarity reasons curves for MSN-SHin-COOHout (red),
MSN-SHin-PEGd8NH2out (green) and MSN-SHin-PEGd8-AlPcS2aout (blue) were shifted along the y-axis
by a value of 0.8 each.
The peak arising at 904 cm−1 in the spectra of MSN-SHin-PEGd8-AlPcS2aout can be assigned to
the stretching vibration of the newly formed N-S bond between the terminal amino-group of the
PEG-linker and AlPcS2a. The two peaks at 743 cm−1 and 720 cm−1 correspond to the non-planar
deformation vibrations of the C-H bonds of benzene rings.
170
1 Details for Chapter 6: Red light photoactivated mesoporous silica nanoparticles
Uptake of MSN-PS-SLB-FA particles with folic acid ligand by KB cells,
imaging after fixation of cells
Figure 7: Unspecific and receptor mediated endocytosis of MSN-PS-SLB-FA particles with folic acid ligand
by KB cells. Cells are fixed with paraformaldehyde after an incubation of 3 h and the cell membrane is
stained with a cell membrane stain (WGA488). (a) Incubation of MSN-PS-SLB-FA particles with FA pre-
incubated KB cells for 3h at 37◦C . b) Incubation of MSN-PS-SLB-FA particles with KB cells, not FA
pre-incubated, 3h at 37◦C . For both a) and b) the orthogonal view in xz and yz plane is shown on the
bottom and right side of the main image. The KB cell membrane is shown in green and the particles in
red. The particles are imaged over the Photosensitizer, and even after fixation one can see the particles in
a dot-like structure which indicates that the photosensitizer is not separated from the particles. The scale
bar represents 10 µm.
Uptake of MSN-PS-SLB-EGF particles with folic acid ligand by HuH7 cells
Figure 8: Unspecific and receptor mediated endocytosis of MSN-PS-SLB-FA particles with EGF ligand by
HuH7 cells. Cells are incubated for 3h and the cell membrane is stained with a cell membrane stain (WGA
633). A) Incubation of MSN-PS-SLB-EGF particles with EGF pre-incubated HuH7 cells for 3 h at 37◦C .
b) Incubation of MSN-PS-SLB-EGF particles with EGF cells, not EGF pre-incubated, 3 h at 37◦C . For
both a) and b) the orthogonal view in xz and yz plane is shown on the bottom and right side of the main
image. The HuH7 cell membrane is shown in green and the particles in red. The scale bar represents 10 µ.
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Chemicals
Tetraethylorthosilicate (TEOS, Fluka, > 99 %), (3-mercaptopropyl)- triethoxysilane (MPTES, Gelest,
95 %), (3cyanopropyl)- triethoxysilane (CN-TES, ABCR, 98 %), cetyltrimethylammonium chloride
(CTAC, Fluka, 25 wt% in H2O), triethanolamine (TEA, Aldrich, 98 %), ammonium fluoride (NH4F,
Sigma, > 98 %), α,ω- bis- amino octa (ethylene glycol) (NH2-PEGd8-NH2, Iris Biotech), Al(III)
phthalocyanine chloride disulfonic acid (AlPcS2a, Frontier Scientific), ammonium nitrate (Sigma,
99 %), conc. hydrochloric acid (Aldrich, > 95 %, 37 wt%), 1,3,5- triisopropylbenzene (TiPB, Fluka,
96 %), sulfo-N- hydroxysuccinimide (sulfo-NHS, Aldrich, 98 %), N-(3- dimethylaminopropyl)-N’-
ethylcarbodiimide (EDC, Sigma, 97 %), calcein (CAL, Sigma), dimethyl sulfoxide (DMSO, Sigma,
>99.5 %), ethanol (EtOH, Aldrich, > 99.5 %), 1,2- dioleoyl-sn- glycero-3- phosphocholine (DOPC,
Avanti Polar Lipids), 1,2- distearoyl-sn-glycero-3- phosphoethanolamine-N- [folate (polyethylene
glycol)-2000] (ammonium salt) (DSPE-PEG2000-FA, Avanti Polar Lipids), 1,2- distearoyl-sn- glycero-
3- phosphoethanolamine -N- [maleimide (polyethylene glycol) - 2000] (ammonium salt) (DSPE-
PEG2000-maleimide, Avanti Polar Lipids), 2-Iminothiolane hydrochloride (Traut’s reagent, Sigma-
Aldrich), 5(6)-Carboxy-X- rhodamine (RD, Sigma), Wheat germ agglutinin (WGA) Alexa Fluor
488 conjugate (Invitrogen), epidermal growth factor (EGF, PeproTech, > 98 %),Folic acid (FA,
Sigma, > 97 %). All chemicals were used as received without further purification. Doubly distilled
water from a Millipore system (Milli-Q Academic A10) was used for all synthesis and purification
steps.
Synthesis of core-shell MSN-SHin-CNout
Bi-functional core-shell colloidal mesoporous silica nanoparticles were synthesized according to a
slightly modified published method. [221, 375] A mixture of TEOS (1.63 g, 9.22 mmol), MPTES
(112 mg, 0.48 mmol) and TEA (14.3 g, 95.6 mmol) was heated under static conditions at 90◦C
for 20 min in a polypropylene reactor. Then a solution of CTAC (25 wt% in water, 2.41 mL,
1.83 mmol), NH4F (100 mg, 2.70 mmol) and TiPB (2.54 g, 12.4 mmol) in water (21.7 g, 1.21 mol)
was preheated to 60◦C and added quickly. The reaction mixture was stirred vigorously (1000 rpm)
at room temperature for 20 min. Subsequently TEOS (138.2 mg, 0.922 mmol) was added in four
equal increments every three minutes. This step was followed by 30 min of stirring at RT. For the
shell functionalization a mixture of TEOS (19.3 mg, 92.5 µmol) and CN-TES (21.4 mg, 92.5 µmol)
was added to the reaction. The resulting mixture was then allowed to stir at room temperature for
12 h. After the addition of 100 mL ethanol, the MSN were collected by centrifugation, re-dispersed
in 100 mL of ethanol and extracted according to the procedure described below.
Extraction of MSN-SHin-CNout
Extraction of the surfactant was performed by heating 250 mg of MSN for 45 min under reflux at
90◦C in a solution containing 2 g ammonium nitrate in 100 mL ethanol. This extraction step was
performed twice. The template-free MSN were separated by centrifugation and washed with ethanol
after each extraction step. MSN-SHin-CNout were obtained as colloidal suspension in EtOH.
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Conversion of MSN-SHin-CNout to MSN-SHin-COOHout
250 mg of MSN-SHin-CNout in EtOH were collected by centrifugation and washed with H2O once.
The particles were re-dispersed in 10 mL H2O and 30 mL hydrochloric acid (37 wt%) was added
carefully. The reaction mixture was heated to reflux for 3 h. After cooling down, 20 mL H2O
were added and the synthesis was stirred at room temperature overnight. The resulting colloidal
suspensionof MSN-SHin-COOHout was diluted further with 100 mL H2O, collected by centrifugation,
and re-dispersed in 100 mL of water. This washing step was repeated twice with both water and
ethanol. MSN-SHin-COOHout were obtained as an ethanolic suspension.
PEGylation of MSN-SHin-COOHout with bi-functional NH2-PEGd8-NH2 to the
sample MSN-SHin-PEGd8-NH2out
An ethanolic suspension containing 20 mg of MSN-SHin-COOHout was centrifuged and re-dispersed
in 60 mL of water. This washing step was repeated twice. EDC (0.85 µL, 4.6 µmol, 1.2 eq) was
added at RT to a diluted suspension of MSN-SHin-COOHout in 40 mL of water. The reaction
mixture was stirred for 5 min before sulfo-NHS (1 mg, 4.6 µmol, 1.2 eq) was added. A second
solution, containing bi-functional NH2-PEGd8-NH2 (7.05 mg, 19.2 µmol, 5 eq.) dissolved in 2 mL
water was prepared. The EDC-activated MSN-SHin-COOHout were added dropwise to the PEG-
containing solution. Afterwards, the pH was adjusted with two drops of hydrochloric acid (37 wt%)
to a value pH < 7 and the reaction mixture was stirred for 12 h at ambient temperature. In order
to remove the excess of the PEG-linker, the reaction mixture was washed five times with 30 mL
of water to remove unbound PEG. All washing steps were followed by centrifugation. Finally, the
sample MSN-SHin-PEGd8-NH2out was re-dispersed in 10 mL ethanol.
Attachment of the photosensitizer AlPcS2a to MSN-SHin-PEGd8-NH2out
yielding the sample MSN-SHin-PEGd8-AlPcS2aout
1 mg of MSN-SHin-PEGd8-NH2out in ethanolic solution was centrifuged and re-suspended in a
500 µL water/DMSO mixture (2:1). Subsequently, 40 cL of an AlPCS2a stock solution (2 mg in
1 mL DMSO) were added to the MSN. The reaction mixture was stirred in the dark at room
temperature for 72 h. The resulting MSN-SHin-PEGd8-AlPcS2aout were extensively washed by
centrifugation with water/DMSO (1:1) in order to remove excess photosensitizer. All supernatants
were investigated with a Nanodrop UV-VIS in order to monitor the content of free photosensitizer.
Results of these measurements can be seen in Figure 6.10 a. In order to remove DMSO from
the mesopores the sample was washed three times with water after no free PS could be detected
(Figure 6.10 b and 6.10 a). The colloidal solution of sample MSN-SHin-PEGd8-AlPcS2aout was used
for further experiments immediately.
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Adsorption of the the dyes calcein and a rhodamine derivative (RD) into the
mesopores of MSN-SH−in-PEGd8-AlPcS2aout
0.5 mg of the sample MSN-SHin-PEGd84-AlPcS2aout in ethanol were centrifuged and re-dispersed
in 1 mL water. This washing step was repeated twice. Then, the suspension was centrifuged again
and re-dispersed in 500 µL calcein in water (1 mM stock solution in water) or RD (1 mM stock
solution in water), respectively. The mixture was stirred over night in the dark yielding the sample
MSN-CARGOin-PEGd8-AlPcS2aout.
Supported DOPC/DOTAP lipid bilayer (SLB) around
MSN-CARGOin-PEGd8-AlPcS2aout
0.5 mg of MSN-CARGOin-PEGd8-AlPcS2aout in 1 mL dye solution were centrifuged (14000 rpm,
16873 rcf, 4 min) and the supernatant discarded. Afterwards, a mixture of 70 µL DOPC and 30 µL
DOTAP (each 2.5 mg/mL in 60:40 H2O:EtOH) were added to the resulting pellet, mixed extensively,
and sonicated for 10 s. To form the supported lipid bilayer around the MSN via solvent exchange
method, 700 µL of water were added. The resulting suspension was mixed and sonicated for 10 s,
yielding DOPC/DOTAP@MSN-Cargoin-PEGd8-AlPcS2aout.
Diffusion of the targeting ligand (TL) construct, DSPE-PEG2000-TL, into the
SLB of DOPC/DOTAP@MSN-CARGOin-PEGd8-AlPcS2aout
0.5 mg of DOPC/DOTAP@MSN-CARGOin-PEGd8-AlPcS2aout in 800 µL water were incubated
with 6 µL of DSPE-PEG2000-TL for 3 h (for DSPE-PEG2000-Folate) and 12 h respectively (for
DSPE-PEG2000-EGF) at 37◦C . The resulting sample DOPC/DOTAP@MSN-CARGOin-PEGd8-
AlPcS2aout-TL was used without further purification for confocal microscopy studies.
Time-based fluorescence release experiments of the sample
DOPC/DOTAP@MSN-CARGOin-PEGd8-AlPcS2aout
Fluorescence time-based release experiments were recorded on a PTI fluorescence system featuring
a PTI 814 photomultiplier detector and a PTI A1010B Xenon arclamp driven by a PTI LPS4220B
lamp power supply. For temperature settings, a Quantum Northwest TC 125 sample holder was used.
Our previously described custom-made release cuvette system was used for all experiments. [40] All
samples were measured at a temperature of 37◦C. For RD an excitation wavelength of 575 nm
was used (emission maximum at 597 nm), whereas calcein was excited with 495 nm and with
an emission maximum at 516 nm. Results are given in Figure 6.5. For all experiments, 0.5 mg
of DOPC/DOTAP@MSN-Cargoin-PEGd8-AlPcS2aout were used. 200 µL of the particle suspen-
sion was filled into the reservoir cap sealed with a dialysis membrane (Molecular weight cut-off
14000 g/mol) allowing released dye molecules to pass into the fluorescence cuvette. In order to
monitor the release of adsorbed dyes upon membrane rupture with singlet oxygen, the sample was
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excited with 0,56 W/mm2 of 633 nm light for 1 min prior the measurement. For triton-mediated
release, 5 µL of a 1 mM stock solution of TritonX-100 was added to the particle solution.
Thermogravimetric analysis
Thermogravimetric analysis of the bulk samples MSN-SHin-CNout, MSN-SHin-COOHout, MSN-
SHin-PEGd8-NH2out and MSN-SHin-PEGd8-AlPcS 2aout was performed on a Netzsch STA 440 C
TG/DSC with a heating rate of 10 K/min in a stream of synthetic air of about 25 mL/min. The
mass was normalized to 100 % at 133.8◦C for all samples and the resulting data is presented in
Figure 6.4.
134C solid state NMR
Cross-polarized 134C solid-state NMR (ssNMR) measurements were perform ed on a Bruker DSX
Avance500 FT spectrometer in a 4 mm ZrO2 rotor. The spinning rate was 10 kHz and a total
number of up to 8000 scans were recorded. Spectra are shown in Figure
175
Appendix
2 Synthesis details for Chapter 7: Polymer pore closing with pH
depended polymer and photoinduced opening mechanism
Further in vitro and in vivo experiments.
Photoactivated release experiments.
With additional attachment of the photosensitizer AlPcS2a the release and therefore the increase of
the cargo fluorescence inside the cell could be detected.
Figure 9: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA (25 µg/mL) nanoparticles loaded with
calcein inside HeLa cells after 24 h incubation. a-c) Calcein (green) and AlPcS2a (red) are co-localized
(yellow) prior to photoactivation. The cell was constantly monitored with a frame rate of 1 frame/s and 0.6
W/mm2 of red light (639 nm). d-i) example images after different time points; spreading of calcein can be
clearly seen over time, whereas AlPcS2a stays at the same location. j) Intensity of calcein fluorescence inside
the cytosol over time in the indicated rectangle, after approximately 2 min an increase can be monitored.
The scale bar represents 10 µm.
In comparison to Figure Appendix 9, the incubation of cells with free photosensitizer and free
calcein (Figure Appendix 10) does not lead to the same effect. It is possible to detect calcein
in the beginning of the experiment, but the endocytosed amount is too low to be detected after
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some time and therefore no spreading could be observed. In contrast to the dot-like pattern of the
particle-bound photosensitizer in Figure Appendix 9, the spreading of the free photosensitizer can
be detected in Figure Appendix 10.
Figure 10: Fluorescence microscopy of free calcein and free AlPcS2a (each 2.5 µg/mL) inside HeLa cells
after 24 h incubation. a-c) Calcein (green) and AlPcS2a (red) are co-localized (yellow) prior to photoac-
tivation. The cell was constantly monitored with a frame rate of 1 frame/s and 0.6 W/mm2 of red light
(639 nm). d-i) example images after different time points, spreading of AlPcS2a can be clearly seen over
time, whereas the calcein fluorescence is too weak to be detected after some time. j) Intensity of calcein
fluorescence inside the cytosol over time in the indicated rectangle; no increase inside the cytosol can be
detected. The scale bar represents 10 µm.
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Targeting.
Prolonged retention in (subcutaneous) tumors of mice.
Figure 11: Intratumoral administration of MSN. a) Retention of MSN in subcutaneous KB-tumors in mice
after intratumoral injection of FA-targeted or untargeted MSN over 168 h. Retention was determined by
fluorescent signal for the Cy7-labeled MSN and normalized to 0 min (3 mice per group). b) Representative
pictures of NIR fluorescence imaging of FA-targeted MSN (top) and untargeted MSN (bottom).
Cy7-labeled targeted and untargeted MSN with cap were also tested in mice bearing subcutaneously
growing human KB carcinomas (Figure 11). Near infrared fluorescence imaging after intratumoral
injection revealed, that for the first hours the folic acid modification results in slightly increased
retention in the tumor tissue compared to untargeted particles (Figure 11a). After more than 24 h
no difference between targeted and untargeted particles is observable. Interestingly, both types of
particles show a prolonged retention in tumors for the whole observation period of 7 d (Figure 11a
and b). This retention in tumors differs from lower persistence upon intravenous administration
(Figure 7.12). The slightly enhanced retention of receptor-targeted over untargeted MSN particles
with cap in the initial phase can be explained by a pronounced washout of non-receptor bound
particles into the blood vessel system.
A bad signal to noise ratio in a similar experiment, but with a slightly different MSN labeling
procedure, prevented a statement on the prolonged retention of these MSN in in vivo KB tumor.
But we also assume that the targeting effect in this tumor model is not that easy traceable for large
MSN as it was already observed for (smaller) polypexes. [376–378] The KB tumor model is known
to poorly form blood vessels [379] and thus we suppose that the blood flow isn’t effective enough to
remove the large particles (over 100 nm) out of the tumor tissue and hence the targeting effect is
negligible.
Chemicals
All reagents were purchased from commercial suppliers: tetraethyl orthosilicate (TEOS, Fluka,
> 98 %), cetyltrimethylammonium bromide (CTAB, Aldrich, 95 %), (3-aminopropyl)triethoxysilane
178
2 Details for Chapter 7:Polymer-Capped Mesoporous Silica Nanoparticles
(APTES, Fluka, 95 %), (3-mercaptopropyl)triethoxysilane (ABCR), N -(3-dimethylaminopropyl)-
N - ethylcarbodiimide hydrochloride (EDC, Fluka, 97 %), α-amino-ω-carboxy terminated poly(2-
vinylpyridine) (NH2-PVP-COOH, Polymer source, Mn = 10000, PDI = 1.08), α,ω-polyethylene-
glycolbisamine (NH2-PEG-NH2, Aldrich, Mn = 2000), Boc anhydride (Aldrich, 95 %), folic acid
(Sigma, 99 %), aluminum (lll) Phthalocyanine chloride tetrasulfonic acid (AlPcS2a, Frontier Sci-
entific), N -hydroxy- sulfosuccinimide sodium salt (Sulfo-NHS, Aldrich, 98 %), 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI, ≥ 98 %), Bis[N,Nâˆ’bis (carboxymethyl) aminomethyl] flu-
orescein (calcein), Folic Acid (FA, > 97 %). Doubly distilled water from a Millipore system (Milli-Q
academie A-10) was used for all syntheses and purification steps. All solvents and buffer contents
above were purchased from Sigma-Aldrich. Wheat germ agglutinin (WGA) Alexa Fluor 488 con-
jugate (Invitrogen), Atto 633 maleimide (ATTO-TEC). Unless otherwise noted, all reagents were
used without further purification.
Characterization.
All samples were investigated with a FEI Titan 80-300 operating at 300 kV with a high-angle
annular dark field detector. A droplet of the diluted MSN solution in absolute ethanol was dried on
a carbon-coated copper grid. Nitrogen sorption measurements were performed on a Quantachrome
Instruments NOVA 4000e. All samples (15 mg each) were heated to 60◦C for 12 h in vacuum
(10 mTorr) to outgas the samples before nitrogen sorption was measured at 77 K. Pore size and
pore volume were calculated by a NLDFT equilibrium model of N2 on silica, based on the desorption
branch of the isotherms. In order to remove the contribution of the interparticle textural porosity,
pore volumes were calculated only up to a pore size of 8 nm. A BET model was applied in the range
of 0.05 - 0.20 p/p0 to evaluate the specific surface area of the samples. Centrifugation was performed
using a Sorvall Evolution RC equipped with a SS-34 rotor or an Eppendorf centrifuge 5418 for small
volumes. Raman spectra were recorded on a Jobin Yvon Horiba HR800 UV Raman microscope
using a He Ne laser emitting at λ = 633 nm. Dynamic light scattering (DLS) measurements were
performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser (633 nm)
and an avalanche photodiode. The hydrodynamic radius of the particles was determined by dynamic
light scattering in ethanolic suspension. For this purpose, 100 µL of an ethanolic suspension of MSN
particles (ca. 10 mg/mL) was diluted with 3 mL of ethanol prior to the measurement. Zeta potential
measurements of the samples were performed on a Malvern Zetasizer-Nano instrument equipped with
a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. Zeta potential measurements were
performed using the add-on Zetasizer titration system (MPT-2) based on diluted NaOH and HCl
as titrants. For this purpose, 1 mg of the particles was diluted in 10 mL bi-distilled water. IR
measurements were performed on a Bruker Equinox 55 FTIR/FTNIR Spectrometer in absorbance
mode (spectra were background substracted). Thermogravimetric analysis was performed on a
Netzsch STA 440 C TG/DSC with a heating rate of 10 K / min in a stream of synthetic air of
about 25 mL/min. The mass was normalized to 100% at 150◦C for all samples. UV-VIS spectra
were recorded with a NanoDrop ND 1000 spectrometer. Usually, 2 µL of sample were used and all
presented spectra are background corrected for water absorption.
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Preparation of shell-functionalized colloidal mesoporous silica nanoparticles
(MSN-NH2).
MSN nanoparticles were prepared by a delayed co-condensation approach as described earlier by
Cauda et al. [37] In detail, a two phase mixture of TEA (14.3 g) and TEOS (1.9 g, 9.12 mmol) was
heated at 90◦C for 20 min without stirring. After removal of the oil bath, a preheated (60◦C)
solution of CTAC (2.14 mL, 1.62 mmol, 25 wt% in H2O) and water (21.7 g) was added and
stirred afterwards at 500 rpm for 30 min at room temperature. Subsequently, a mixture of 3-
aminopropyltriethoxysilane (22.5 µL, 96 µmol) and TEOS (20.5 µL, 92 µmol) was added. The
resulting solution was stirred overnight at room temperature at 500 rpm. Extraction of the organic
template was achieved by heating the ethanol-suspended sample (10 mg/mL) under reflux at 90◦C
for 1 h in a mixture of 2 g ammonium nitrate and 100 mL ethanol. Afterwards, the sample was
centrifuged for 20 min at 19000 rpm (43146 rcf), redispersed in ethanol and heated under reflux at
90◦C in a solution of 8 mL concentrated HCl and 32 mL ethanol for 45 min. After centrifugation,
the particles were redispersed in ethanol, resulting in a colloidal suspension.
Figure 12: Synthesis scheme of a fully funtionalized MSN particle.
Protection of NH2-PVP-COOH (Boc-PVP-COOH).
To a solution of 500 mg (50 µmol) NH2-PVP-COOH in 10 mL dry dichloromethane, 15 µL (0.11 mmol)
triethylamine and 15 mg (69 µmol) Boc anhydride were added. The solution was stirred overnight
and extracted several times with brine. The organic phase was dried over MgSO4 and evaporated
to dryness to afford the Boc protected polymer. The polymer was used without further purification.
180
2 Details for Chapter 7:Polymer-Capped Mesoporous Silica Nanoparticles
General procedure for the attachment of poly(2-vinyl pyridine) to MSN-NH2
(MSN-PVP-Boc).
To a dispersion of 50 mg MSN-NH2 in 10 mL tetrahydrofuran (THF), 60 mg (5.6 µmol) polymer
dissolved in 1.5 mL THF were added. The amidation was activated by the addition of 10 µL
(57.2 µmol) EDC and 1.3 mg (6 µmol) Sulfo-NHS. The mixture was stirred at room temperature
for 12 h. Afterwards the particles were separated by centrifugation (19000 rpm, 43146 rcf, 20 min)
and washed 3 times by repeated centrifugation and redispersion in 30 mL THF.
Deprotection of MSN-PVP-Boc (MSN-PVP-NH2).
Deprotection of the polymer was achieved through stirring 10 mg polymer functionalized particles
in a mixture of 2 mL trifluoroacetic acid and 8 mL water for 24 h. After deprotection, the particles
were extensively washed by centrifugation (19000 rpm, 43146 rcf, 20 min) and redispersion in a
mixture of 0.01 M HCl and EtOH.
Conversion of MSN-PVP-NH2 to MSN-PVP-COOH.
10 mg MSN-PVP-NH2 in 2 mL EtOH were reacted with a large excess of oxalic acid (5 mg, 55 µmol)
and EDC (9 µL, 51 µmol) for 1 h. Afterwards the particles were extensively washed by centrifugation
(19000 rpm, 43146 rcf, 20 min) and redispersion in a mixture of 0.01 M HCl and EtOH.
PEGylation of MSN-PVP-COOH (MSN-PVP-PEG-NH2).
To a dispersion 1 mg MSN-PVP-COOH in 500 µL EtOH, 2 mg (100 nmol) NH2-PEG-NH2 in 500 µL
bidistilled water was added and the reaction was started through the addition of 0.5 µL (2.8 µmol)
EDC. After stirring for 1 h at room temperature, the sample was washed 3 times by centrifugation
with a mixture of EtOH:water 1:1.
Attachment of folic acid to MSN-PVP-PEG-NH2 (MSN-PVP-PEG-NH2-FA).
The amino functionalities of 1 mg MSN-PVP-PEG-NH2 in 1 mL EtOH:water 1:1 were partially
reacted with 0.44 µg (1 nmol) folic acid. To start the reaction, 0.5 µL (2.8 µmol) EDC and a
catalytic amount (approx. 1 mg) of Sulfo-NHS were added. After 1 h, the sample was washed 3
time by centrifugation with a mixture of EtOH:water 1:1.
Attachment of AlPcS2a to residual amino groups of MSN-PVP-PEG-NH2-FA
(MSN-PVP-PEG-FA- AlPcS2a).
To the sample MSN-PVP-PEG-NH2-FA in 1 mL DMSO:water 1:1 was added 20 µL of AlPcS2a
(1 mg/mL in DMSO). The resulting mixture was stirred at room temperature in the dark for
24 h. Subsequently, the sample was washed extensively with DMSO:water 1:1 until there was no
photosensitizer in the supernatant.
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Drug/dye loading.
1 mg MSN-PVP-PEG-NH2 were dispersed in 500 µL of a 1 mM drug/dye solution in water. To
open the pores and enable the uptake, 50 µL of citrate buffer (pH 2) were added. The particles
were stirred overnight, centrifuged, and redispersed in 1 mL SSC buffer (pH 7) to trigger closure of
the polymer shell. The particles were washed extensively with SSC buffer until no fluorescence was
detected in the supernatant.
In vitro fluorescein release.
1 mg fluorescein loaded MSN-PVP-NH2 or MSN-PVP-PEG-NH2 were redispersed in 200 µL SSC
buffer and transferred to the cap of the fluorescence cuvette. This cap is sealed with a dialysis
membrane (molecular weight cutoff of 16000 g/mol) and placed on top of the fluorescence cuvette,
which is also filled with SSC buffer. The “release” of fluorescein out of the closed particles was
monitored for 2 h (λex = 490 nm, λem = 512 nm). Subsequently, the cap was removed and the
particles were centrifuged and redispersed in 200 µL citrate-phosphate buffer (pH 5), before being
put into the cap of the release setup. The fluorescence cuvette was also filled with citrate-phosphate
buffer (pH 5). After reassembling of the release setup, the release of fluorescein was measured for
10 h continuously. For comparison of the obtained curves, calibration curves of fluorescein in SSC
buffer (pH 7) and in citrate-phosphate buffer (pH 5) were recorded.
Experimental Setup. Fluorescence experiments were performed to show the time-dependent
release of fluorescein from the mesopores of colloidal mesoporous silica spheres. The measurements
were recorded on a PTI fluorescence system featuring a PTI 814 photomultiplier detector and an
PTI A1010B Xenon arclamp driven by a PTI LPS-220B lamp power supply. For temperature
settings, a Quantum Northwest TC 125 sample holder was used. Fluorescein was excited with
490 nm and emission was detected at 512 nm (excitation slit 1.0 mm, emission slit 1.0 mm, 1 point
per 30 min). For the release experiment, a ROTH Visking Typ 8/32 dialysis membrane with a
molecular cut-off of 14000 g/mol was used. An image of this custom made Teflon container can be
seen in Figure 13a.
1 mg MSN were loaded by redispersing them in 500 µL of a 1 mM fluorescein solution that was
acidified with 50 muL of a citrate/phosphate buffer of pH 2. After 12 h, the particles were washed
by centrifugation and redispersion in SSC buffer pH 7 until no fluorescence was observed in the
supernatant. For the release experiment, the particles were redispersed in 200 µL SSC buffer pH 7
and put into a container, that was subsequently closed by a dialysis membrane. The closed container
was then put onto a fluorescence cuvette, which was completely filled with SSC buffer pH 7. The
released dye is able to pass through the applied membrane while the relatively larger particles are
retained. After 16 h, the particles were centrifuged and redispersed in 200 µL Mc Ilvaine’s buffer
pH 5, put into the container and closed by the dialysis membrane. The closed container was then
put onto the fluorescence cuvette, which was completely filled with Mc Ilvaine’s buffer pH 5. The
release was measured every 30 min until no further release was observed (Figure 13 c).
As the fluorescence of fluorescein is strongly dependent on the pH, calibration curves at pH 7 and
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Figure 13: a)Custom made release experiment setup featuring a 200 µL Teflon tube (a) which is closed
by a dialysis membrane (b). This setup is put onto a fluorescence cuvette filled with the desired buffer
(c).b)Calibration curves of fluorescein at pH 7 (red) and pH 5 (blue).c)Longterm release curve (normalized
fluorescence intensity).
pH 5 were recorded (Figure 13 b) to be able to compare fluorescence signals in the closed and open
state.
UV-VIS Spectroscopy
The loading capacity of the particles was quantified with UV-Vis spectroscopy. 1 mg of particles
were loaded with 500 µg calcein and washed as described above.The absorption of the supernatants
was measured on a Thermo Scientific PeQLab Nanodrop 2000c. Afterwards the particles were stirred
for 48 h in 1 mL Mc Ilvaine’s buffer pH 5, centrifuged and the absorption of the supernatant was
measured again. For determination of the calcein concentration, calibration curves of calcein in Mc
Ilvaine’s buffer pH 5 and SSC buffer pH 7 at 495 nm were recorded (Figure 14)
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Figure 14: Calcein calibration curves for determination of loading and release capacity at pH 7 (red) and
pH 5 (blue).
The calcein supernatant solution after loading was diluted by the factor of 20. The measured
absorbance at 495 nm for the loading capacity of 0.155 leads to an amount of 432 µg by using the
calibration curve’s linear regression. After several washing steps with SSC buffer to close the pore
system, the supernatants were collected and measured. The measured absorbance of 0.151 leads to
an additional amount of 16µg. Consequently, the total amount of calcein loaded in 1 mg MSN was
0.052 mg.
Loading capacity: 0.05 mg/mg MSN
The released amount of calcein was then measured as described above. The measured absorbance
at 495 nm of 0.147 leads to an amount of 21µg by using the calibration curve’s linear regression.
The total amount of calcein released from 1 mg MSN was 0.021 mg.
Release capacity: 0.02 mg/mg MSN
Stability tests
After immersion of the particles in DMEM for different times at different pH, they were extensively
washed and dried from an acidified (several droplets of 0.01 M HCl) aqueous solution at 60◦C otain
opened particles for sorption experiments. Nitrogen sorption measurements were performed on a
Quantachrome Instruments NOVA 4000e at 77 K. It can be seen that all isotherms maintain the
shape of a type IV isotherm. Additionally, no changes in the NLDFT pore size distribution are
observed, which shows that the pore structure is not affected by the medium.
In vivo experiments with MSN-PVP-PEG-NH2-FA
All in vivo experiments from Chapter 7 were performed by Annika Hermann (group of Prof. Wag-
ner).
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For in vivo experiments female Rj:NMRI-nu (nu/nu) (Janvier, Le Genest-St-Isle, France) mice were
housed in isolated ventilated cages with a 12 h day/night cycle and food and water ad libitum.
Animal experiments were performed according to guidelines of the German law of protection of
animal life and were approved by the local animal experiments ethical committee.
MSN biodistribution
MSN were prepared in 20mM HEPES (Biomol GmbH, Hamburg, Germany) with 5 % glucose
(Merck, Darmstadt, Germany) (HBG). For analysis of MSN, mice were anesthetized with 3 %
isoflurane in oxygen. A 100 µg (5 mg/kg) dose of Cy-7 loaded MSN-PVP-PEG-NH2â€“FA or
unfunctionalized MSN dispersed in 200 µL (HBG) was injected intravenously into the tail vein of
tumor-free mice. Near-infrared fluorescence imaging by a CCD camera using the IVIS Lumina
system with Living Image software 3.2 (Caliper Life Sciences, Hopkinton, MA, USA) was started
immediately after injection and was repeated after 0.25, 0.5, 1, 4, 24 and 48 h.
Clinical chemistry and histopathology
Mice (n=9) were sacrificed with isoflurane (Isofluran CP ®, CP-Pharma Handelsgesellschaft mbH,
Burgdorf, Germany) 48 h after intravenous injection of pure HBG or a 100 µg (5 mg/kg) dose
of Cy-7 loaded MSN-PVP-PEG-NH2-FA or unfunctionalized MSN. Blood was collected in serum
tubes (Multivette, Sarstedt, Nuembrecht, Germany) and clinical chemistry parameters (alanine
transaminase/aspartate transaminase, creatinine levels and blood urea nitrogen) were analyzed.
Organs were dissected and fixed in formalin, embedded into paraffin and stained with eosin and
hematoxylin. Results were documented using an Olympus BX41 microscope (Olympus, Germany).
MSN retention in tumors
Human cervix carcinoma cells (KB wild-type) were cultured as described above. Mice were injected
with 5 x 106 cells subcutaneously into the nape and tumors were allowed to grow for 14 days.
At day 14, mice were anesthetized with 3 % isoflurane in oxygen and 100 µg (5 mg/kg) of Cy-
7 labeled MSN-PVP-PEG-NH2 with and without folic acid ligand solved in 50 µL (HBG) were
injected intratumorally to test for differential retention in tumors. The near infrared fluorescence
signals were recorded by a CCD camera immediately after injection and repeated after 0.25, 0.5, 1,
4, 24 h and daily for one week using the IVIS Lumina system. Data interpretation was done with
equalized color bar scales for each trial and pictures were analyzed using the Living Image software
3.2 (Caliper Life Sciences, Hopkinton, MA, USA).
Human breast cancer cells (MDA-MB-231) were cultered in DMEM-medium. Mice were injected
subcutaneously into the left flank with 5 x 106 cells suspended in 50 % Matrigel (BD Biosciences)
in PBS. At day 42, mice were injected intravenously via tail vein with 100 µg (5 mg/kg) of Atto633-
labeled MSN-PVP-PEG-NH2 with and without folic acid ligand solved in 100 µL HBG. Mice were
sacrificed by cervical dislocation under isoflurane anesthesia 3 h after injection of MSN. Tumors
and organs (liver, spleen, kidneys and lungs) were harvested and embedded in Tissue Tek (Sakura
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Finetek, Heppenheim, Germany) and immediately stored at −20◦C Celsius. For preparation of
cryosections with a thickness of 5 µm a cryotom was used. The cryosections were fixed in 4 %
paraformaldehyde, stained with 4’,6-Diamidino-2- phenylindol (DAPI) and results were documented
with Zeiss Cell Observer SD (recording z-stacks).
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3 Synthesis details for Chapter 8: Dendrimeric shell and disulfide
binding of cargo - proton sponge effect
IR spectra
Figure 15: IR spectroscopy data of a) AzTMS, b) dendron-silane S1, c) dendron-silane S2, and d) dendron-
silane S3.
Figure 16: IR spectroscopy data of functionalized MSNs.
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NMR spectra
Figure 17: 1H and 13C NMR spectrum of propargyl-dendron D3.
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13C solid state NMR
Figure 18: 13C solid state NMR spectra of functionalized MSNs. a) MSN-SHIN -N3OUT (black), b)MSN-D3
(blue)
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DAPI release
Figure 19: Fluorescence microscopy of HeLa cells incubated with MSN-D3-MTS-DAPI (a, b, c), MSN-
NH2-MTS-DAPI (d, e, f), and the supernatant of MSN-D3-MTS-DAPI (g, h, i). The nanoparticles have
been loaded with covalently attached DAPI (MTS-DAPI, blue) and labeled with Atto633 (red). The cells
have been incubated with the samples for 5 h (a, d, g), 24 h (b, e, h) and 61 h (c, f, i). The nuclei are
indicated with dashed circles. A time-dependent nuclei staining can be observed for MSN-D3-MTS-DAPI,
suggesting triggered release of the cargo molecules from the nanocarriers after endosomal escape via the
proton sponge effect and excess to the cytosol. For MSN-NH2-MTS-DAPI and the supernatant incubation
almost no nucleic staining can be detected which implies that no DAPI has been release form the particles
or has been present in the solution, respectively. The scale bars represent 10 µm.
Cytotoxicity studies
The cytotoxic impact of the PAMAM dendron-coated MSNs was determined by using immortal-
ized human microvascular endothelial cells (HMEC-1; Centers for Disease Control and Prevention,
USA). HMEC-1 were cultivated in Gibco® MCDB 131 medium (Life Technologies GmbH, Germany)
supplemented with 10 % (v/v) fetal bovine serum (FBS, Life Technologies GmbH, Germany), 1 %
(v/v) GlutaMAXTM I 100X (Life Technologies GmbH, Germany), 1 µg/ml hydrocortisone (Sigma-
Aldrich Chemie GmbH, Germany) and 10 ng/ml epidermal growth factor (Life Technologies GmbH,
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Germany) at 37◦C in a 5 % CO2 humidified environment by changing the growth medium every
2-3 days. Subcultivation was performed after reaching cellular confluency of 70-85 % using GIBCO®
trypsin (Life Technologies GmbH, Germany) for cell detachment. PCR was routinely performed to
test that the cells were free of mycoplasma infection. For cytotoxicity evaluation, 12.000 cells/cm2
were seeded in a 96 well cell culture plate. 24 h after seeding they were exposed to PAMAM dendron-
coated MSNs of different concentrations (10 fg/ml to 100 µg/ml) for 3 to 72 h. After the defined
incubation times, the cells were washed with Hank’s BSS and freshly cell culture medium and 20 µl
Cell titer 96 Aqueous One Solution Reagent (Promega GmbH, Germany) per well were added. The
absorbance of the supernatants was measured at 492 nm via a microplate reader (Sunrise™ Tecan
Group Ltd., Switzerland) and the relative cellular dehydrogenase activity of endothelial cells was
calculated by normalizing the values to untreated control cells. For evaluation of nanoparticle up-
take kinetics, 12.000 cells/cm2 were seeded in 8-well LabTek-II slides (Nunc). Cells were exposed to
100 µg/ml of PAMAM dendron-coated MSNs 24 h after seeding for 3, 24 and 48 h. After that, cells
were washed twice with phosphate buffered and plasma membrane was stained with a 10 µg/ml
wheat germ agglutinin Alexa Fluor 488 conjugate (WGA488, Invitrogen) solution in cell medium
during 1 min. Staining solution was removed and cells were washed twice with cell medium. Fresh
cell medium was added and cells were imaged immediately by spinning disc confocal microscopy
with a Z-spacing of 0.25 µm (63x objective). Calibration experiments were carried out with PA-
MAM dendron-coated MSNs deposited on a cover slip and covered with cell medium. The images
were evaluated with the subroutine Calibration of Particle_in_Cell-3D and the mean intensity value
showed a Gaussian distribution with the mean at 64632 pixel intensities per nanoparticle.
Chemicals.
Propargylamine (Aldrich, 98 %), N,N- diisopropylethylamine (DIPEA, Sigma-Aldrich, ≥ 99 %),
copper(I) iodide (Aldrich, 99.999 %), (3- aminopropyl) triethoxysilane (APTES, Aldrich, 99 %),
tetraethyl orthosilicate (TEOS, Fluka, > 98 %), triethanolamine (TEA, Aldrich, 98 %), cetyltrimethy-
lammonium chloride (CTAC, Fluka, 25 % in H2O), (3-mercaptopropyl) trimethoxysilane (MPTMS,
Gelest, 95 %), methanethiosulfonate 5(6)- carboxy-X- rhodamine (MTS-ROX, Biotium), colchicine
methanethiosulfonate (MTS-Col, Santa Cruz Biotechnology), 4,6- diamidino-2- phenylindole di-
hydrochloride (DAPI, Sigma Aldrich), folic acid (FA, Sigma), Atto633 maleimide (ATTO-TEC),
1-ethyl-3-(3- dimethylaminopropyl) carbodiimide hydrochloride (EDC, Fluka, 97 %), N-hydroxy-
sulfosuccinimide (sulfo-NHS, Sigma Aldrich, > 98.5 %), poly (ethylene glycol) bisamine (PEG2000-
bisNH2, MW2000, Sigma Aldrich), N-succinimidyl oxycarbonylethyl methanethiosulfonate (NHS-3-
MTS, Santa Cruz Biotechnology), and oxalic acid were used as received. Methyl acrylate (Aldrich,
99 %) and 1,2-ethylendiamine (Aldrich, 99.5 %) were freshly distilled prior to use. Ethanol (EtOH,
absolute), N,N-dimethyl formamide (DMF, Sigma Aldrich, anhydrous) and methanol (MeOH, an-
hydrous, Sigma) were used as solvents without further purification. Bidistilled water was obtained
from a Millipore system (Milli-Q Academic A10). (3-Azidopropyl) trimethoxy silane (AzTMS) was
freshly prepared as previously reported. [219]
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Synthesis of propargyl-PAMAM dendrons.
Starting with propargylamine, the synthesis of PAMAM dendrons employs a Michael addition with
methyl acrylate and amidation with 1,2-ethylendiamine in an alternating fashion. The methodology
was developed by Lee et al.. [320]
General procedure for Michael addition.
A solution of the amino-terminal compound in anhydrous methanol (80 mL) was added drop-wise
to a stirring solution of freshly distilled methyl acrylate in methanol over a period of approx. 1 h
at 0◦C. The resulting solution was allowed to warm up to room temperature and stirred for 48 h.
The reaction progress was monitored by NMR spectroscopy and stopped when the N-H signal had
disappeared. Solvent and methyl acrylate were removed in vacuo, traces of methyl acrylate were
removed by redissolving the residue in methanol and repeated removal of the solvent. Drying under
high vacuum gave the desired pure product as orange viscous oil.
General procedure for amidation.
A solution of the ester-terminal compound in methanol (80 mL) was added drop-wise to a stirring
solution of freshly distilled 1,2-ethylendiamine in methanol over a period of approx. 1 h at 0◦C. The
resulting solution was allowed to warm up to room temperature and stirred for 48 h. The reaction
was monitored by NMR spectroscopy and stopped when no methyl ester signal could be detected
anymore. Solvent was removed in vacuo, the excess of 1,2-ethylendiamine was removed successively
by adding 100 mL of an azeotropic toluene/methanol mixture (9:1) and removal of the volatiles in
vacuo. This procedure needed to be repeated four to six times with a final pressure after removal
of < 10 mbar. Remaining toluene was removed by azeotropic distillation using methanol. Drying
under high vacuum gave the desired pure product as orange viscous oil.
Dendron D3:
Dendron D0.5: Starting material: Propargylamine (1.50 g, 1.74 mL, 27.2 mmol, 1+eq.); Reagents:
methyl acrylate (17.0 g, 17.9 mL, 197 mmol, 7.3 eq.) in 20 mL methanol; Yield: 5.74 g (25.3 mmol,
93 %);
Dendron D1: Starting material: D0.5 (4.90 g, 21.6 mmol, 1 eq.); Reagents: 1,2-ethylendiamine
(111 g, 100 mL, 1.85 mol, 86 eq.) in 30 mL methanol; Yield: 6.23 g (21.2 mmol, 98 %);
Dendron D1.5: Starting material: D1 (5.78 g, 20.4 mmol, 1 eq.); Reagents: methyl acrylate
(28.5 g, 30.0 mL, 331 mmol, 16 eq.) in 40 mL methanol; Yield: 12.3 g (19.6 mmol, 96 %);
Dendron D2: Starting material: D1.5 (10.5 g, 16.7 mmol, 1 eq.); Reagents: 1,2-ethylendiamine
(111 g, 100 mL, 1.85 mol, 110 eq.) in 20 mL methanol; Yield: 12.1 g (16.4 mmol, 98 %);
Dendron D2.5: Starting material: D2 (6.7 g, 10.4 mmol, 1 eq.); Reagents: methyl acrylate (85.5 g,
90.0 mL, 0.99 mol, 96 eq.) in 30 mL methanol; Yield: 14.5 g (10.2 mmol, 98 %);
Dendron D3: Starting material: D2.5 (6.42 g, 4.50 mmol, 1 eq.); Reagents: 1,2-ethylendiamine
(122 g, 110 mL, 2.0 mol, 452 eq.) in 10 mL methanol; Yield: 6.5 g (3.91 mmol, 87 %);
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IR (film): 3271, 3074, 2933, 2863, 1636, 1540, 1436, 1359, 1197, 1127, 935 cm−1;
1H NMR (270 MHz, CDCl3) d = 7.98 (s, 2H, NHCO), 7.77 (s, 4H, NHCO), 7.57 (s, 8H, NHCO),
3.39 (d, 4J = 2.0 Hz, 2H, N-CH2-Câ‰¡CH), 3.29-3.11 (m, 32H), 2.79-2.72 (m, 24H), 2.70-2.64
(m, 12H), 2.63-2.56 (m, 12H), 2.51-2.42 (m, 8H), 2.38-2.21 (m, 24H), 2.12 (t, J = 2.0 Hz, 1H,
CH2-Câ‰¡C-H), 1.65 (br s, 16H, NH2);
13C NMR (68 MHz, CDCl3) d = 173.37 (C=O), 173.15 (C=O), 172.82 (C=O), 77.43 (CH2-
Câ‰¡CH), 72.69 (CH2-Câ‰¡CH), 53.05, 52.66, 52.17, 50.75, 50.25, 46.46, 45.01, 42.49, 42.32,
41.66, 37.86, 34.51, 34.13 (NMR spectra are shown in Figure Appendix 17/18);
HRMS (ESI) (C73H145N29O14): m/z (%) = 827.0835 (24) [M+2H]2+, 1653.1595 (9) [M+H]+.
Synthesis of PAMAM Silanes.
Huisgen azide-alkyne 1,3-dipolar cycloaddition with amino-terminated propargyl-PAMAM dendrons
and AzTMS was performed based on a similar reaction of AzTMS with an alkyne compound reported
by Lim et al.. [380]
General procedure: The amino-terminated propargyl-PAMAM dendron D1-3 (1 eq.) was dissolved
in a suspension of molecular sieves (3 Å) in anhydrous methanol (15 mL) and DIPEA (2 eq.). The
resulting suspension was degassed afterwards. Under an atmosphere of nitrogen, copper(I) iodide
(10 mol%), as catalyst, and AzTMS (0.25 eq.) were added. The reaction was stirred for 24 h at
room temperature and subsequently filtered using a syringe filter. After exposure to air the solution
turned purple-blue very quickly. The solvent was removed in vacuo, drying of the crude product at
high vacuum yielded a blue gum which was used without further purification.
S3 Starting material: D3 (3.31 g, 2.00 mmol); Reagents: AzTMS (103 mg, 103 mL, 0.500 mmol),
DIPEA (517 mg, 697 mL, 4.00 mmol), CuI (38.1 mg, 0.200 mmol); Crude product: 3.5 g containing
836 mg (450 mmol) of S3.
Synthesis of dendron-functionalized MSNs (MSN-SHIN -D3OUT ).
Colloidal mesoporous silica nanoparticles (MSN-SHIN -D3OUT ) were prepared according to a syn-
thesis procedure published by Cauda et al.. [37] The amount of functionalized silane was calculated
to be 1 % of total silica. A mixture of TEA (14.3 g, 95.6 mmol), TEOS (1.56 g, 7.48 mmol)
and MPTMS (92.3 mg, 87.3 mL, 0.47 mmol) was heated for 20 min at 90◦C without stirring in a
polypropylene reactor. Afterwards, a preheated mixture of CTAC (2.41 mL, 7.29 mmol) and H2O
(21.7 g, 1.21 mol) to 60◦C was added to the first solution and stirred for 20 min at room tempera-
ture. Then, every 3 min 37.2 µL TEOS (34.6 mg) was added to the stirring suspension four times
in total. The reaction was stirred for further 30 min. After this time, a mixture of TEOS (19.2 mg,
92.2 mmol) and functionalized trialkoxysilane (RTMS: AzTMS, S3) (92.2 mmol) was added. In the
case of the PAMAM silanes S3, the amount of crude product to be used for particle functionalization
was calculated from the percental mass of the silane in the crude product. Furthermore, the mixture
of TEOS and PAMAM silane was dissolved in a solution of 2 mL methanol and 1 mL water briefly
before the addition. The reaction was stirred at room temperature over night. The suspension was
193
Appendix
Figure 20: Synthesis of propargyl-PAMAM dendrons (D0.5 - D3). Reagents and reaction conditions: a)
methyl acrylate (large excess), MeOH, 0 → 25◦C, 48 h and b) 1,2-ethylenediamine (large excess), MeOH, 0
→ 25◦C, 48 h.
diluted 1:1 with absolute ethanol, the colloidal MSNs were separated by centrifugation (19,000 rpm,
43,146 rcf, 20 min) and redispersed in absolute ethanol. The template extraction was performed by
heating the samples under reflux at 90◦C (oil bath) for 45 min in a solution of ammonium nitrate
(2 wt% in ethanol) followed by 45 min under reflux at 90◦C in a solution of 10 mL conc. HCl
(37 %) in 90 mL ethanol. The extracted MSNs were collected by centrifugation after each extrac-
tion step and finally washed with 100 mL absolute ethanol. The resulting MSNs were stored in an
ethanol/water solution (2:1).
Cargo loading.
MSN-D3 (1 mg) was incubated for 2 h at room temperature in the dark with MTS-ROX (5 µL,
5 mg/mL in DMF), MTS-Col (50 µL, 5 mg/mL in DMF), or MTS-DAPI for a one-step covalent
attachment of the cargo molecules to the internal surface of the mesopores via disulfide bridges.
MTS-DAPI was prepared in-situ by mixing DAPI (10 µL, 5 mg/mL in DMF) and NHS-3-MTS
(100 µg) in an aqueous solution for 1 h at room temperature in the dark. This reaction mixture
was subsequently added to MSN-D3. The particles were washed five times (centrifugation, 4 min,
14,000 rpm, 16,837 rcf) with water and were finally redispersed in 1 mL H2O.
MSN labeling.
MSN-D3 (0.5 mg) were mixed with Atto633 maleimide (1 µL, 2 mg/mL in DMF). After 2 h of
stirring at room temperature in the dark the labeled particles were washed three times with water
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by subsequent centrifugation (4 min, 14,000 rpm, 16,837 rcf) and redispersed in H2O.
Attachment of the targeting ligand folate.
Oxalic acid, EDC, and sulfoNHS (each 5 mg) were successively added to an aqueous dispersion of
MSN-D3 (0.5 mg) and the resulting reaction mixture was stirred at room temperature in the dark for
another 2 h. Subsequently, the particles were washed three times (centrifugation, 4 min, 14,000 rpm,
16,837 rcf) and redispersed in 300 µL H2O. The PEG linker was attached via EDC amidation. EDC,
sulfoNHS and PEG2000-bisNH2 (each 5 mg) were consecutively added to the particle dispersion and
stirred for another 2 h at room temperature in the dark. The particles were washed three times
by centrifugation (4 min, 14.000 rpm) and redispersed in 100 µL water. Then 400 µL of a folate
stock solution (0.75 µM in H2O), EDC (5 mg), and sulfoNHS (5 mg) were added. The reaction
mixture was stirred over night at room temperature in the dark. After washing the particle three
times with water (centrifugation, 4 min, 14,000 rpm, 16,837 rcf) the MSN-D3-FA sample was finally
redispersed in 1 mL H2O.
Characterization.
IR spectra were recorded on a Bruker Equinox 55. The dried powder of the silica nanoparticles
(1.5 mg) was mixed with KBr (200 mg) to produce pressed, transparent pellets to be measured in
absorbance mode. For background measurements a neat KBr pellet (200 mg) was used. IR spectra
of the organic compounds were recorded in the attenuated total reflectance (ATR) mode on the same
devise or on a Perkin-Elmer FT-IR Spektrum BXII spectrometer with Schmith Dura SampIIR II
ATR-Unit.
Acid-base titrations were performed on a Metrohm 905 Titrando potentiometric titrator combined
with the software tiamo. The titration method met the following parameters: monotonic equivalence
point titration (MET); stirring speed 5; measurement value drift 20.0 mV/min; min. delay 0 s; max.
delay 300 s; volume increment 0.025 mL; dosing speed maximal; stop value pH 10.2. The samples
were prepared as follows: A volume containing 13.7 mg particles from the suspensions was added
to 30.0 mL H2O. The starting pH was set to 3.000 using HCl (0.1 M) and NaOH (0.01 M) from the
dosing unit. The samples were titrated against NaOH (0.01 M).
TGA of the bulk extracted samples (about 10 mg of dried powder) were performed on a Netzsch
STA 440 Jupiter thermobalance (heating rate of 10 K/min in a stream of synthetic air of about
25 mL/min).
Nitrogen sorption measurements were performed on a Quantachrome Instruments NOVA 4000e at
−196◦C. Sample out-gassing was performed at 120◦C for 12 h at a pressure of 10 mTorr. Pore size
and pore volume were calculated using a NLDFT equilibrium model of N2 on silica, based on the
desorption branch of the isotherm. The BET model was used in the range of 0.05 â€“ 0.20 p/p0 to
estimate the specific surface area.
DLS and zeta potential measurements were performed on a Malvern Zetasizer-Nano instrument
equipped with a 4 mW He-Ne laser (633 nm) and avalanche photodiode detector. DLS measurements
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were directly recorded on aqueous colloidal suspension at a constant concentration for all sample
solutions of 1 mg/mL. For determination of the zeta potential profiles, one to three drop of the
ethanolic suspension (ca. 3 wt%) was mixed with 1 mL of commercial Hydrion Buffer solution of
the appropriate pH prior to measurement. Hückel’s approximation was used for interpretation.
For TEM (using a Titan 80-300 kV microscope operating at 300 kV), samples were prepared by
dispersing MSNs (1 mg) in 4 mL absolute ethanol, by means of an ultrasonic bath, and drying a
drop of the resulting diluted suspension on a carbon-coated copper grid.
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4 Synthesis details for Chapter 9: Enzyme based pH-sensitive
cap system for MSNs.
Chemicals.
Tetraethyl orthosilicate (TEOS, Fluka, > 99 %), triethanolamine (TEA, Aldrich, 98 %), cetyl-
trimethylammonium chloride (CTAC, Fluka, 25 % in H2O), (3-mercaptopropyl)- triethoxysilane
(MPTES, Sigma Aldrich, > 80 %), 6-maleimidohexanoic acid N-hydroxysuccinimide ester (Fluka,
> 98 %), bovine carbonic anhydrase (bCA, Sigma, > 95 %), 4-(2-aminoethyl) benzenesulfonic
acid (Aldrich, 98 %), ammonium nitrate (NH4NO3, Aldrich), ammonium fluoride (NH4F, Aldrich),
hydrochloric acid (37 %), fluorescein disodium salt dihydrate (Aldrich, 90 %), and Hank’s balanced
salt solution (HBSS-buffer, Sigma Aldrich) were used as received. Ethanol (EtOH, absolute, Aldrich)
and dimethylformamide (DMF, dry, Aldrich) were used as solvent without further purification. Bi-
distilled water was obtained from a millipore system (Milli-Q Academic A10). Citric-acid phosphate
buffer (CAP-buffer, pH 5.5) was freshly prepared by carefully mixing a certain amount of disodium
hydrogen phosphate (Na2HPO4, 0.2 M in H2O) and citric acid (0.2 M in H2O) to adjust a pH value
of 5.5. Subsequently, the solution was diluted with bidistilled H2O to a total volume of 500 mL.
Synthesis of thiol-functionalized MSNs (MSN-SH).
A mixture of TEOS (1.92 g, 9.22 mol) and TEA (14.3 g, 95.6 mmol) was heated to 90◦C for 20 min at
static conditions in a polypropylene reactor. Then, a preheated (60◦C) mixture of CTAC (2.41 mL,
1.83 mmol, 25 % in H2O) and NH4F (100 mg, 0.37 mmol) in bidistilled H2O (21.7 g, 1.21 mol) was
added and the resulting reaction mixture was stirred vigorously (700 rpm) for 30 min while cooling
down to room temperature. Afterwards, TEOS (18.2 mg, 92 µmol) and MPTES (18.1 mg, 92 µmol)
were added as a 1:1 solution premixed to allow premature condensation. The final reaction mixture
was stirred over night at room temperature. After dilution with absolute ethanol (100 mL), the
nanoparticles were collected by centrifugation (19,000 rpm, 43,146 rcf, 20 min) and redispersed in
absolute ethanol. Template extraction was performed in an ethanolic solution of MSNs (100 mL)
containing NH4NO3 (2 g) which was heated at reflux conditions (90◦C oil bath) for 45 min. Followed
by a second extraction step (90 mL absolute ethanol and 10 mL hydrochloric acid (37 %)) under
reflux conditions for 45 min (the material was washed with absolute ethanol after each extraction
step and collected by centrifugation), the particles were finally redispersed in absolute ethanol and
stored as colloidal suspension.
Synthesis of sulfonamide-functionalized MSNs (MSN-phSA).
For the covalent attachment of a sulfonamide derivative to the external particle surface, a thiol-
reactive linker was synthesized. 6-maleimidohexanoic acid N-hydroxysuccinimide ester (mal-C6-
NHS, 10 mg, 33 µmol) was dissolved in DMF (500 µL, dry) and was added to an ethanolic solution
(15 mL) containing 4-(2-aminoethyl)benzene sulfonamide (6.7 mg, 33 µmol). The resulting reaction
mixture was stirred for 1 h at room temperature. Afterwards, thiol-functionalized silica nanoparticles
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(MSN-SH, 100 mg) in absolute ethanol (10 mL) were added and the mixture was stirred over night
at room temperature. Subsequently, the particles were collected by centrifugation (19,000 rpm,
41,146 rcf, 20 min), washed twice with absolute ethanol and were finally redispersed in ethanol
(15 mL) to obtain a colloidal suspension.
Cargo loading and particle capping.
MSNs (MSN-phSA, 1 mg) were immersed in an aqueous solution of fluorescein (1 mL, 1 mM)
or DAPI (500 µL, 14.3 mM) and stirred over night or for 1 h, respectively. After collection by
centrifugation (14,000 rpm, 16,837 rcf, 4 min), the loaded particles were redispersed in a HBSS
buffer solution (1 mL) containing carbonic anhydrase (1 mg) and the resulting mixture was allowed
to react for 1 h at room temperature under static conditions. The particles were thoroughly washed
with HBSS buffer (4 times), collected by centrifugation (5,000 rpm, 2,200 rcf, 4 min, 15◦C), and
finally redispersed in HBSS buffered solution.
Characterization.
DLS and zeta potential measurements were performed on a Malvern Zetasizer Nano instrument
equipped with a 4 mW He-Ne-Laser (633 nm) and an avalanche photodiode detector. DLS measure-
ments were directly recorded in diluted colloidal suspensions of the particles at a concentration of 1
mg/mL. Zeta potential measurements were performed using the add-on Zetasizer titration system
(MPT-2) based on diluted NaOH and HCl as titrants. For this purpose, 1 mg of the particles was
diluted in 10 mL bi-distilled water. Nitrogen sorption measurements were performed on a Quan-
tachrome Instrument NOVA 4000e at −196◦C. Sample outgassing was performed for 12 hours at a
vacuum of 10 mTorr at 60◦C. Pore size and pore volume were calculated by a NLDFT equilibrium
model of N2 on silica, based on the desorption branch of the isotherms. In order to remove the
contribution of the interparticle textural porosity, pore volumes were calculated only up to a pore
size of 8 nm. A BET model was applied in the range of 0.05 â€“ 0.20 p/p0 to evaluate the specific
surface area. Infrared spectra of dried sample powder were recorded on a ThermoScientific Nicolet
iN10 IR-microscope in reflexion-absorption mode with a liquid-N2 cooled MCT-A detector. Raman
spectroscopy measurements were performed on a confocal LabRAM HR UV/VIS (HORIBA Jobin
Yvon) Raman microscope (Olympus BX 41) with a SYMPHONY CCD detection system. Dried
sample powder was directly measured on a coverslip. UV/VIS measurements were performed on a
Perkin Elmer Lambda 1050 spectrophotometer equipped with a deuterium arc lamp (UV region) and
a tungsten filament (visible range). The detector was an InGaAs integrating sphere. Fluorescence
spectra were recorded on a PTI spectrofluorometer equipped with a xenon short arc lamp (UXL-
75XE USHIO) and a photomultiplier detection system (model 810/814). The measurements were
performed in HBSS buffer solution at 37◦C to simulate human body temperature. For time-based
release experiments of fluorescein a custom made container consisting of a Teflon tube, a dialysis
membrane (ROTH Visking type 8/32, MWCO 14,000 g/mol) and a fluorescence cuvette was used.
The excitation wavelength was set to λ = 495 nm for fluorescein-loaded MSNs. Emission scans
(505 - 650 nm) were performed every 5 min. All slits were adjusted to 1.0 mm, bandwidth 8 nm).
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Small-angle X-ray diffraction.
Figure 21: Small-angle X-ray diffraction pattern of MSN-SH (black) and MSN-phSA (red).
Raman spectra.
Full range of Raman spectra in Figure 22. Various additional bands (*) can be observed for the
benzene sulfonamide-functionalized particles. A sharp band at 1780 cm−1 can be assigned to the
carbonyl stretching vibration of the diacylamine group of the maleimide residue that is covalently
attached to the thiol groups of the MSN surface. The presence of phenyl groups is confirmed
by characteristic bands of aromatic C=C stretching vibrations (1600 cm−1 and 1055 cm−1) and
aromatic =C-H out-of-plane deformation vibrations (693 cm−1). The broadening of the signal at
1600 cm−1 can be assigned to the partial overlap by amide II vibration modes. The bands at 1326
and 1156 cm−1 are related to the characteristic asymmetric and symmetric stretching vibrations of
the sulfonamide group, respectively.
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Figure 22: Raman spectroscopy data of functionalized MSNs. MSN-SH (black) and MSN-phSA (red). For
clarity reasons, the curves are shifted along the y-axis by 0.1 units.
Fluorescein calibration curve.
Figure 23: Calibration curves of fluorescein at pH 7.4 (HBSS buffer, black curve) and pH 5.5 (CAP buffer,
red curve)
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5 Synthesis details for Chapter 10: Modifications for supported
lipid bilayer coated MSN
5.1 Chapter 10.1: Large pore MSN
Synthesis of unfunctionalized LP-MSN with the dual surfactant system F127 and FC-4 and
the swelling agent TiPB at 30◦C
Pluronic® F127 (0.25 g, 19.8 µmol) and FC-4 (0.70 g) were dissolved in hydrochloric acid (HCl,
30 mL, 0.02 M), followed by the addition of the swelling agent TiPB (0.34 g, 1.66 mmol). The
reaction mixture was stirred in a polypropylene reactor for 2 h at 30◦C before TEOS (1.5 g, 7.2 mmol)
was added dropwise. The resulting suspension was vigorously stirred over night at 30◦C.
Synthesis of LP-MSN-NH2/Ph via co-condensation
The applied amounts of TEOS, APTES/PTES, FC-4 and the amount of the swelling agent TiPB
(30◦C) or TMB (10◦C) for the synthesis of LP-MSN-NH2/Ph are summarized in Table 3. (3-
azidopropyl)triethoxysilane was used as synthesized according to a procedure published by Nakazawa
et al.. [321] Pluronic® F127 (0.25 g, 19.8 µmol) and fluorocarbon surfactant FC-4 were dissolved
in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by the addition of the swelling agent 1,3,5-
triisopropylbenzene (TiPB) or 1,3,5-trimethylbenzene (TMB) respectively. The reaction mixture
was stirred in a polypropylene reactor for 2 h at 10◦C/30◦C before a mixture of TEOS and organ-
otriethoxysilane (APTES/PTES ) was added dropwise. The resulting suspension was vigorously
stirred over night at 10◦C/30◦C.
Table 3: List of synthesized LP MSN
sample TEOS amount of FC-4 [g] swelling T[◦C] Hydrothermal
name [mmol] functionalization FC-4 [g] agent [g] T[◦C] treatment
T[◦C] T[◦C]/days
MLA-004 7.12 0.036 mmol APTES (0.5%) + 0.70 0.2 TMB 10 150/1; 140/2
0.036 mmol PTES (0.5%)
MLA-004 7.20 0.036 mmol APTES (0.5%) + 1.40 0.34 TiPB 30 150/2; 140/2
7.20 0.036 mmol PTES (0.5%)
Hydrothermal treatment of LP-MSN The as-synthesized particles were transferred to an au-
toclave and heated at 150◦C for 1-2 d under static conditions The mixture was centrifuged (15 min,
20500 rpm, 50228 rcf), re-suspended in hydrochloric acid (HCl, 30 mL, 0.2 M) and heated un-
der static conditions at 140◦C for two days. The resulting precipitate was centrifuged (15 min,
20500 rpm, 50228 rcf) and re-suspended in absolute ethanol.
Template removal of LP-MSN The organic template was removed via extraction. For this
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purpose, the particles were refluxed for 2 h at 75◦C in a mixture of absolute ethanol, acetone and
hydrochloric acid (HCl, 37 wt%; ethanol:acetone:HCl: 50:50:10 vol %). Afterwards, the particles
were collected by centrifugation (15 min, 20500 rpm, 50228 rcf). This procedure was repeated once.
The particles were stored in tightly sealed glass vials.
Size separation centrifugation In order to separate large agglomerates from the synthesized
nanoparticles, a size separation centrifugation was performed (15 sec, 3.000 rpm, 775 rcf). The
resulting supernatant comprising a nanoparticle yield of 50 % (relative to the synthesis yield) was
employed for all further applications. The obtained particles in ethanol were stored in tightly sealed
glass vials.
Synthesis of SLB@LP-MSNcargo and SLB@LP-MSN-AlPcS2a-cargo for drug delivery
Attachment of the red light photosensitizer AlPcS2a to LP-MSN-NH2/-Ph
2 mg of size separated LP-MSN-Ph/NH2 in EtOH were centrifuged, washed three times with 500 µL
of water and finally resuspended in 500 µL of water. After the addition of 50 µL of an AlPCS2a stock
solution (2 mg AlPcS2a in 1 mL DMSO), the mixture was stirred in the dark at room temperature
for 72 h. The obtained LP-MSN-AlPcS2a particles were washed by repeated centrifugation and
redispersion in water/DMSO (1:1 vol%) to remove excess photosensitizer. To investigate the content
of free photosensitizer in all supernatants, the absorbance at 680 nm was measured by NanoDrop
UV-Vis. Subsequently, the sample was washed three times with Millipore water to remove DMSO
from the mesopores.
Adsorption of differently sized cargos into the pores of LP-MSN-AlPcS2a An ethanolic so-
lution of LP-MSN-AlPcS2a, was washed three times by repeated centrifugation (5 min, 14.000 rpm,
16873 rcf) and redispersion in H2O. After the last centrifugation step the received pellet was dis-
persed in 500 µL cargo solution (Table 4) (in case of Alexa Fluor dextran 488 in 110 µL cargo-
solution). The mixture was stirred over night in the dark yielding the sample LP-MSN-AlPcS2a-
cargo.
Table 4: Loading of LP-MSN-AlPCS2a with differently sized cargos.
sample name amount of cargo composition of
applied NP [mg] cargo solution
MLA-014 1 calcein 500µL solution-
1mM in H2O
MLA-034/71.1 0.5 PI 500µL solution-
0.5mM in H2O
MLA-030 0.5 Alexa Fluor Dextran 10µL solution - 2 mg/mL
488 (10000Da) in PBS + 100µL H2O
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Supported DOPC/DOTAP lipid bilayer (SLB) around LP-MSN-AlPcS2a-cargo (SLB
@ LP-MSN-AlPcS2a-cargo) The amount of 0.5 mg of LP-MSN-AlPcS2a-cargo was separated by
centrifugation (4 min, 14000 rpm, 16873 rcf). The supernatant was discarded and the obtained
pellet was re-dispersed in a mixture containing 70 µL DOPC and 30 µL DOTAP (each 2.5 mg/mL
in 60:40 H2O:EtOH). The suspension was mixed extensively and sonicated for 2 s. To form the
supported lipid bilayer around the LP-MSN via a solvent exchange method, 700 µL of millipore
water was added. The resulting suspension was mixed and sonicated for 2 s, yielding SLB@LP-
MSN-AlPcS2a-cargoSLB@LP-MSN-cargo and was used without further purification.
Synthesis of polyvinylpyridine-capped large pore MSN
Attachment of a Boc protecting group to poly(2-vinyl-pyridine) α amino-, ω carboxy-
terminated poly(2-vinyl-pyridine) (PVP, Mn:10 000, 474 mg, 4.7 µmol, 1 eq) was dissolved in
10 mL anhydrous dichloromethane. Triethylamine (14.5 µL 0.10 mmol, 21.3 eq) and di-tert-butyl-
dicarbonate (Boc) anhydride (14.2 mg, 6.5 µmol, 1.4 eq) were added subsequently to the polymer
solution. The reaction mixture was stirred over night at ambient temperature. After removal of
CH2Cl2 in vacuo the crude product was dissolved in toluene. The organic phase was washed several
times with brine and dried over anhydrous MgSO4. Toluene was removed and the product was
dissolved in EtOH. The obtained HOOC PVP Boc in ethanol was used without further purification.
Attachment of HOOC-PVP-Boc to LP-MSN -NH2/-Ph (LP-MSN-PVP-Boc) 250 mg of
LP MSN NH2/Ph were collected by centrifugation (15 min, 20500 rpm, 50228 rcf) and re-dispersed
in 30 mL THF. 250 mg HOOC-PVP-Boc (2.5 mL of a 1 g/10 mL ethanolic solution, 19 µmol, 1 eq)
were added to the particle suspension. Subsequently, EDC (50 µL, 286 µmol, 15 eq) and sulfo-NHS
(6.5 mg, 30 µmol, 1.6 eq) added. The mixture was stirred at room temperature for 12 h. The
particles were collected by centrifugation (15 min, 20500 rpm, 50228 rcf) and re-dispersed in 30 mL
THF. This purification step was repeated three times. The obtained LP-MSN-PVP-Boc were stored
in ethanolic solution.
Deprotection of LP-MSN-PVP-Boc (LP-MSN-PVP-NH2) Selective removal of the N-Boc
protection group from LP-MSN-PVP-Boc was achieved by stirring 225 mg LP-MSN-PVP-Boc in
5 mL TFA and in 20 mL Millipore water for 24 h at ambient temperature. Afterwards, the LP-MSN
were collected by centrifugation (15 min, 20500 rpm, 50228 rcf) and redispersed in 30 mL EtOH :
0.01 M HCl mixture (1:1 vol%). This washing step was repeated three times.
Attachment of oxalic acid to LP-MSN-PVP-NH2 (LP-MSN-PVP-Ox) To 20 mL of an
ethanolic solution containing 120 mg LP MSN-PVP-NH2 oxalic acid (100 mg, 1.1 mmol, 47.8 eq),
EDC (40 µL, 228.8 µmol, 9.9 eq) and sulfo-NHS (5 mg, 23 µmol, 1 eq) were added. The resulting re-
action mixture was stirred for 2 h at ambient temperature. Afterwards, the mixture was centrifuged
(15 min, 20500 rpm, 50228 rcf) and washed 3 times by repeated centrifugation and redispersion in
a 1:1 vol% mixture of 0.01 M HCl and EtOH (30 mL).
PEGylation of LP-MSN-PVP-Ox with bi-functional H2N-PEG44-NH2 of the sample
LP-MSN-PVP-Ox (LP-MSN-PVP-PEG-NH2) To a suspension of 80 mg LP-MSN-PVP-Ox
in 20 mL H2O:EtOH (1:1 vol%) EDC (50 µL, 286 µmol, 12.4 eq) and sulfo-NHS (5 mg, 23 µmol,
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1 eq) were added at room temperature. The mixture was stirred for 10 min, followed by the addition
of 20 mg bi-functional H2N-PEG44-NH2 (Mw: 2000 g/mol, 448.3 µmol, 21.2 eq) and stirring 24 h
at ambient temperature. In order to remove unreacted PEG-linker, the resulting sample LP-MSN-
PVP-PEG-NH2 was washed three times with 30 mL H2O/EtOH. All washing steps were followed
by centrifugation (15 min, 20500 rpm, 50228 rcf).
Attachment of the red light photosensitizer AlPcS2a to LP-MSN-PVP-PEG-NH2 (LP-
MSN-PVP-PEG-AlPcS2a) 4 mg of LP-MSN-PVP-PEG-NH2 in ethanolic solution were cen-
trifuged and re-suspended in 1 mL DMSO in an Eppendorf tube. Subsequently, 100 µL of an
AlPCS2a stock solution (2 mg in 1 mL DMSO) was added to the LP-MSN. The reaction mixture
was stirred in the dark at room temperature for 12 h. Afterwards, the suspension was extensively
washed by centrifugation (5 min, 14000 rpm, 16873 rcf) with DMSO to remove excess photosen-
sitizer. In order to monitor the content of free photosensitizer, all supernatants were investigated
with a NanoDrop UV-Vis. Subsequently, the sample was washed three times with water to remove
DMSO from the mesopores. The colloidal suspension of sample LP-MSN-PVP-PEG-AlPcS2a was
stored in ethanolic solution and used for further experiments.
Loading of LP-MSN-PVP-NH2 / LP-MSN-PVP-PEG-AlPcS2a with calcein and cap-
ping of the pores 0.5 mg of LP-MSN-PVP-NH2 were centrifuged (5 min, 14000 rpm, 16873 rcf)
and the received pellet was redispersed in a mixture of a calcein solution (500 µL of a 1 mM so-
lution in H2O) and citrate/HCl buffer (50 µL, pH 2). The suspension was stirred for 12 h in the
dark. To seal the pores, the particles were centrifuged (5 min, 14000 rpm, 16873 rcf) and the pellet
was redispersed in SSC-buffer. The sample was extensively washed by subsequent centrifugation
(5 min, 14000 rpm, 16873 rcf), until no free calcein could be detected in the supernatant. This
was monitored by UV-Vis measurements. After the last centrifugation step, the particles were re-
dispersed in 200 µl SSC buffer (for cuvette-release test) or in 500 µL (for cell test). The sample
LP-MSN-PVP-PEG-AlPcS2a was loaded with calcein identically to the above described procedure.
Characterization
Time-based fluorescence release experiments for SLB-capped samples
In order to show the time-dependent release of different cargos out of the mesopores of LP-MSN,
fluorescence spectroscopy was carried out. For all experiments the temperature was set at 37◦C
using a Quantum Northwest TC 125 sample holder. 200 µL of the applied nanoparticle suspension
was transferred into a specially designed Teflon cap, as described in the literature. The container
was closed by a holey lid lined with a ROTH Visking Typ 8/32 dialysis membrane (MWCO =
14.000 g/mol). For release tests with SLB@LP-MSN-AlPcS2a-cargo particles, the cuvette was filled
with water. The released cargo is able to pass through the membrane while the MSN are held back.
First, release experiments were performed with nanoparticles in the closed state (with intact SLB)
for 3 h. Afterwards, the nanoparticles were transferred from the Teflon cap into an Eppendorf tube.
In case of SLB@LP-MSN-AlPcS2a-cargo the red light photosensitizer AlPcS2a was activated by laser
light (639 nm, 1 min, 5.4 W/cm2). This way, the SLB was disrupted, resulting in the release of
the cargo. Immediately, the opened nanoparticles were transferred back into the Teflon cap and a
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second release experiment was performed for 8-13 h.
Time-based fluorescence release experiments for poly(2-vinylpyridine)-capped samples
For the release experiments using LP-MSN-PVP-NH2-particles, the cuvette was filled with SSC
buffer solution (1:40, pH 7.34) for the closed-state test in neutral medium. After 3 h, the nanoparti-
cles were transferred from the Teflon cap into an Eppendorf tube. The suspension was separated by
centrifugation and re-dispersed in McIlvaine buffer (pH 5.0) leading to a protonation of the polymer
chains and the opening of the pores. Immediately, the opened nanoparticles were transferred back
into the Teflon cap and the cuvette was likewise filled with McIlvaine buffer (pH 5.0). A second re-
lease experiment was performed for 13 h. The emission maxima of calcein at 5115 nm and excitation
maxima at 495 nm were used.
5.2 Chapter 10.2: Fusion-SNARE
MSN-SHin-NH2out.The inner functionalization was obtained by adding a mixture of TEOS (83
mol%, 1.74 mL, 7.8 mmol) and MPTES (5 mol%, 123.5 µL, 0.50 mmol) slowly to TEA (14.3 g,
95.6 mmol) and heating the solution for 20 min at 90◦C under static conditions. A mixture of CTAC
(25 wt% in water, 2.41 mL, 1.83 mmol) and ammonium fluoride (NH4F, 100 mg, 2.70 mmol) in
water (21.7 g, 1.21 mol) heated to 60◦C was quickly added to solution A. After stirring the resulting
reaction mixture for 20 min at room temperature TEOS (10 mol%, 206 µL, 0.922 mmol) was added
in four equal steps every three minutes followed by 30 min of stirring at room temperature. The
outer functionalization was created by adding a mixture of TEOS (1 mol%, 20.5 µL, 92.5 µmol)
and APTES (1 mol%, 21.5 µL, 92.5 µmol) and stirring the solution overnight at room temperature.
The obtained particles were centrifuged (15 min, 19000 rpm, 43146 rcf), resuspended in EtOH and
extracted in a solution containing ammonium nitrate (NH4NO3, 2 g) in absolute ethanol (100 mL).
The second extraction step was performed in an ethanolic solution of hydrochloric acid (37 wt%,
10 mL). MSN-SHin-NH2out were obtained as a colloidal suspension in ethanol.
SLB@MSN-SHin-Atto633out labeled with Atto633-Mal In order to create SLB@MSN-Atto633
MSN-SHin-NH2out (0.5 mg, 15.4 mg/mL) were washed with EtOH by centrifugation (4 min, 14000
rpm, 16873 rcf). The particles were resuspended in absolute ethanol (500 µL) and labeled with a
Atto633-Mal stock solution (1 mg Atto in 500 µL DMF, 5 µL). The solution was stirred for 5 h
at room temperature in the dark before the NPs were washed three times with absolute ethanol
and once with water. After centrifugation (4vmin, 14000 rpm, 16873 rcf) the SLB was formed by
adding a mixture of DOPC (70 µL) and DOTAP (30 µL) (each 2.5 mg/mL in 60:40 H2O:EtOH)
subsequently followed by adding water (700 µL) and treatment in an ultrasonic bath.
Diffusion of LPK into the SLB After formation of the SLB 50 µL of LPK (50µM) were added
and the mixture was incubated on a shaker at room temperature for 48 h to form SLB@MSN-LPK.
5.3 Chapter 10.3: Fusion-H5WYG
MSN-SHin-NH2out. The Particle Synthesis and lableing is analog to the synthesis described in
Chapter 5.2.
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Synthesis of SLB@MSN-SHin-NH2out modified with lipid-PEG-H5WYG moieties. In
order to create H5WYG-modified MSN the fusion peptide was attached to a lipid via a PEG
(polyethylene glycol) linker in a first step. Therefore the employed PEG-linker possessed both NHS
and maleimide as terminal groups. The bi-functional PEG-linker was connected to the lipids by
amide formation with the NHS group and with the maleimide group to a terminal cystein group
of H5WYG. Two different combinations of lipids and PEG linkers were tested: DOPE-PEG4 and
DSPE-PEG2000. MSN-SHin-NH2out were coated with a DOPC/DOTAP-SLB.
DSPE-PEG2000-H5WYG. DSPE-PEG2000-H5WYG was synthesized by adding the fusiogenic
peptide H5WYG labeled with FITC (fluorescein isothiocyanat) (5 µL) to DSPE-PEG2000-Mal stock
solution (5 µL) solved in water (50 µL). The reaction mixture was shaked for 3 h at room temper-
ature.
DOPE-PEG4-H5WYG.DOPE-PEG4-H5WYG was obtained by adding DOPE (5 µL; 2.5 mg/mL
in 60:40 H2O: EtOH) to NHS-PEG4-Mal solved in water (50 µL) and stirring the solution for 3 h
at room temperature. Afterwards, FITC-H5WYG (5 µL) was added and stirred for 3 h at room
temperature.
Integration of DSPE-PEG2000-H5WYG/ DOPE-PEG4-H5WYG into SLB@MSN-SHin-
NH2out-Atto633. In order to diffuse the lipid-PEG-H5WYG to the SLB@MSN the complete
solution containing the SLB@MSN-SHin-NH2out-Atto633 was added to the solution with the DSPE-
PEG2000-H5WYG or DOPE-PEG4-H5WYG. The reaction mixture was treated in an ultrasonic bath
and incubated overnight at 37◦C in the dark.
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